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Pasteurella haemolytica serotypes At and A2 and Pasteurella trehalosi serotype T10 were cultured in "in-vivo" fluids (ruminant
tracheobronchial washings and serum), under defined iron-restrictive conditions, and compared for changes in cellular
composition. In analyses by SDS PAGE and Western blotting, envelope and cell contents of the bacteria showed differences in
protein content and changes in antigens recognised by convalescent antiserum. Capsule size was not influenced by growth
medium. Lipopolysaccharide was detected by PAGE in all the fluids except bovine tracheobronchial washings. However, a
Limulus amoebocyte lysate assay did detect trace amounts of endotoxin. Leukotoxin activity was only detected in broth and irohr
, restricted cultures and not in any "in vivo" fluids. Neutralisation of the toxin with homologous and heterologous convalescent
antiserum showed little cross-reactivity in the neutralisation capacity against A1 leukotoxin but heterologous antiserum was
effective with leukotoxin of the other serotypes.
Using the same fluids to monitor long term culture, all serotypes showed the capacity for extended survival and resucitation with
the addition of nutrents. All three strains survived better in ruminant than in other species' fluids. In non-ruminant fluids and
natural water viability was detected only at low temperatures. Morphological changes in both colonial and microscopic
appearances were apparent during long term survival. These results imply that this organism possesses some starvation survival
mechanisms.
Immunomagnetic beads with bound antibody specific for the three serotypes proved a useful reagent for the isolation of target
organisms from host tissues and fluids. "Differing protein profiles from those seen in bacteria grown in-vitro were demonstrated.
Western blotting unexpectedly failed to identify many antigens when recovered whole cells were compared to those grown in
laboratory culture, indicating that perhaps mechanisms were present which helped to evade an immune response.
Superoxide dismutases were detected in all three strains. Levels of enzyme activity, electrophoretic mobility on native PAGE, and
metal-active sites were shown to differ. Specific inhibition of activity by potassium cyanide identified a copper/zinc superoxide
dismutase only in serotype A2 and this was confirmed by polymerase chain reaction on DNA using specific primers for a
fragment of the sodC gene. Analysis of cytoplasmic and periplasmic fractions showed superoxide dismutase activity in A1 and
A2 to be periplasmic whereas the activity in T10 was cytoplasmic. Under iron-restricted conditions the overall activity of the
enzyme was lower and T10 showed presence of superoxide dismutase in the periplasm. In the presence of extraneous superoxide
the viability of A1 declined to zero between 15 and 30 minutes whereas that of A2 and T10 were similar to unexposed controls.
No specific serum antibody response towards superoxide dismutase was detected by any of the convalescent antisera.
No significant differences could be demonstrated between the interaction of all three serotypes with ovine or bovine macrophages
in an in vitro phagocytic assay. A2 survived best in ovine and bovine macrophages over a 2 hour period. The effect of various
opsonins on phagocytosis and subsequent bacterial survival was investigated. Differences were revealed between serotypes but
there was no significant difference within each serotype. Killing of macrophages by T10 was high (-50% killing) and
opsonisation increased the killing of macrophages. Using cell inhibitors cytochalasin D and monodansylcadaverine, in the
absence of opsonins, the mechanism of entry into the macrophage was shown to be by phagocytosis with serotype A2 in ovine
macrophages but was inconclusive with the other serotypes. Differential fixation, using formalin and methanol, of macrophages
infected with bacteria revealed that the percentage of macrophages with associated bacteria was lowest when macrophages were
incubated with Al, and higher with the other two serotypes. Macrophages infected with serotype A2 had significantly more
intracellular bacteria than those infected with the other two serotypes, where they remained predominantly surface associated.
P. haemolytica serotype A2 was more robust throughout the survival experiments than the other two serotypes both in duration
and cell morphology. This serotype also possessed a different superoxide dismutase enzyme whose activity was higher than the
other serotypes tested and was continually predominantly located in the periplasm. The capacity for A2 to survive in macrophages
was superior. This was particularly unusual since the majority of A2 bacteria were located intracellularly in comparison to the
other serotypes. Serotype A2 differs markedly with respect to pathogenic mechanisms from Al and T10 and this may explain
why it is the predominant cause of ovine pasteurellosis in the U.K.
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Bacterial diseases are a source of great economic loss to the farming industry and
respiratory infections are amongst the most important. In the U.K. during the years
1987-1994 Pasteurella haemolytica was the largest cause of bacterial respiratory
mortality in cattle, sheep and goats (Central Veterinary Laboratory Report, 1994;
Veterinary Laboratories Agency, 1995). Pasteurellosis was also identified as the major
systemic disease in sheep. The actual number of deaths is thought to be much higher
due to non-reporting or non-diagnosis. In the United States cattle losses from
respiratory disease due to pasteurellosis are estimated at upwards of one billion dollars
per annum which is greater than all other diseases combined (cited Whiteley et al.,
1992). A review by Yates (1982) cited a report in 1972 that 350,000 cattle were lost at
a cost of 76 million dollars. Hidden costs including treatment and decreased
productivity was estimated at 300 million dollars for that year. The surviving
"pulmonary cripples" may also represent a greater loss financially than do the acutely
sick animals.
Globally, pasteurellosis has been reported from many countries including South
Africa (Cameron, 1966), Ethiopia (Pegram et al., 1979), Sri Lanka (Horadagoda et al.,
1981), New Zealand (Prince et al., 1985), Mexico (Colin et al., 1987), Hungary
(Fodor et al., 1988), Germany and Syria (Younan et al., 1988) and Malaysia (Mustafa,
1995).
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Treatments for Pasteurellosis appear largely ineffective. The use of antibiotics during
outbreaks has been reported to be useful (Gilmour & Gilmour, 1989), but the potential
for resistant strains to occur is high and animals can be impaired if treatment is
delayed (Chang & Carter, 1976; Zimmerman & Hirsh, 1980). The sporadic nature of
the disease, occurrence of outbreaks and short clinical manifestation especially with
systemic disease point to prevention with vaccination as the best option of protection.
Although vaccination has been available it has done little to reduce the impact of
disease (Gilmour, 1980; Mosier et al., 1989). The problems associated with the
ineffectivness of vaccines include the variety of strains and serotypes involved. There
is also an apparent specificity of serotypes for a "host" with A2 and Al being the most
common isolate from ovine and bovine pasteurellosis cases respectively (Frank, 1989;
Gilmour & Gilmour, 1989). In the case of cattle, so called "shipping fever" is
exacerbated by the bovine respiratory disease complex in which numerous viral
potentiators are also present in infection. The specificity of the pathogen for
ruminants, and high carriage rates in apparently healthy animals, poses problems in
the reproduction of experimental pasteurellosis in conventional animals and
laboratory animal models which is problematic for successful vaccine efficacy testing
(Gilmour, 1980; Donachie, 1994). The historic methodology of vaccine development
in cattle has been criticised by Mosier et al. (1989), who says that it is difficult to
compare the success of vaccine trials between different groups when standardisation
of strains, serotypes, animals and other conditions are not met and reporting in depth
is lacking.
All factors have prompted further research into the improvement of vaccines and the
exploration of novel treatments by understanding the pathogen-host interactions.
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Most important in this is which components or situations may effectively produce
protection from disease.
1.2. The Respiratory Tract
In ruminants the mucous membrane at the nasal cavity has different types of
epithelium. The membrane within the nostril is stratified squamous epithelium and
consists of numerous serous glands. Pseudostratified columnar ciliated epithelium is
present and contains numerous mucus-secreting goblet cells. Further down, the
mucous and serous cells become mixed (Hare, 1975). Lining the nose down the
tracheobronchial tree to the terminal bronchioles is ciliated epithelium. The
respiratory bronchioles and alveolar ducts are covered with unciliated cuboidal cells.
Throughout the ciliated epithelium goblet cells are found as the major cell type and
they become sparser as the airways narrow. Underlying the tissue are the acinar
glands comprising glycoprotein and serous and mucous cells. The mucous cells are
important in that they produce mucus glycoproteins. The mucus in the
tracheobronchioles consists of about 97% water in which inorganic salts, proteins,
glycoproteins, proteoglycans and lipids are present (Richardson, 1988). Mucinous
glycoproteins in submandibular saliva have been reported to occur in at least two
different forms. MG1 is a high molecular weight protein whilst MG2 is of lower
molecular weight, though they share common properties (Pruitt et al., 1994).
Thornton (1994) also reported two glycoproteins which differ in molecular mass at
the protein core level where the two proteins are glycosylated differently and so differ
slightly. These then are the building blocks for distinct larger mucins and the relative
concentrations of the glycoproteins varies in different secretions. The bovine mucins
3
contain highly repetitive amino acid sequences dominated by threonine and serine at
45 and 50 % respectively. Proline, alanine and glycine are also present and are 75-80
% of the total amino acid content where they act to link the peptide and carbohydrate
of the glycoprotein (Kent, 1978; Schrager & Cumming, 1978). Gottschalk (1960)
reported that bovine submaxilliary mucoprotein contained equimolar amounts of
sialic acid, (22.4% expressed as N-acetylneuraminic acid) N-acetylglucosamine and
small amounts of other sugars such as fucose and galactose. In the sheep the
mucoprotein carbohydrate (42%) consists only of N-acetylneuraminic acid and N-
acetylglucosamine in the ratio 1:1. These glands are the main mucus secreting salivary
glands in ruminants. The mucins are acidic in humans due to the sialic acid properties
afforded by N-acetylneuraminic acids (in other mammals N-glycol- and O-acetylated
sialic acids are responsible) 2-3% is also due to ester sulphate residues (Kent, 1978).
Underneath the mucous cell lined epithelium lie the acinar glands made up of
lymphoid tissues. Present here are follicles of B cells and defined T cell areas adjacent
to them. The epithelium overlying the follicles is made up of M cells. These are
termed bronchus associated lymphoid tissue (BALT) in a similar manner to the term
gut associated lymphoid tissue (GALT). Due to the similarities and functions of the
two lymphoid tissues they are collectively referred to as mucosa associated lymphoid
tissue (MALT). In the lower respiratory tract the alveolar epithelium contains two
types of cells. Type I is the larger squamous cell type for gas exchange whilst type II
is a granular pneumocyte and is secretory. This area is where pulmonary surfactant is
produced to reduce surface tension in the alveoli and to prevent them from sticking
together. The lipid extracts of surfactant contain 74% phospholipid, plus cholesterol,
triglycerides and fatty acids (Scarpelli, 1986). In sheep, surfactant consists of 73-79%
phosphatidyl choline, 11-12% phosphatidyl glycerol and 8-9% other (Brogden et al.,
4
1986). The lung environment contains other cells connected mainly with defence and
includes mast cells, lymphocytes and alveolar macrophages.
1.3. Respiratory Defence Mechanisms
The lung anatomy provides both mechanical and humoral defence against invasion by
particles inhaled and more importantly from microorganisms. The ciliated epithelium
supports around 200 cilia per cell. They beat in perciliary fluid and are distinct from
the viscoelastic layer of mucus (Richardson, 1988). The co-ordinated beating of cilia
propels an overlying layer ofmucus at a rate of 1 cm/minute toward the pharynx where
it is swallowed (Kaliner, 1991). The attachment of strongly negatively charged,
multiple disaccharide to the side chains of the protein core of the mucus gives a high
degree of viscosity to the molecule. The distribution of neuraminic acid, the strongest
stable organic acid produced in the metabolism of the animal cell, is especially suited
for the functions of lubrication and protection (Gottschalk, 1960). The glycoproteins
produced by salivary and mucus-secreting cells have an affinity for micro-organisms
and agglutinate and prevent bacteria from adhering based on calcium binding
(Rundegren, 1986). These carbohydrate components are also important in that mucus
carbohydrates are similar to those on mucous cells and bacteria that adhere to mucosal
cell surface carbohydrates will also adhere to mucus and can be removed (Salyers &
Whitt, 1994).
The products produced by the serous cells are the innate humoral factors and include
lactoferrin. This molecule chelates iron and is bactericidal, bacteriostatic and growth
limiting for many species of micro-organisms. It kills and inhibits growth in its apo
(iron free) form rather than when it is saturated with iron (Kalmar & Arnold, 1988;
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Masson & Heremans, 1966). The action of lactoferrin binding to membranes has been
shown to damage the outer membrane of gram negative bacteria, in a manner similar
to EDTA, resulting in the subsequent release of LPS, increased cell permeability and
increased susceptibility to hydrophobic antibiotics (Ellison et al, 1988; Ellison et al,
1990; Visca et al, 1989). Some organisms are resistant to lactoferrin which has been
suggested to correlate with organisms which produce siderophores. There are clinical
isolates of E. coli that do not bind lactoferrin and are also not inhibited by it (Visca, et
al, 1990).
The presence of other secretory products can overcome this resistance. In humans
lysozyme exerts its anti bacterial effect by hydrolysing the peptidoglycans of the
bacterial cell wall by cleaving the (3(1-4) glycosidic bond between N-acetyl muramic
acid and N-acetylglucosamine. It also activates bacterial autolysins, aggregates
bacteria, inhibits bacterial adherence and in the case of oral streptococci inhibits acid
production (Iacocno et al, 1980; Laible & Germaine, 1985; Rundegren, 1986).
The respiratory mucous membrane is constantly exposed to oxygen on its luminal
surface. To restrict opportunities for oxygen-induced injuries, secretions include
antioxidants. These are in the form of peroxidases such as lactoperoxidase which
protect the mucosal surface from micro-organisms by catalysing the peroxidation of
halides and thiocyanate ion to generate reactive oxygen products with antibacterial
properties. The catalase and peroxidase activities of these enzymes also protect the
mucosal surface in tandem by preventing the accumulation of toxic products of
oxygen reduction (Pruitt et al., 1994; Kaliner, 1991).
The geographic distribution of BALT identified in sheep is consistent with the pattern
of localisation of gut IgA secreting B cells in the sheep respiratory tract (Scicchaitamo
et al., 1984). BALT is made up of both locally derived as well as recirculating cells
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which form the pool of thymus-derived lymphocytes which are in the region of 18% T
cells and 40% B cells. Of 90% lymphocytes present, approximately 1/3 do not possess
either a T or B cell marker. Few immunoglobulin-containing cells are present in
tissue sections but those that are contain IgA, and differentiation into IgA producing
cells can occur (Bienenstock et al, 1976). The collection of follicles in the BALT are
called Peyers patches and the M cells (microfold) which line these follicles aid in the
presentation of antigens to underlying cells of the immune system. Bacteria are passed
to the M cells by secretory (S) IgA which binds bacteria and the Fc portion binds
mucin components trapping the bacteria. They are then ingested by the M cells by
phagocytosis and passed to the underlying macrophages. The bacterial antigen is
processed and presented and MALT T cells are activated which in turn stimulate B
cells to produce IgA (Salyers & Whitt, 1994).
IgA is the dominant immunoglobulin in the upper respiratory tract in contrast to the
domination of IgG in the lower respiratory tract. Watson & Lascelles (1971) detected
IgA in most mucous secretions of sheep and cattle. Antigenic stimulus has been
shown to increase IgA secretion. Smith,1975 & Smith et al, 1975 showed IgA as the
major immunoglobulin in saliva, lung, lachrymal fluid and nasal secretion, IgG was
present as 40% of antibody in nasal secretions but dominated in colostrum, milk, bile
and serum. In another experiment he showed that nasal antibody was only detected
after intra-nasal inoculation. Wells et al. (1977) using injected, radioactively labelled
IgG found that 95% was in the serum whereas in nasal secretions the amount varied
from 5-47%. The concentrations in nasal secretions of IgG, and IgG2 were similar and
were approximately 2% of the serum concentration, which indicates a lack of transfer
from the blood to the nasal secretions in sheep. This finding was similar to that of
lachrymal secretion in calves. Scicchitano et al. (1986) reported that 81% of IgA was
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of local origin in respiratory tract secretions (RTS) and saliva. IgM, IgG 1 and IgG 2
were wholly derived from plasma. IgA and IgM can be transported by secretory
component (Sc) which does not bind IgGs. Serum IgA is of gut origin and can be
transported selectively into the RTS and saliva depending upon the availability of Sc.
In lung lymph 35% of IgA is of plasma origin and its transport is inversely
proportional to the extent of local production of IgA and this is reflected by Sc
availability.
Secretory component binds dimeric IgA and is an epithelial glycoprotein of ~ 80kDa.
Pentameric IgM is also associated with Sc but not in a covalently stabilised complex.
The binding of poly IgA and pentameric IgM into the polymer structure depends upon
the J chain. IgG producing cells constitute 3-5% of the population in normal human
intestinal mucosae but a considerably larger percentage are found in nasal and gastric
mucosae. IgD producing cells are 2-10% of glandular immunocytes in the URT.
Begin et al. (1981) showed that sheep bronchoalveolar lavage yielded an effluent that
was 60% of the affluent volume. The effluent contained an average of 9xl06 cells
which comprised >70% macrophages, 11% lymphocytes, 4% neutrophils 7%
eosinophils and 4% epithelial cells. This is similar to the situation in humans
(Reynolds & Newball, 1976).
Macrophages are the first line of phagocytic defence in the LRT. Ryter &
DeChastellier (cited, 1983) discussed the lectin like receptors on phagocyte
membranes and how the authors postulated on the binding of bacterial surface
ligands. Complement, however, is the major product that initiates phagocytic uptake.
There are two methods by which complement acts: the classical pathway is triggered
by the binding of antibody (mainly IgG) to antigen, the antibody having a receptor
on the phagocyte membrane; the alternative pathway involves direct interaction of
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bacterial surface components and complement component C3 (present in serum and
lung fluids). Phagocytes have receptors for C3b and iC3b (which is C3b with a
portion enzymatically removed). Once the macrophage has engulfed the bacterium it
is encased in a vacuole called a phagosome where the pH rapidly decreases. A
lysosome fuses with the phagosome to produce a phagolysosome (Cross & Kelley,
1990).
Toxic substances are released such as hydro lytic enzymes (lysozyme, proteases),
small cationic peptides called defensins are oxygen-independent killing mechanisms
(Lehrer, 1992). The respiratory burst which is an oxygen-dependent killing
mechanism is one of the major methods by which phagocytes kill bacteria.
The phagocytes do this by using reactive forms of oxygen and of nitrogen created by
enzymes. Respiratory burst is accompanied by increased oxygen consumption and
increased metabolism of glucose via the hexose monophosphate shunt to form C02
and a pentose sugar, in the process generating NADPH and H202. Reactive oxygen
species are produced by myeloperoxidase from lysosomes and the NADPH oxidase
system located in the membrane to produce the superoxide radicals as shown below
(Klebanoff, 1992);
Superoxide anion (0"2) - 202 + NADPH —»202~ + NADP+ + H
Singlet oxygen ('02) - CI + H202 ->OCl"+ HzO
ocr + h2o2 -> :o2 + cr + h2o
Hydroxyl Radical (OH-) - 0-2 + H202 -> OH- OH" + ' 02
Phagocytic cells which produce these oxygen radicals and other cells protect
themselves by producing the metalloenzyme superoxide dismutase (SOD). This
enzyme catalyses the conversion of the oxygen radicals into hydrogen peroxide and
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oxygen. There are three types of SOD, each with a different metal at the active site.
They are split into two families, the Fe and Mn SODs are found in prokaryotic
organisms and mainly deal with respiratory oxygen that spontaneously produces an
oxygen radical. The Cu/Zn SOD is present in eukaryotic cells and more recently has
been discovered in bacteria. Bacterial Cu/Zn SODs are still fairly rare and due to their
periplasmic location are implicated in the protection of the bacteria from the effects of
oxygen-dependent killing mechanisms in phagocytes (Hassan, 1989; Kroll et al.,
1995)
If the oxygen reacts with chlorine hypochlorous acid is produced. Alternatively
nitrogen oxides are recognised as being involved in killing mechanisms. Nitrogen in
the form of NO •, N02" , N03", produced from L-arginine is recognised in murine
macrophages but is not definitive in other species. Alveolar macrophages typically
release lower quantities of oxygen than blood monocytes and elicited or activated
macrophages respond by producing more superoxide and hydrogen peroxide than do
resident macrophages (Cross & Kelley, 1990; Salyers & Whitt, 1994; Klebanoff,
1992; Lehrer, 1992).
1.4. In-vivo Bacteria
Multiplication of some pathogens in-vivo has been shown to be slow, especially at the
beginning of infection. Mean generation times may be lengthened from 30 minutes to
20 hours in experimental infections in-vivo (Dalhoff, 1985; Smith, 1990). This has
been interpreted to mean that nutritional conditions may be limiting. Host defences,
however, also play a part in this. With many organisms the crucial nutrients or
environmental factors which determine the growth rate in-vivo are largely unknown.
10
Carbon, magnesium and phosphate limitation have been studied though more work
has focussed on iron restriction. Iron has been shown to be essential to many
organisms and adaptation of bacteria to acquire iron in-vivo has been the subject of
many reviews ( Weinberg, 1978; Bullen, 1981; Neilands, 1981; Martinez et al., 1990).
The localisation of infections has sometimes been shown to be linked to the
nutritional environment as in the case of Corynebacterium renale, a bacterium
infecting the kidney in cattle. When this organism is grown in bovine urine and urea
enriched peptone water it produces a urease and uses urea for growth (Lovell &
Harvey, 1950). Brucella abortus which causes another disease of cattle, preferentially
utilises erythritol and is localised in tissues such as the placenta, chorion and foetal
fluids. Mammalian species such as man , guinea-pigs, rats and rabbits do not have
erythritol and so Brucella do not show the tissue predilection (Smith et al, 1962).
Bacteria recovered and directly examined after in-vivo growth appear more
capsulated and have been shown to be resistant to serum killing and phagocytosis.
Common observations of fimbrial and pili variation and changes in LPS components
are thought also to be advantageous to the bacterium in-vivo (Dalhoff, 1985; Smith,
1990).
Williams (1988) discussed the adaption of bacterial cell envelope structures in vivo.
These are involved in promoting adhesion to and colonisation of host tissues by
pathogenic bacteria. They help in the acquisition of essential nutrients and in
conferring resistance both to host defence mechanisms and to antibiotics used to treat
infections. Temperature, pH, osmolarity and oxygen tension have all been identified
in influencing bacterial growth. The question of whether the bacteria are attached to a
surface and surrounded by a glycocalyx or found as a single cell in suspension are
important. Williams (1988) also pointed out the problems of modelling conditions in-
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vivo. The influence of nutrient depletion, restriction or limitation need to be
considered carefully. Whether growth is to be carried out in media or body fluids, in
batch or continous culture need to be considered also. Changes may take place in the
envelope during log phase before the onset of stationary phase due to exhaustion of a
specific nutrient. Examination of cells at different stages is important. This kind of
situation is common in those bacteria in which in-vivo like conditions are monitored.
As an example, growth of Enterococcus (Streptococcus) faecalis in serum showed
marked differences in cell surface protein antigens and lectin-receptor profiles to those
cells grown in broth (Williams, 1988). Allan & Poxton (1994) studying 12
Bacteroides strains found varying degrees of serum resistance when grown in minimal
media or heat inactivated sheep serum. Although differences in capsule and LPS were
apparent these did not correlate with the serum resistance. E. coli LPS was monitored
by Nelson et al. (1991) after growth in depleted media and serum. Increased core
production, depletion of O-polysaccharide and decreased core and increased O-
polysaccharide were all observed. Changes in capsule production were again also
apparent.
In natural environments bacterial biofilms on mucosal surfaces composed of
microcolonies embedded in glycocalyx exopolysaccharide are the preferred mode of
growth for most bacteria (Coghlan, 1996).
1.5. Bacterial Starvation and Survival
It is established that nutritional availability is an essential bacterial control mechanism
in natural environments. The slow growth rates in-vivo may be linked to survival
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mechanisms as the probability of spore formation is inversely related to growth rate.
In the non-sporulating bacteria different mechanisms of survival are used. Vibrio
fisheri uses a cell density mechanism due to the differing environments in which it
establishes niches. At high cell density they exist as a symbiont in the light organs of
squids and fish and are luminescent. When free swimming they exist at low densities
and are not luminescent. The Vibrio fisheri luxl gene encodes an enzyme responsible
for N-3-( oxohexanoyl) homoserine lactone (HSL) synthesis and the luxR gene
encodes the HSL receptor. The extracellular HSL concentration reflects the local cell
density and is thus used to regulate their bioluminescence. At >10nM HSL triggers
the lux /^-regulated transcription of the luciferase gene (Claiborne fuqua et al., 1994;
Gomer, 1994). Myxococcus xanthus aggregate together and secrete 8 amino acids (A
factor) at 10-50pM which will allow cell division and is proportional to the number of
bacteria present (Kaiser & Losick, 1993; Gomer, 1994).
When nutrients are low, however, bacteria have to adapt to starvation in order to
survive this transitory period. Sporulation in some gram-positive bacteria is well
understood and will not be reviewed here. Many gram-negative bacteria have adapted
so that they remain viable and do not divide. Kaprelyants et al. (1993) cited the
suggestion that bacteria could be reduced to three groups: i)viable, to refer to a cell
which can form colonies on agar; ii)vital, to cells which can only do so after
resuscitation and iii)non-viable to a cell which cannot do so under any tested
condition.
Studies with static cultures limited by various elements show that bacteria in the death
phase reach an extended steady state, a so called 8th phase with 2-4% of cells
remaining viable. This state being termed cryptic growth. This condition is present
when a portion of starved microbial cells die releasing products of lysis which can
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support growth of survivors (Roszak & Colwell, 1987a). Postgate & Hunter had
shown in 1962 that at least 50 dead bacteria are needed to support the growth of one
viable bacterium. When studying parameters of Aerobacter aerogenes growth, varied
responses to starvation have been observed such as reduced respiration and
metabolism, differing oxygen uptake and size reduction which serves to increase the
surface to volume ratio (Roszak & Colwell, 1987a).
Many survival studies are carried out on marine bacteria whose environment,
nutritionally, is one of change for varying lengths of time. There have been few
reports of starvation behaviour with human and animal pathogens but E. coli, Ps.
aeruginosa, Enterobacter cloacae, B. bronchiseptica are examples of some bacteria
which have been identified (Porter & Wardlaw, 1993; Moreira et al., 1994). Those
organisms which grow slowly at very low nutrient concentrations (oligotrophs) do not
revert when high nutrient levels exist. The eutrophs or copiotrophs differ in that they
grow only at higher concentrations of nutrients but may well survive low nutrient
conditions. An experiment by Koch (1959) on E. coli showed that some bacteria use
different strategies, based on oligotrophic and eutrophic behaviour,during periods of
their life cycle using sensing and switching mechanisms. He found that only two
thirds of chemostat grown cells were actively engaged in protein synthesis at any
instant. A substantial part of the population was in a "dormant" state during slow
culture (Roszak & Colwell, 1987a; Kjelleberg et al., 1987).
Kondo et al., (1994) looking at cell morphology of Vibrio cholerae under starvation
conditions, showed that they were short rods or spherical with loss of intracellular
structures. The surface can be covered in fibrous layers not seen in growing cells. A
thick electron dense area in the periplasmic space was observed and thought to be
peptidoglycan and may function to reduce nutrient loss. Undulations in the outer
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membrane probably aid in reducing cell volume. Kjelleberg & Hermansson (1984)
also monitored the cell surface characteristics of marine isolates in response to
starvation. They found that all isolates showed size reduction and most increased in
hydrophobicity, indicating a dearth of water binding groups and a low degree of
polarity.
A strain of Vibrio (SI4) was used to identify three adaptive phases to starvation. A
stringent control phase between 0-30 minutes where observations were made that
macromolecular synthesis decreased, 38 proteins were observed to increase, increases
in guanosine 3'-diphosphate 5'diphosphate and protein degradation were also shown.
The second phase (0.5-6 hours) where 15 proteins increased with the introduction of
eight new ones, shifts in fatty acid composition ofmembranes (Morita, 1993) from cis
monoenotic fatty acids to trans monoenoic acids or modification to cyclopropyl
derivatives), chemotactic responses to different solutes, degradation of reserve
material and the onset of resistance to a variety of stress conditions. The third phase
sees decline in the respiration rate, RNA, protein and peptidoglycan synthesis. The
synthesis of starvation proteins in the periplasmic space allows for a shift from low to
high affinity uptake. Synthesis of exo enzymes takes place transiently during phases 2
and 3. All these changes serve to increase the potential for efficient nutrient
acquisition by increasing membrane fluidity, utilising broad substrate specific uptake
systems whilst closing down activities not associated with nutrient acquisition and
utilisation (Kjelleberg et al., 1993; Ostling et al., 1993).
Zobell & Grant, 1942 (cited by Morita, 1993) who documented the differences in
species requirements for growth. Morita (1993) cited the longest experiment studying
survival in which 14 isolates of Ps syringae subsp syringae survived in distilled water
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for 24 years. Viable counts were ~108 /ml and dropped only 2-3 logs during this time.
They also retained their antigenic properties.
Postgate & Hunter (1962) used the term dead in relation to bacteria, in reference to
those bacteria which failed to multiply. Some, however, retained their osmotic barriers
and could be considered alive. Since then many studies have been undertaken and a
review by Kaprelyants et al. (1993) pointed out that some bacteria are not revealed by
agar plating techniques and can only be monitored by metabolic activity or vital
staining.
The viable, non-culturable state was described when discrepancies were noticed
between viable and total counts with marine and soil samples. The identification of
this state for pathogens and genetically engineered organisms has greatly increased
interest in this area (Colwell et al., 1985). Viable non-culturable cells (VBNC) do not
differ from starvation cells and have the same morphologic characteristics (Oliver,
1993). Resuscitation can be achieved in liquid or diluted agar media and may need
only a narrow nutrient concentration range (Kaprelyants et al., 1993). Oliver (1993)
lists those bacteria for which VBNC has been identified. These include Aeromonas
salmonicida, Campylobacter jejuni, Klebsiella pneumoniae, E. coli, Enterobacter
aerogenes, Legionella pneumophila, Salmonella enteritidis, shigellas and vibrios.
These are all human or animal pathogens and as Morita (1985) pointed out the study
of microbial ecology involves aspects important to public health, especially when
there is the ability of pathogens to survive in an ecosystem.
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1.6. Nutritional status of the respiratory system
Bacteria within hosts have to contend with defence mechanisms which serve to keep
the numbers low, as does competition between the different species present.
Nutritional requirements are also important and although the respiratory environment
is not as nutritionally harsh as marine or fresh waters, or soil environments, it is one
of nutritional restriction. Restriction is a term that is used to imply that nutrients are
present but whether they can be acquired or utilised by the bacteria is probably a
matter of adaptation.
The volume of respiratory secretions in normal adult humans is 10-100 ml/day. The
secretions are 95% water with 1% of carbohydrate, protein, lipid and inorganic
material (Yeager, 1971). Respiratory secretions consist of a mixture of mucus
glycoproteins (which is 10-15% of lavage proteins), glandular products and plasma
proteins. There are few reports on the constitutive amounts of respiratory secretions
which differ slightly between reports. All amounts given here are for human
secretions unless otherwise stated. Secretions contain the following: protein has been
reported to be 4.2mg/ml or 67.6pg/ml (Low et al., 1978; Kaliner, 1991). Albumin is
15% of the total protein (17.4pg/ml Low et al., 1978; 1.42 mg/ml Reynolds &
Newball, 1976), and can be used as a standard reference component to differentiate
the amount of complement activity present in washings compared with serum. Low et
al. (1978) reported carbohydrate to be at 8.28pg/ml (20-50% nondializable, Yeager,
1971), non polar lipids 77.8pg/ml, polar lipids 44.1pg/ml and lipid phosphorus
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1.09pg/ml. Protein constituents present according to Kaliner (1991) include IgG at 2-
4% of total protein, slgA - 15%, lactoferrin at 2-4%, lysozyme 15-30% (this is all
mainly nasal secretion), non secretory IgA-1%, IgM <1%. Nucleic acid is present in
secretions at a concentration of 0.017 mg/gm, probably from disrupted cells,
indicating that other cell constituents may be present at undetectable levels (Yeager,
1971). Reynolds & Newball (1976) reported the presence of IgE at 77.2 ng/ml and
a 1-antitrypsin- 0.04mg/ml while transferrin and a2 macroglobulin are present.
The mucous membranes contain many substances. The nasal membranes may contain
glutathione, ceruloplasmin, vitamin C and uric acid (5pm, but can achieve 16pm).
Serous cells contain products which include neutral endopeptidase, aminopeptidase
and glandulin. Components derived from plasma include albumin, immunoglobulins,
carboxypeptidase N, angiotensin converting enzyme, kallikrein, calcitonin gene-
related peptide, and urea. Many inflammatory mediators are present such as
histamine, TAME esterase, PGD2, bradykinin, LTC4, tryptase, major basic protein
eosinophil derived neurotoxin (Kaliner, 1991). Yeager (1971) reported that many
fractions can be resolved from mucous gland glycoproteins. The two major fractions
are a neutral fraction and an acidic fraction with sulfo- and sialoglycoproteins. He also
acknowledged work that has been carried out on the osmolality of secretions. The
pulmonary environment is hyperosmotic with respect to serum with sodium at
211mM, chloride- 157mM, potassium- 16.6mM and calcium -2.45mM. Adamson
1969 also pointed out the presence of salts but stated also that phosphates and
carbonate were synthesised in the lung and that differences did occur between alveolar
fluid, lung lymph and plasma. Low et al. (1978) analysed phospholipids from human









The fatty acid composition of lavage phosphatidylcholine, the largest constituent of
lavage phospholipid is ;
stearic (carbon chain length - 18:0) 3.9% palmitic (16:0) 72.5%
oleic (18:1) 10% palmitoleic (16:1) 5.6%
linoleic (18:2) 4.8% myristic (14:0) 3.2%
Much of the phospholipid components of lung lavage originate from pulmonary
surfactant. Harwood et al. (1975) carried out an extensive study on the surfactant of
sheep. The yield from lungs was 1.21mg/g fresh weight of which protein was present
at 14% w/w and lipid 86% w/w. Though mostly lipid, the amino acids constituents of
the protein identified were varied.
Amino acids pM/mg dry weight of surfactant.
Aspartamine - 0.09 Proline-0.21
Threonine -0.06 Glycine-0.10
Serine - 0.08 Alanine - 0.06
Glutamine -0.12 Valine - 0.08
Isoleucine -0.06 Leucine-0.12
Tyrosine - 0.03 Phenylalanine - 0.04
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Histidine - 0.02 Lysine - 0.07
Arginine - 0.09 Methionine - 0.02
1/2 Cystine - 0.05
The lipid constituents consisted of;
Lipids % w/w of total lipid
Triacylglycerol 6.5 unesterified fatty acid 9.9
Cholesterol 2.9 Phosphatidylethanolamine 1.5
Phosphatidylcholine 58.4 Phosphatidylglycerol 4.4
Phosphatidylinositol 3.5 Lysophosphatidylcholine 10.9
Sphingomyelin 2.5 Others 0.6
The carbon chain lengths of the fatty acids present exhibited considerable variation.
The information here suggests that the respiratory airway systems have an abundance
of nutrients available to any organism which has the capability to exploit the
environment.
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1.7. Characteristics of Pasteurella haemolytica and Pasteurella trehalosi
Pasteurella are gram-negative coccobacilli which are non-motile, facultatively
anaerobic, chemo-organotrophic and have both respiratory and fermentative
metabolism. D-glucose and other carbohydrates are catabolised with the production of
acid, but not gas, and nitrates are reduced to nitrites. Bipolar staining is observed,
especially from freshly prepared clinical isolates and slight pleomorphism can also be
seen (Holt et al., 1994).
In 1921 Jones first described the bacterium in a slaughterhouse survey giving it the
name Bacillus boviseptica. Newson & Cross in 1932 named the bacteria which had
been isolated from pneumonic sheep lungs as Pasteurella haemolytica. In 1959 Smith
observed two morphological types of the organism which were in 1961 designated A
and T types with the following criteria (Table 1).
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Tablel. Differentiation of A and T biotypes according to Smith (1961).
A types T types
Colony morphology small grey colonies large colonies with
brownish centres
Arabinose fermentation positive negative
Trehalose fermentation negative positive
Penicillin and tetracycline
sensitivity
sensitive less sensitive than A types




In 1968 Biberstein & Francis employed DNA-RNA hybridisation studies and found a
low degree of relationship between A and T type representative strains, but found
100% relationship between the A type strains tested. These differences continued to
be of interest and Olmos & Biberstein (1979) investigated penicillin sensitivity. They
also showed culture with brain heart infusion broth containing basic fuchsin, brilliant
green or methylene blue allowed growth of T biotypes but not A biotypes. Biberstein
& Kirkham (1979) extended antibiotic susceptibility testing, showing that inhibition
by ampicillin, cephalothin, chloramphenicol, tetracycline, erythromycin and
nitrofurantoin which was significantly higher for A biotypes. A numerical taxonomic
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study (Sneath & Stevens, 1985) with Pasteurella genus created three major clusters,
of which A and T biotypes were under the cluster designated A. However, A biotypes
were then located into phenon group 7 and T biotypes into phenon group 9 using
colonial and morphological features, growth, temperature and heat resistance, growth
on special media and inhibitors, biochemical properties and acid from carbohydrates.
Table 2 is a summary of the differences found between A and T biotypes.
Table 2. Differentiation of A and T biotypes according to Sneath & Stevens (1985).
A types T types
Production of catalase positive negative













Levan production negative positive
Growth on Hugh and
Leifson medium
positive negative
Fermentation of arabinose positive negative
Fermentation of dextrin positive negative




Fermentation of arbutin negative positive
Fermentation of mannose negative positive
Fermentation of trehalose negative positive
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The phenotypic evidence suggested that the species should be separated. In 1987 Craft
et al. investigated the ability of P. haemolytica to be agglutinated by various lectins.
Wheat germ lectin agglutinated T but not A biotypes. In 1990 Sneath & Stevens
finally separated T biotypes into a new species designated Pasteurella trehalosi.
Although now separate, identification of both species is still carried out by serotyping.
The indirect haemagglutination assay (IHA), first developed by Biberstein et al. in
1960, defmined the typing substance as a freely diffusable surface material which is
absorbed to erythrocytes. The IHA complemented serotypes with A and T biogroups
(Biberstein & Gills, 1962). The assay has been modified to a microtitre plate format
(Shreeve et al., 1972) and a rapid microtitre plate assay using glutaraldehyde fixed
cells (Fraser et al., 1983). Adlam et al. (1984) showed that the system distinguishes
strains on the basis of capsular polysaccharide and to date there are 17 distinguishable
serotypes (Younan & Fodor, 1995). Pasteurella haemolytica comprises serotypes 1, 2,
5, 6, 7, 8, 9, 11, 12, 13, 14, 16, and 17 and Pasteurella trehalosi serotypes 3, 4, 10 and
15.
Many isolates cannot be serotyped. In a study by Fraser et al. (1982) 6 and 11% (in
the years 1974-75 and 1977-81 respectively) of ovine isolates were found to be
untypable. With bovine isolates this percentage was higher at 24.2 (Quirie et al.,
1986). Most of the untypable isolates were associated with the nasopharynx of healthy
animals or the bovine female genital tract, udder and milk. Biberstein (1978) had
suggested they were unencapsulated mutants and belonged to the A biotype due to
fermentation patterns. Aarsleff et al. (1970) showed differences in the production of
salicin by untypable strains from classic A types. Techniques using double agar
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diffusion and counter current electrophoresis by Donachie in 1984 grouped untypables
into nine serogroups as opposed to Frank and Wessman (1978) who used slide
agglutination and defined only three groups. Simons et al. (1992) identified shared
antigens in untypable strains and P. haemolytica Al. In 1996 Fodor et al. used co-
agglutination to serotype strains but this technique was less sensitive than IHA and
untypable strains were not investigated. Davies & Donachie (1996) used OMP, LPS
and 16S rRNA sequencing profiles to investigate untypables. Five untypable groups
(UG 1-5) were created with the first two comprising profiles similar to those of
serotypes Al and A2. UG3 were similar to Al 1 isolates and UG 4 and 5 were part of
distinct groups which were distantly related to P. haemolytica.
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1.8. Pneumonic Pasteurellosis of Sheep
In temperate climates pneumonia in sheep and lambs is caused primarily by P.
haemolytica. A wide variety of serotypes are isolated from clinical cases. Fig 1.1
Fig 1.1. Prevalence of P. haemolytica (A)
and P. trehalosi (T) serotypes in




shows that P. haemolytica A2 is the serotype most associated with enzootic
pneumonia in lambs and sheep. The disease affects all ages of sheep which are
extensively or intensively managed. Lambs under 2 months may develop a generalised
septicaemia. Outbreaks in flocks may start suddenly. Obvious respiratory disease is
characterised by high temperatures (>40°C), tachypnoea or dyspnoea.
Other animals in the flock may display mild respiratory disease (coughing, oculo-nasal
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discharges). Morbidity and mortality from acute disease rarely exceeds 10% of the
flock. Those which recover may develop chronic lung lesions. Pneumonia outbreaks
peak in May and June of each year in the U.K.
Gilmour (1980) reported that pathologically the necropsy findings of animals with
acute pasteurellosis are pneumonia with pleurisy and pericarditis. Fibrin clots in fluid
are observed in the pleural cavity. The lungs are swollen and are found to be solid,
oedematous and haemorrhagic. In lambs which are septicaemic, petechiae are present
on the surface of the liver, spleen, kidneys and myocardium. Lymph nodes are
swollen and haemorrhagic and fatty degeneration of the liver occurs. Severe pleurisy
and pericarditis with restricted lung lesions are observed. Microscopically, alveolar
necrosis is seen, with the alveoli filled with fluid containing P. haemolytica . The
lesion is also filled with large numbers of spindle shaped cells with intensely
basophilic nuclei (so called oat cells). In animals which survive disease a collagen
capsule infiltrated with neutrophil and lymphoid leukocytes surrounds the oat cells.
Predisposition is an important factor in P. haemolytica infections. Climatic changes,
flock management, stress, parainfluenza type 3 virus infection, adenovirus,
mycoplasma, waning PI3 immunity, reovirus, RSV, pulmonary adenomatosis and
some parasitic infections have all been implicated in predisposition. However, this
still remains to be well defined epidemiologically. Atypical pneumonia (chronic
pasteurellosis) is also observed due to P. haemolytica and Mycoplasma
ovipneumoniae. M. arginini, Chlamydia psittaci and other organisms have also been
isolated but their role is thought to be concurrent. In the case of the mycoplasmas they
preceed P. haemolytica infection (Gilmour & Gilmour, 1989).
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1.9. Systemic Pasteurellosis of Sheep
Systemic disease is caused by P.trehalosi and P. haemolytica serotype A2. It affects
older sheep and lambs born earlier the same year. Although most cases are due to P.
haemolytica serotype A2, P. trehalosi pathology has been studied in relation to this
syndrome. Four serotypes of P. trehalosi exist of which T10 has been shown to be
isolated most often from systemic cases. Fig 1.2 (source MRI Pasteurella serotyping
service) shows the distribution of serotypes in the disease.
Fig 1.2 Prevalence of P. haemolytica (A)
and P. trehalosi (T) serotypes in




Outbreaks are defined usually by the finding of dead sheep. Clinical signs are usually
not observed, but include dullness, disinclination to move, pyrexia followed by
recumbency, frothy discharge at the mouth, dyspnoea, prostration and finally death
(Gilmour, 1980). The course of the disease is usually 6-8 hours. Sporadic deaths occur
for a few days with occasional losses over the next few days. The disease due to
trehalosi occurs all year round and cases peak during the autumn. This is in contrast to
that seen for P. haemolytica infections ( Fig 1.3, source MRI Pasteurella serotyping
service).
Fig 1.3. Monthly distribution of P. hand P. trehalosi
isolates
from pasteurellosis in sheep 1982-96
Pathologically the carcass is in good condition. Subcutaneous ecchymoses are found
over the neck and thorax and haemorrhages on the pleurae, epicardium and diaphragm
are seen. Lung lesions are always seen but must be distinguished from apical
consolidation due to P. haemolytica which may occur concurrently. The air passages
contain frothy fluid. The liver is frequently congested with observations of miliary
necrotic foci. Lesions also occur in the upper alimentary tract in the form of necrotic
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erosion of the posterior pharyngeal epithelium especially in the tonsillar crypts. The
necrotic lesions of pharynx and oesophagus consist of necrosis of the epithelium and
enlargement of blood vessels with no cellular reaction. Masses of gram negative
bacteria adhere to luminal surfaces of ulcers and occlude epithelial vessels and
lymphatics. Bacterial emboli are present in the terminal arterial system. The emboli
consist of bacteria surrounded by areas of necrosis enclosed by basophilic spindle
shaped cells. Large numbers of P. trehalosi can be isolated from all areas.
Characteristic lesions are found in the lungs, liver, spleen and kidneys. This has been
postulated as a systemic disease and not a true septicaemia. The bacteria spread as
emboli where they multiply inducing a fatal endotoxaemia. Predisposition to disease
is thought to involve climatic changes, transportation and the switch from poor
pastures to improved feeding which coincides with observation of peak cases. In
lambs tick borne fever has been implicated (0veras et al., 1993) as well as the mould
Stachybotrys atra in an outbreak in Hungary. The organism was present in straw used
for littering and feeding and it is thought that gastrointestinal mucosal damage and
immunosuppression were the possible mechanisms of predisposition (Hajtos et al.,
1983). Antibiotics against systemic disease do work but due to the rapid onset and
duration of the infection, vaccination is possibly the best control measure.
1.10. Bovine Pasteurellosis
The disease caused by P. haemolytica is a major problem in the large cattle producers
of the Americas and in Britain it is also the largest bacterial cause of pneumonia in
cattle. Its importance should not be underestimated (CVL, 1994; VDL, 1995). The
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terms pneumonic pasteurellosis, shipping fever, bovine respiratory disease complex,
bovine fibrinous pneumonia, transit fever, stockyard fever and exposure disease have
all been used to describe infection with Phaemolytica and P. (Yates,
1982). Studies in the U.S. correlate with data at Moredun that A1 is the predominant
serotype in cases of pneumonia in cattle (Quirie et 1986; Wilkie & Shewen, 1988).
This data is observed in Fig 1.4. (source MRI Pasteurella serotyping service).
Fig 1.4. Prevalence of P. haemolytica (A)
and P. trehalosi (T) serotypes in
pneumonic pasteurellosis in cattle 1982-96.
Other
In contrast to the findings with sheep, P. haemolytica is not readily isolated from
healthy unstressed cattle. It is carried but is such a small population of the flora that
isolation is sporadic. This may answer the question as to why respiratory disease is not
sporadic in the cattle industry but related directly to the gathering ofweaned calves,
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holding, collection and transportation over long distances to a feed yard. It is
postulated that an individual carrier stressed under these conditions and developing
respiratory disease will shed and infect other stressed animals in the small confined
spaces usually found. This management regime promotes infection throughout the
animals present (Frank, 1989).
Clinical disease is similar to that of sheep with observations of fever, depression and
nasal discharge. Anorexia is observed, and in some cases increased lacrimation,
coughing and diarrhoea (Yates, 1982). At necropsy accumulation of serofibrinous
exudate and neutrophils in the air spaces and lymphatics of the lungs is seen. Areas of
coagulation necrosis surrounded by inflammatory cells and fibrinous tissue. Acute
fibrinous or serofibrinous pleuritis is seen in gross lesion with lobular consolidation and
blood stained fibrinous exudate in the air passages. Microscopically the pathology is
characterised by acute fibrinous pneumonia with distension of lymphatic vessels with
fibrin and neutrophils, and small areas of coagulation necrosis, some of which could be
liquefaction necrosis.
A number of viruses ubiquitous to cattle are associated with bovine respiratory disease
including PI-3, IBR, RSV, BVDV. Adenoviruses along with, rhinoviruses, herpes
viruses, enteroviruses and reoviruses have also been isolated. Although these have
been shown to predispose to P. haemolytica infection P. haemolytica causes
pneumonic pasteurellosis independently of viral or other microbial agents and they are
not a prerequisite for pneumonia, which is dependent upon the dose and virulence of
P. haemolytica serotype Al.
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1.11. Virulence determinants
The bacterial envelope ("Fig 1.5)
The gram-negative envelope consists of multilayered structures giving the bacterium
shape and rigidity which protects against osmotic lysis and acts as a permeability
barrier. The inner membrane is similar to the gram-positive cytoplasmic membrane
with phosphatidyl ethanolamine as the major phospholipid.
Between the inner and outer membrane is the periplasm which contains the
peptidoglycan layer. This layer is thinner than that found in gram-positive bacteria but
still consists of linear amino sugar chains containing alternating residues of N-
acetylglucosamine and N-acetylmuramic acid covalently linked to each other via
tetrapeptides. Evidence is emerging that the periplasm contains peptidoglycan in the
form of a gel with the volume dependent on the osmolarity of the external medium
(Williams, 1988). Also in the periplasm are to be found enzymes such as the P-
lactamases, lipoproteins, porin channels, partial flagella structures and chaperone
proteins (which are responsible for the tertiary structure of proteins). The outer
membrane consists of phospholipid, lipopolysaccharide and protein structures with
the most abundant proteins being the porins which are arranged as trimers and allow
movement of solutes in and out of the cell. The other outer membrane proteins (OMP)
can act as receptors phage and adhesins. The lipopolysaccharide (LPS) is the only
lipid in the outer leaflet of the outer membrane and LPS confers on the outer
membrane the property of being a rigid structure. LPS can be defined as rough or
smooth depending on the presence or absence of O-antigen polysaccharide chain. The
exterior of the cell is often covered by the capsule. This is usually polysaccharide in
nature and can be homopolysaccharides composed of single sugar long chain
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molecules such as cellulose and glucan polymers, or heteropolysaccharides, composed
of two or more monosaccharides. Capsules are implicated in the avoidance of immune
response mechanisms and are widely used as serotyping antigens due to the diversity
of structures.In some organisms, fimbriae, sex pili and flagella protrude outwith the
envelope and are implicated in attachment, plasmid transfer and motility respectively
(Poxton, 1993).



















Investigations of the envelope proteins of P. haemolytica and P. trehalosi have
concentrated mainly on those which elicit an immune response. Durham et al. (1986)
used various extraction procedures on serotype Al to identify protein bands and
antigens by immunoblotting. The envelope proteins of all serotypes were compared
(Knights et al, 1990) and it was concluded that A and T types could be differentiated.
However, different isolates of the same strain, or within A or T types showed very
similar profiles, thus not allowing differentiation outside of a biotype separation.
A specific protein of 116 kDa has been identified for serotype Al. The gene for this
protein has been cloned and expressed in E. coli. The DNA fragment is present in
serotypes 2, 5, 6, 7, 9 and 12 but is not expressed. The 116 kDa protein is recognised
by immune serum from calves and increased levels of the transcript are observed in
iron-rich media (Gonzalez-Rayos et al., 1986, 1991, 1995; Lo et al., 1991). A
segment of DNA from Al was shown to code for three proteins of 28, 30 and 32 kDa
proteins of which 28 and 30 reacted with antiserum and were present in serotypes 1-
15 when reacted with antiserum against the recombinant protein. This showed that
high antibody responses against the 30 kDa protein correlated with resistance to
challenge (Craven et al., 1991). A 94 kDa immunogen of the outer membrane was
identified in Al ( Nelson & Frank, 1989a; 1989b). Also from Al a 44 kDa protein
was recognised by a monoclonal antibody raised against the 35kDa major OMP of P.
multocida. The protein in P. haemolytica was proposed to act as a monomer with
pore-forming ability as it was not detected as a trimer (Lubke et al., 1994). Gatewood
et al. (1994) reported the expression of unique proteins which were expressed in 46-
69 kDa region expressed when cultured in RPMI with and without FCS. These
proteins were also recognised by immune calf serum. Serotype A1 lipoproteins in the
28-30 kDa region have also been shown to be antigenic and the recognition of
recombinant lipoprotein in serum has been shown to correlate with resistance in
calves to infection (Dabo et al., 1994). Sutherland et al (1990) identified proteins
expressed in-vivo from A2 organisms grown in chamber implants in sheep. Some
differed from in-vitro grown organisms and the identification of host proteins bound
to the bacterial surface was suggested. Al was also investigated for in-vivo expressed
proteins using chamber implants in calves and bacteria from infected lungs and
compared them with in-vitro iron-deficient and iron-sufficient media grown bacteria
and bacteria grown in newborn calf serum (NCS). All conditions showed differences
with increases, decreases and induction of various proteins with the conclusion that
growth in NCS best represented the protein profile ofAl grown in-vivo (Davies et al.,
1994a).
The different growth conditions, extraction procedures and isolates used suggest that
the proteins of P. haemolytica and P. trehalosi still remain incompletely
characterised.
Iron-Regulated Proteins (IRPs)
One area which has received consistent extensive investigation is that of iron-
regulated proteins (IRPs). Schade & Caroline (1944; 1946) first discovered that a
specific iron binding protein in avian blood and egg white inhibited bacterial growth.
This was later identified as ovotransferrin (Alderton et al., 1946). Ten years later it
was discovered that animals injected with various iron compounds were more
susceptible to infection (Jackson & Burrows, 1956a). Iron is an essential requirement
for bacterial growth usually in concentrations of 0.4-4pM, but free iron is only
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available at 10~18 M in the mammalian host environment. This is due to binding
proteins with association constants of 1036 for the element and only partial saturation
of between 30-40%. Most iron is found intracellularly as ferritin, haemosiderin or
haem, the haem proteins being the most abundant iron proteins in nature. The
transferrins are glycoproteins which bind free iron in the blood while lactoferrin is
abundant in mucosal secretions, milk and neutrophils. In an infection the host
responds by making any iron even more unavailable. The amount of iron bound to
serum transferrin is reduced and this has been suggested to be due to lactoferrin from
polymorphonuclear leukocytes which are present at sites of inflammation and can
withstand the acidity of that environment. Haemoglobin is sequestered by binding to
haptoglobin in the ratio of 1:1. Free haem is bound by another acute phase protein
haemopexin and/or serum albumin.
Bacteria, however, have also created elaborate systems for acquiring the iron from
these proteins. Siderophores secreted from the bacterial cell are the best characterised
of the iron-acquisition mechanisms and are usually of two main types. Organisms
such as E. coli, Salmonella spp and Klebsiella spp produce a hydroxamate type of
siderophore while catechol siderophores are produced by organisms such as
Agrobacterium tumefaciens and Paracoccus dentrificans. Siderophores are produced
by the organisms and secreted into the surroundings where they chelate iron. This
iron is transported back to the cell where attachment to a specific receptor initiates
release of the iron into the cell.
Bacteria which do not produce siderophores can acquire iron by direct binding of host
iron containing molecules where again iron is released into the cell. There are
extensive reviews with Haemophilus and Neisseria two of the most studied bacterial
species (Otto et al, 1992; Williams & Griffiths, 1992; Wooldridge & Williams,
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1993). The importance of iron in pasteurella infection was first implicated by
Chengappa et al. (1983) who showed enhanced infection of mice when bovine
haemoglobin was mixed and administered with serotypes Al, A2, A8, and A9.
Disease in mice was also enhanced in the presence of ferric ammonium citrate
administered intravenously immediately before the intraperitoneal administration of T
biotypes (Al-Sultan & Aitken, 1984). Studies with P. haemolytica Al grown in RPMI
and substituting FBS with transferrin, lactoferrin or conalbumin at 60-70% iron
saturation increased the toxicity of the bacteria against bovine peripheral blood
leukocytes. In these series of experiments ferritin was not stimulatory whereas
haemoglobin and other haem containing molecules did increase toxicity but not to the
levels of the transferrins (Gentry et al., 1986). Reissbrodt et al. (1994) showed that
cross-feeding tests allowed growth of iron-limited P. haemolytica in the presence of
siderophores ferrioxamine B, E,G, rhizoferrin and 2,3-dihydroxybenzoic acid. Growth
was also induced when alpha- ketoacids and alpha-hydroxyacids, acting as primary
metabolites, were added indicating a more complex iron acquisition system.
P. haemolytica A2 iron-restricted cells were compared with homologous bacteria
recovered from the pleural fluid of experimental lambs. The envelope preparations
showed 70 and 100 kDa proteins induced under iron restriction which were not
apparent in cells from iron-replete media, but were present in pleural fluid cells
(Donachie & Gilmour, 1988). Using convalescent serum on Western blots two
proteins were shown to be highly immunogenic only in the pleural fluid cells (70 kDa
and 55 kDa) but the 100 kDa protein was not recognised. The 55 kDa protein which
was recognised in pleural fluid cells by Western blot but could not be induced in-vitro
nor could it be seen on PAGE gels and was discounted as being an IRP. However. P.
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haemolytica A2 from chamber implants in sheep showed decreased amounts of 70 and
100 kDa proteins (Sutherland et al., 1990).
Similar in-vivo experiments were carried out by Morck et al., (1991) who compared
P. haemolytica Al grown in iron-depleted media with those grown in rabbit chamber
implants. Proteins were induced at 71, 77 and 100 kDa in iron-restricted media and
corresponded to bands from chamber implant cells. The bands were confirmed to be
the same using Western blots probed with bovine convalescent sera and rabbit
antisera. The bands were not recognised in iron replete grown cells.
Growing serotypes 1-12 under iron restricted conditions using the chelators EDDA
and a,a, dipyridyl Deneer & Potter (1989) identified a 77 kDa protein present only in
iron restricted cells. Proteins at 71 and 100 kDa were produced at increased amounts
under iron restriction. These IRPs were detected by convalescent serum and the 71
and 77 kDa proteins were present in all serotypes and the 100 kDa protein was present
in all but serotypes 3 and 9. A 60 kDa protein in iron restricted cells was also present
in serotypes 2, 3, 4, 5, 6, 7, 8, 9 and 12 with a 95 kDa present in serotypes 3-7 and 43
kDa only in serotype T10. In a separate study an iron-regulated 35 kDa protein was
identified in P. haemolytica A2 and shown to be present primarily in the periplasm
and was proposed to be important in transportation of iron into the cell (Lainson et al.,
1991). Differentiation of iron restricted proteins in A and T biotypes was reported by
Murray et al., (1992). A biotypes had proteins at 35 and 70 kDa whilst T biotypes
expressed IRPs of 37 and 78 kDa. A monoclonal antibody against the 35 kDa IRP
reacted only with A serotypes as did a polyclonal antiserum against the 70 kDa
protein.
When P. haemolytica Al isolates from a pneumonic pasteurellosis case and nasal
passage isolate were compared for IRPs, 71 and 100 kDa were present in both but 77
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kDa protein increased only in the pneumonic isolate. This was the same when the
isolates were grown in the presence of ovo and bovine transferrin with the exception
that the 77 kDa IRP was not present in either isolate (Davies et al., 1992). The OMPs
of in-vitro and in-vivo grown cells were again compared (Davies et al., 1994a) 71, 77
and 100 kDa IRPs were identified in cells retrieved from the lungs. Western blotting
identified a 100 kDa protein in in-vitro iron restricted cells but not those from the
lungs while the opposite reaction was seen with the 71 kDa IRP. Chamber grown cells
showed no enhancement of the proteins which were seen with those isolated from the
lungs.
More detailed characterisation of these proteins began when Ogunnariwo & Schryvers
(1990) showed that cells would grow in EDDA excess with iron saturated transferrin.
This growth, however, was dependent upon the transferrin present. P. haemolytica
would not grow in the presence of porcine, human, equine or avian transferrins but
would grow in the presence of bovine transferrin. This was confirmed with a dot blot
assay and indicated a specific receptor. Using affinity purification the receptor was
found to be a 100 kDa protein and was similar to that already identified in Neisseria
and Haemophilus spp. No binding was apparent after SDS PAGE and immunoblotting
and two other proteins of 71 and 77 kDa were also isolated. This study was extended
by Yu et al. (1992) who grew P. haemolytica in the presence of bovine, ovine or
caprine but not human transferrin. This was confirmed again with the dot blot assay,
which also showed the proteins were capable of competitively binding bovine, ovine
and caprine transferrin only in the presence of unlabelled equine, porcine and human
transferrin and not ovine, bovine and caprine. The transferrin receptors of P.
haemolytica were shown to be composed of two receptor proteins designated Tbpl
and Tbp2 (Yu & Schryvers, 1994). Affinity isolation of Tbpl by immobilised bovine
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transferrin was inhibited when excess bovine transferrin or C-lobe domain of the
transferrin protein but not the N-lobe domain were added to soluble membranes. This
confirmed that C-lobe is the binding domain for Tbpl receptor. Tbp2, however, was
also not inhibited by excess N-lobe. Thus regions of the C-lobe are involved in
binding both Tbpl and 2 and /or the association is so strong that blocking of one
receptor interferes with binding of the other.
Although the proteins are still being fully characterised, the importance of IRPs were
shown when Gilmour et al. (1991) vaccinated SPF lambs with SSE extracts of cells
grown under iron restriction. Significant protection was observed in lambs given the
IRP/SSE extract upon homologous challenge with P.haemolytica A2. The sera from
immune animals which recovered recognised on Western blot proteins of 35, 70 and
100 kDa, the reported IRPs for this serotype. Protection was also reported when a P.
haemolytica Al iron regulated bacterin vaccine was used in calves. The sera from
protected animals also showed a strong response to IRPs on Western blots (Houghton
etal., 1994).
Lipopolvsaccharide.
Bacterial lipopolysaccharide (LPS) is found as part of the outer membrane. The LPS
consists of three covalently linked regions: lipid A, core oligosaccharide and O-
antigen polysaccharide. Lipid A is integrated into the membrane and consists of 6 or 7
short chain fatty acids linked to a glucosamine disaccharide backbone. Lipid A is one
of the most potent bacterial non-protein toxins known. The core extends out from this
and in enteric bacteria, this short oligosaccharide chain is linked to lipid A via an
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unusual 8 carbon sugar called 3-deoxy-D-mnnno-octulosonic acid (KDO). The O-
antigen is the outer and serodominant part of the LPS. The LPS which possesses O-
antigen side chains is termed smooth LPS whereas those without an O-antigen are
termed rough LPS. Pasteurella LPS is similar to that of other gram negative bacteria
and the endotoxin is reported to comprise 12-25% of the cell wall (dry weight), it is
the major surface antigen of formalin killed cells ( cited Confer et al., 1990) and has
received much attention both structurally and biologically. Perry & Babiuk (1984)
reported the structure of Pasteurella trehalosi T4 O- polysaccharide to be different
from other smooth type LPS by having a linear polymer composed of a repeating
disaccharide unit with the structure;
[-3(-a-D-Gal/?-(l-3)-p-D-Gal/-(l-]n
Leitch & Richards (1988) reported the structure for T3 polysaccharide O- antigen;
[3)-p-D-GlcpNAc-( 1 ->4)-a-L-Rhap-( 1 -»] n
Richards & Leitch (1989) elucidated the O-antigen of T10;
[->3)-cc-D-Gal/?-(l->3)-p-D-Gal/-(l-»]n.
As Richards pointed out although T3 and T4 both have repeating disaccharide units
their sugar residues differ and so observed immunological cross reactivity between T4
and T10 can be related to structural similarity. This is very different from the structure
of the O-polysaccharide of P.haemolytica Al which is a repeating trisaccharide;
—»4).p.D-Gal/?.(l->3).p.D.Galp.(l->3).p.D.GalpNac.(l—>■. The core oligosaccharide
also contained \-glycero-D-manno heptose, D-glycero-D-manno heptose, D-glucose, D-
galactose and KDO (Severn & Richards, 1993). Durham et al. (1988) probed various
serotypes with a monoclonal antibody against Al LPS and found it cross reacted with
serotypes 5, 6, 7, 8 and 12 but less with serotypes 4 and 14 which suggests similar O-
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antigens amongst some serotypes. A1 and A2 LPS showed differences in the core
oligosaccharides and only A1 possessed an O-side chain. When A1 isolates from
pneumonic cases and nasal isolates were compared, low molecular mass components
differed (McCluskey et al., 1994). Ali et al. (1992) went further in characterising LPS
from Pasteurella spp separating into 10 types with various attributes. The majority of
Al isolates had LPS types 1 or 2 which were smooth with apparently identical O-
antigen side chains but different core regions. A2 had types 3 and 4, type 3 being
rough with core similar to type 1 and type 4 rough LPS which was different from the
rest. Three ovine Al isolates had type 3 LPS and this was thought to be involved in
host specificity vs LPS type. Lacroix et al. (1993) identified serotypes A2 and A8 as
having rough LPS with other serotypes having smooth types. NMR showed the O-
polysaccharide of serotypes Al, 6 and 9 to be identical. Western blots confirmed this
with cross reactions between an Al specific monoclonal antibody and the core
oligosaccharide of several A biotypes. Al, 6, 8, 9, and 12 cores were similar but
distinct from T biotypes. PAGE profiles of Al, T3 and A5 were shown to be smooth
with typical O chain heterogeneity. T3 O chain and core fractions revealed the
presence of rhamnose only which was also present in the core of A2. Sialic acid was
identified in the O chain of Al and A5 (Utley et al., 1992). McCluskey et al. (1994)
used the LPS types of Ali and showed Al isolates from pneumonic and healthy cattle
to be smooth while A2 isolates were rough types 3 and 5. The core regions of LPS
types 1 and 3 found in Al and A2 are identical.
In 1981 Rimsay et al. used a sequential extraction procedure to separate endotoxic
fractions. Smooth LPS precipitate was the most endotoxic and pyrogenic in chick
lethality tests and limulus amoebocyte lysate (LAL) assays. The rough LPS was equal
in toxicity and Shwartzman reaction to standard Salmonella and Serratia strains. The
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supernatant from smooth LPS was least endotoxic but equally pyrogenic with
standard endotoxin preparations. The rough polysaccharide caused no pyrogenicity
and had low reactions with other tests.
P. haemolytica A1 endotoxin was infused into sheep using the soluble supernatant
fraction of Rimsay et al. (1981). The prostaglandin family have been shown to
mediate some of the detrimental effects of endotoxin. PGF2a TxB2 PGI2 and serotonin
were all measured in plasma (Emau et al, 1984). Investigating the differences
between rough and smooth LPS in calves Emau et al. (1987) identified a rise in
cAMP which was prolonged for smooth LPS. cGMP rose slowly and these
observations coincided with the presence of several free fatty acids. The increase
appears to result from adenylate cyclase stimulation either by endotoxin or indirectly.
Preliminary characterisation of lung surfactant, which binds Al LPS and shows
bactericidal activity towards whole cells, pointed to a proteinaceous component being
responsible for the effects. The LPS was investigated in-vivo when P. haemolytica Al
ovine and bovine strains were given to calves along with 500pg of LPS associated
protein (LAP) and 500pg of LPS (Brogden et al., 1986; 1992 and 1995). The effects
were varing degrees of bronchopneumonia. Severity of lesions was less with LAP,
which was less than LPS, which was less than whole bacteria. LAP resulted in the
largest number of macrophages and lowest number of neutrophils in the lungs which
was similar with LPS but the opposite to whole bacteria, however, lesions were more
severe. Slocombe et al. (1989) investigated P. haemolytica Al deposited in the lungs
of calves with or without E. coli endotoxin. They showed that E. coli endotoxin
alone failed to cause any physical derangement. P.haemolytica alone however caused
severe hypoxaemia, with increased alveolar arterial oxygen difference and total
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pulmonary resistance. The animals became hypercarbic with decreased functional
residual capacity and developed systemic hypotension without change in arterial
pressure. Necropsy showed extensive multifocal areas of necrohaemorrhagic and
purulent pneumonia. When E. coli was added in combination none of the effects of P.
haemolytica were changed. Using immunohistochemistry A1 LPS deposition was
located in the cytoplasm of neutrophils of the alveolus and alveolar wall, alveolar
macrophages, endothelial cells, pulmonary vascular macrophages and epithelial
surfaces of calves (Whiteley et al., 1990).
Looking at the direct effect on PMNs Confer & Simons (1986) used phenol water
extracted LPS from Al. Trypan blue exclusion showed the LPS was not toxic for the
PMNs. Phagocytosis and NBT reduction by PMNs was enhanced in the presence of
LPS and a 2.5-3 fold increase in migration of cells was observed in a whole peripheral
blood leukocyte preparation. Lipopolysaccharide binding protein (LBP), a liver
derived acute phase protein, was shown to complex LPS and bind the CD 14 receptor
of monocytes and neutrophils (Horadagoda et al., 1995). Cytokine release from
bovine alveolar macrophages was monitored after incubation with Al LPS by Yoo et
al. (1995a). Interleukin 1 (IL-1) was released and tumor necrosis factor (TNFa)
peaked at 4 hours and then decreased steadily. Specific mRNA was first detected at
30 minutes and were present at maximum levels at 1-2 hours.
The vast majority of LPS/ cell interaction work has been carried out using bovine
pulmonary arterial endothelial cells (BPAEC). Breider et al. (1991) added live P.
haemolytica to monolayers and recorded Cr release and cytotoxic changes by
microscopy. Both live and killed P. haemolytica produced extensive damage which
was prevented by the addition of polymyxin B and so implicated LPS as the major
factor in the damage. Al LPS prepared by the hot phenol water method was incubated
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with thymidine labelled BPAEC. The release of radioactivity was time and dose
dependent. Neutrophil adherence to BPAEC was increased after exposure of either
cell type to LPS. Neutrophil adherence to endothelial cells was inhibited by
polymyxin B, actinomycin D and cyclohexamide, the latter two compounds inhibit
expression of ELAM-1 one of the adhesion molecules found on endothelial cells and
points to an association between LPS and ELAM-1 (Paulsen et al., 1990). The
addition of Al LPS caused expression of tissue factor and an additive effect was
observed when recombinant IL-1 (3 was also added. IL-1 receptor antagonist reduced
expression but did not inhibit it. It was postulated that the secretion of IL-1 in-vivo by
macrophages may be detrimental by enhancing the effect of LPS on endothelial cells
(Breider & Yang, 1994).
Capsular Polysaccharide.
The bacterial capsule, sometimes referred to as glycocalyx, is thought to be anchored
to the outer membrane non-covalently but this is poorly understood. Capsules have
been shown to function as shields in the absence of anti-capsular antibodies from the
bactericidal action of complement and phagocytes. The structural similarities between
the same types of capsular polysaccharide and host tissue materials also serve to
protect the bacterium from the immune system (Williams, 1988). The structure of
some of P. haemolytica and P. trehalosi capsules have been elucidated by Adlam et
al. (1986):
Al- ->3)"P-N- acetylaminomannuronic -(l-»4)-P-N- acetylmannosamine-(l—»
the position 4 of the uronic acid is O-acetylated.
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A2- —»2)-a-D-N acetylneuraminc acid - (8—»






T3 - -^4)-a-D-gal p -(l->l)-L-glycerol-(3—>
( T3, repeating unit, Richards & Leitch, 1990)
The capsule of A1 is similar to enterobacterial common antigen. The polymer was
purified and was immunogenic in sheep but not in rabbits. Passive haemagglutination
showed it to be specific for A1 (Adlam et al., 1984). A2 capsule is identical to the
capsular polysaccharide of Neisseria meningitidis group B, E. coli K1 and Moraxella
nonliquefaciens in that they contain colominic acid. These are well known as poor
immunogens and were implicated in the lack of immunity observed in producing
effective bacterin vaccines against A2 strains (Adlam et al., 1987). The capsule of A7
has been shown to be similar to N. meningitidis group L and II. influenzae type f. The
importance of the similarity between pasteurella capsules and capsules of other
species was shown when monoclonal antibodies against N. meningitidis group B
capsule reacted strongly in IHA test and were protective against a septicaemic A2
infection in mice showing the importance in protection of anti-capsule antibodies
(Mustafa, 1995). Adlam et al. (1985) investigating the capsule of T4 showed it to be
a glycerol, galactose phosphate teichoic acid, unusual for a gram-negative. T15 is
similar in structure to T4 but the phosphate was linked to C6 of the galactose moeity
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rather than C4. This slight difference in structure was enough to make the two
serotypes non-cross reacting. T15 is identical to N. meningitidis group H and E. coli
K62 and K2 ( Adlam et al., 1985; Richards & Leitch, 1990). Using ELISAs, low
level cross reactivity between A2 and antisera against heterologous serotypes and
strong cross reactivity between Al and A6 serotypes was abolished by absorption and
suggested shared capsular antigens (Fodor & Donachie, 1988).
During culture the capsule of Al was observed in early log phase and was greatest in
size between 2 and 6 hours and showed diminished presence with time (Corstvet et
al., 1982). The observation that CPS (capsular polysaccharide) production occurs in
early log phase by Gatewood et al. (1994) agrees with this but only when the bacteria
were grown in RPMI with FCS (Foetal Calf Serum) and FeS04 compared with RPMI
alone, RPMI + FCS or BHI. Gilmour et al. (1985) studying the surface of P.
haemolytica and P. trehalosi with ferritin labelling and maneval stain showed thinner
capsular material produced with T biotypes. Using EM, irregular halos were observed
with polycationic ferritin, suggesting an incomplete layer but in contrast to Corstvet et
al. (1982) there was no degradation of CPS in 18 hour cultures observed under SEM.
Gentry et al. (1987) showed that 128 serial passages of Al did not diminish the
presence of capsule.
The capsule polysaccharide of P. haemolytica Al are important structures in virulence
and immunity. When P. haemolytica Al purified capsular polysaccharide was
incubated with bovine neutrophils it dramatically reduced their ability to ingest and
kill whole bacteria even though they were still able to undergo a respiratory burst.
This effect was the same when the bacteria were opsonised so that capsule was not
competing for opsonising antibodies. The same experiment was carried out with
bovine alveolar macrophages and showed reduced phagocytosis even when the
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number of macrophages was greater than that of the bacteria (Czuprynski et al., 1989;
1991a). Czuprynski (1991b) reported that capsular polysaccharide (CPS) induced the
release of IL-1 from bovine blood monocytes but not from alveolar macrophages. The
addition of polymyxin B, abrogated this effect, probably as a result of binding LPS
(estimated at 5pg per pg CPS). TNF (Tumor Necrosis Factor) activity was
undetectable using blood monocytes even after 18 hours incubation. The capsule of
serotype Al was located using immunohistochemistry after inoculation of whole
bacteria intratracheally in calves. Capsule was identified in the alveolus and alveolar
macrophages but not cells of the alveolar wall (Whiteley et al., 1990). Chamber
implants in sheep containing serotype A2 showed no difference in the capsule size of
bacteria collected compared to A2 cultured in laboratory media, but did show a high
degree of aggregation (Sutherland et al., 1990). Brogden et al. (1989) deposited Al
capsule into lungs and showed that, in itself, capsule was not a major factor in lung
damage and lesions were minimal. When capsule was incubated with lung surfactant
the density of the surfactant increased but did not alter the surface tension. A
hypothesis was put forward that P. haemolytica may attach to a lectin in the surfactant
which itself binds alveolar epithelial cells or that the capsule binds surfactant in order
that the bacteria masks itself.
Resistance to P. haemolytica infection has been shown to correlate with high antibody
response to capsule (Confer et al., 1989). Townsend et al. (1987) also found that
systemic and humoral response to vaccination was inversely related to the magnitude
of antibody against capsule found in secretions before vaccination. Using ELISA an
adjuvant-treated culture supernatant from log phase growth induced a large titre of
capsule specific IgG antibodies in lung lavage. Inoculation of calves and mature cows
with purified capsule of serotype Al showed differing responses (Tigges et al., 1993).
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In calves specific IgM, IgGl and IgG2 were present whereas in cows only IgM and
IgGl were detected. An oil adjuvant mixture produced the highest levels of IgGl and
IgG2 whereas capsule mixed with aluminium hydroxide stimulated the highest IgM
specific response. A second inoculation did not increase titres in cows or calves.
McVey et al. (1990) followed serum antibody against capsule from calves in transit.
The antibody titres rose by day 15 and stayed at high levels until day 56. Those
animals which did not contract bovine respiratory disease complex had higher initial
antibody titres. IgGl anticapsular antibody increased from days 8-29 as evidenced by
a decrease in serotype A2 absorption inhibition from 60% on day 8 to 15% on day 29.
IgA, IgG2 and IgM were more serotype specific. Both in-vitro complement dependent
bacteriolysis and C3 deposition on the surface of the bacteria increased in a serotype-
specific fashion. It appears a humoral response to carbohydrate antigens of capsule
increase specifically during the course of a response.
Leukotoxin.
The leukotoxin of P. haemolytica is an exotoxin specific for ruminant leukocytes
which exerts a variety of detrimental effects on these cells and is probably the best
characterised virulence factor of the organism. Since P. haemolytica culture
supernatants were found to be toxic for bovine bronchoalveolar macrophages
(Benson et al., 1978; Markham & Wilkie, 1980a) much work has been carried out.
Shewen et al. (1982) demonstrated P. haemolytica Al culture supernatant caused
damage to bovine leukocytes. Sutherland et al., (1983) showed the same effect for
ovine bronchoalveolar macrophages and in 1985 for peripheral blood leukocytes and
gastric lymph cells. Shewen & Wilkie, (1985) showed that the cytotoxicity was
present in actively growing cells and was typical of an exotoxin.
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The use of the bovine lymphoma cell line (BL-3 ) has advanced the knowledge of the
mechanism by which leukotoxin acts. In these cells rapid release of intracellular
potassium and uptake of calcium are found. The release of potassium is accompanied
by cell swelling, aggregation and adherence to the reaction vessel. Chromium51 release
increased after 20 minutes and cells showed variable membrane defects. After 1 hour
cells were shrunken and 100% of cell LDH was released. The addition of
carbohydrate molecules indicated that the pore size in the membrane is 0.9nm
(Clinkenbeard et al., 1989 a, b). Cytotoxicity for BL-3 cells was influenced by
calcium, as introduction of verampil, a calcium channel blocker, prevented death
(Gerbig et al., 1989). Styrt et al. (1990) looking at the effects of leukotoxin on bovine
granulocytes found the release of LDH at 94% was higher than the lysosomal enzyme
arylsulphatase (38%). It appears leukotoxin may selectively disrupt the membrane.
Chang et al. (1987) identified leukotoxin as a 105kDa polypeptide which
could be neutralised by antibodies. Bovine platelets also release LDH in the presence
of P. haemolytica Al culture supernatant (Clinkenbeard & Upton, 1991). Majury &
Shewen (1991a & 1991b) reported that leukotoxin caused inhibition of mitogen and
antigen proliferative lymphocyte responses. When B and T cell populations were
compared, the B enriched populations were more susceptible to the effects of
leukotoxin. The effects on bovine polymorphonuclear leukocytes by leukotoxin were
measured in terms of viability and chemiluminescence. Inhibition of the latter was
observed with the non selective [3-adrenoreceptor antagonists propanolol and
alprenolol but not oxprenol. Cell receptors were not thought to be blocked or
membrane stabilising carried out by the antagonists (Henricks et al., 1990).
Conlon et al. (1990) using bovine bronchoalveolar macrophages, induced oxygen
radical generation with opsonised zymosan but Al culture supernatant delayed the
time taken to reach maximum oxygen radical production although total production
was increased and the presence of supernatant diminished the effects of
cycloxygenase inhibitors. Proliferation of peripheral blood mononuclear cells was
inhibited by leukotoxin, the effect being lifted in the presence of anti-leukotoxin
monoclonal antibody (Czuprynski & Ortiz-Carranza, 1992). Rabbit anti-leukotoxin
serum also prevented the release of histamine from bovine pulmonary mast cells
which was induced in the presence of leukotoxin (Adusu et al., 1994).
In immunohistochemical studies Whiteley et al. (1990) showed leukotoxin associated
with the membranes of degenerating inflammatory cells located in the alveolus. In
1991 Whiteley et al. also showed the cytotoxic changes in macrophages but not
parenchymal cells of the lungs. Serotype Al supernatant incubated with bovine
tracheal smooth muscle produced contractions in the muscle similar to those induced
by the agonists tested but was not dose related and had decreased responsiveness not
seen with the agonists. Antagonists abolished or diminished the supernatant effects on
the muscle. The supernatant did not act as in a drug receptor manner and showed an
all or none response (Belanger et al., 1993). Leukotoxin directly effected the
expression of MHC class II molecules on bovine macrophages and proliferation in a
mixed lymphocyte assay. Marked downregulation was observed and when cells were
activated with interferon (IFNy), leukotoxin had little or no effect. This reaction,
however, is limited only to cells from naive animals (Hughes et al., 1994).
Henricks et al. (1992) investigated the effect of leukotoxin on PMN's with respect to
the 5-lipooxygenase products arachidonic acid, leukotriene B4 and 5-
hydroxyeicosatetraenoic acid which are known to recruit PMN's, exacerbate
inflammatory events and microvascular injury. When cells were exposed to
arachidonic acid 5-, 12- and 15-hydroxyeicosatraenoic acids and LTB4 were released.
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Leukotoxin-dose-dependently enhanced release of 5-HETE and LTB4 in arachidonic
acid stimulated cells or in the absence of exogenous arachidonic acid.
Czuprynski & Noel (1990) and Czuprynski et al. (1991a) monitored the effects of
leukotoxin on bovine neutrophils. Cells were monitored for oxidative activity using
chemiluminescence stimulated by opsonised zymosan. Leukotoxin was shown to
diminish the chemiluminescence response rapidly but only in cells which were
stimulated. Sucrose was shown to neither prevent nor reverse the effect which is the
opposite to that shown with BL-3 cells. High concentrations of leukotoxin were
inhibitory or lethal to bovine neutrophils. Exposure to leukotoxin in this study
resulted in significant neutrophil activation and stimulation of an oxidative burst
which is in contrast to the previous study. A possible explanation for this is the use of
purified leukotoxin in this study in contrast to the crude leukotoxin preparation of the
previous experiment which may have contained an inhibitory factor. Dilute leukotoxin
stimulated cytoskeletal alterations indicated by significant shape change. Preferential
release of secondary granule constituents (lactoferrin) took place and primary granule
release was measured only at low dilutions of leukotoxin and resulted in significant
release of cytosolic constituents. Bovine neutrophils were labelled with the
fluorescent calcium probe fluo-3 by Ortiz-Carranza & Czuprinski (1992). Incubation
with leukotoxin produced an increase in fluorescence of the neutrophils indicating an
influx of calcium and a vigorous chemiluminescence response (the latter dependent
on extracellular calcium). These effects were blocked effectively with the calcium
channel blockers verapamil and propanolol along with a neutralising, anti-leukotoxin
monoclonal antibody.
Using bovine neutrophils, exposure to leukotoxin produced increased synthesis of
LTB4 but not thromboxane B2. An anti-leukotoxin antibody neutralised neutrophil
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lysis and LTB4 synthesis. The effects were calcium dependent. The leukotoxin
induced LTB4 synthesis from endogenous arachidonic acid required leukotoxin
induced plasma membrane damage, whereas exogenous arachidonic acid occurs in
the absence of plasma membrane damage (Clinkenbeard et al., 1994).
Breider et al. (1990) using bovine pulmonary arterial endothelial cells, showed that
leukotoxin had little direct effect on the cells. The effects have been put down to LPS
although when an anti-leukotoxin monoclonal antibody was incorporated no effect
was observed. Using the same cell type Maheshweran et al. (1993) confirmed
minimal injury to the endothelial cells by leukotoxin. In the presence of neutrophils,
however, the endothelial cells were killed. The proposed mechanism of this damage is
the release of 02~ (superoxide), H202 (hydrogen peroxide) and lysosomal proteases.
Hydrogen peroxide enters the endothelial cells and produces a reactive hydroxyl
radical (HO—) which initiates lipid peroxidation and cell membrane damage. Catalase
offers a low degree of protection against this as it can only scavenge extracellular
hydrogen peroxide. l,3-dimethyl-2 thiourea (DMTU) which can scavenge
intracellular peroxide caused a high degree of protection. The elastase inhibitor
pentoxifylline, N-methoxy-succinyl-ala-ala-pro-val-chloromethyl ketone (CMK) also
gave protection indicating that elastase from degranulated lysosomal of
polymorphonuclear leukocytes also contributes to damage. DMTU and CMK together
had an additive protective effect.
Leukotoxin mutants have been produced using non-molecular techniques
(Chidambaram et al., 1995; Murphy et al., 1995) and used to study haemolysis with
the mutant showing no greater release of haemoglobin than the uninoculated media
concentrate. Also, lack of toxic activity to BL-3 cells and polymorphonuclear
leukocytes has been shown. In animals reduced virulence in both goats and cattle were
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observed along with a reduction in lung lesions. Stevens & Czuprynski (1996) has
observed the induction of apoptosis in bovine mononuclear cells and granulocytes in-
vitro by leukotoxin.
The genes for leukotoxin have been cloned, sequenced and expressed in E. coli K12.
The gene shows extensive homology ranging from 50-90% with the a-haemolysin of
E. coli (Lo et al., 1985; 1987; Strathdee & Lo, 1987). Four open reading frames have
been identified and designated Ikt C,A,B and D in order of their genetic organisation.
Ikt A codes for the structural polypeptide of the toxin and is activated by the
intracellular component encoded by 167 amino acid IktC protein (Strathdee & Lo,
1989). From the deduced sequence leukotoxin consists of 953 amino acids with a
molecular size of 101.9 kDa. Non denaturing conditions for the Ikt A protein and
activated toxin are identical. Lkt A is slightly negatively charged which suggested that
activation involved the addition of small charged moieties. Strathdee & Lo (1987)
found IktA contained conserved hydrophobic regions as well as a set of tandemly
repeated domains (6 consisting of L-X-GGXG(N/D)DX) also found in the HlyA gene
of a-haemolysin. In hlyA this has been found to be important in calcium binding of oc-
haemolysin to target cells (Ludwig et al., 1988). Due to these tandemly repeated
domains identified in the E.coli haemolysin and and P. haemolytica leukotoxin Welch
and Lo designated these toxins RTX toxins (Repeats in ToXin). More toxins have
been identified and the list to date comprises Actinobacillus actinomycetemcomitans
leukotoxin, A. pleuropneumoniae (3 different haemolysins or leukotoxins), A. suis
haemolysin, Proteus vulgaris haemolysin, Morganella morganii haemolysin,
Enterohaemorrhagic E. coli haemolysin, Bordetella pertussis adenylate cyclase toxin
(cited Czuprynski & Welch, 1995). Not all members of the family have haemolytic
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activity but are potent cytotoxins for various types of nucleated cells. Some, as in the
case of Pasteurella haemolytica are very specific (ruminants only) and some in the
case of E. coli which lyses erythrocytes from a wide range of species (Welch, 1991).
The Ikt B and D genes have been shown to be responsible for the secretion of the toxin
from the bacterial cell. This is a type 1 pathway secretion and is signal sequence
independent (Salmond & Reeves, 1993). In the hlyB gene the c terminal domain
contains the ABC (ATP binding cassette) transporter mechanism. Many bacteria
possess this type of transporter as do the RTX toxins (Fath & Kolter, 1993). The Ikt D
gene produces a product which facilitates the movement of leukotoxin out of the
bacterial cell (Koronakis et al., 1992). Complementation studies show that in the
absence of hly C or Ikt C, hly A or Ikt A were not toxic. When hly C was added to Ikt A
the product was toxic. Ikt C and hly A were, however, neither haemolytic nor
cytotoxic (Forestier & Welch, 1990). E. coli hly B and D genes will efficiently secrete
hly A or Ikt A in an E. coli background but not vice versa (cited Welch, 1991). The
genes point to activation being similar but requirements different. The transport
products have evolved to accommodate differences in host cells without
compromising recognition of the A protein export signal.
Leukotoxin has been implicated in protection of animals with the presence of
neutralising antibodies in experimentally infected sheep (Sutherland, 1989) and
naturally-occurring neutralising activity in serum of cattle (Frank, 1989). Crude
leukotoxin vaccines in sheep and cattle have conferred protection (Shewen & Wilkie,
1988; Sutherland et al., 1989). The economically viable recombinant leukotoxin has
however been shown to be ineffective alone in calves and sheep (Conlon et al., 1991;




Neuraminidase is an enzyme responsible for the removal of sialic acid from
glycoproteins. Scharmann et al. (1970) first reported that 3 out of 5 strains of P.
haemolytica tested produced neuraminidase, Frank & Tabatabai (1981) described the
production of neuraminidase by bovine and ovine isolates of P. haemolytica. Type
strains of serotypes 2, 3, 4, 10, and 11 showed no measurable activity. No enzyme
activity was found in ovine field isolates except serotype A2, but only at low levels.
Serotypes 1, 6, and 7 were intermediate in activity with serotypes 5, 9 and 8 showing
the highest levels. There was no significance between the origin of the isolate and the
production of the enzyme.
Tabatabai & Frank (1981) also assayed for activity in P. haemolytica Al. Fetuin acted
as the best substrate and calcium was not necessary for catalysis but activity was
increased by the presence of magnesium and manganese. Normal serum did not
inhibit but increased activity and is thought to be due to proteolysis of the enzyme by
serum proteases or reversible aggregation. Rabbit antiserum was able to inhibit
activity indicating it could be part of an antigenic complex. Straus et al. (1993)
investigated all 16 serotypes. The enzyme in P. haemolytica Al was found to be
extracellular and produced at maximum levels during stationary phase. The molecular
weight was between 150-170 kDa which would make it the largest neuraminidase
identified so far. Al produced the most active enzyme by the measurement of released
sialic acid from all the substrates tested. All did not produce a detectable enzyme.
Rabbit antiserum against Al neutralised activity but was not as effective against
serotypes 10 and 15. This was unusual as Al, A6, A12, T10 and T15 all share an
enzyme of the same size where the rest of the serotypes produce a larger enzyme.
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In 1994 Straus & Purdy detected specific antibodies against neuraminidase 14 days
after a transthoracic challenge of P. haemolytica A1 in goats. The antibody levels
were significantly higher than those in the control animals. This indicates that the
enzyme is produced in-vivo and antibody production against the enzyme may be
important in protection.
Sialoglvcoprotease.
Another important enzyme produced by P. haemolytica was first described by
Otulakowski et al. (1983). A P. haemolytica A1 leukotoxin preparation was shown to
release thymidine labelled products from erythrocyte ghosts. The activity was shown
to be present in serotypes 1, 2, 3, 5, 6, 7, 8, 9 and 12 but not 4, 10 and 11. The
fragments released were a sialic acid containing fragment and sialic acid. The enzyme
has a broad pH range around pH7 and was not inhibited by trypsin, chymotrypsin,
thermolysin, thio and serine proteases or neuraminidase, but was inhibited by high
concentration and prolonged incubation with O-phenanthroline. It hydrolysed
glycophorin more than casein by a factor of four. The enzyme was described as a
neutral protease possibly metal dependent and specific for sialoglycoproteins.
Abdullah et al. (1992) purified the enzyme and confirmed its specificity for
glycophorin A, an O-glycosylated erythrocyte membrane glycoprotein. The activity of
the enzyme was abolished when the sialic acid residues were removed from the
substrate with neuraminidase. The site of hydrolysis of the enzyme does not
correspond to the specificity of known bacterial proteases. The molecular mass of the
protein is 35kDa.
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Investigating a role in-vivo for the protease, Steininger et al., 1992 showed that it
removed the ligand for P-selectin from the surface of myeloid cells, HL-60 cells and
neutrophils. The protein removed was -115 kDa which is close to the apparent
molecular weight of P-selectin ligand. The effect was inhibited only by the addition of
bovine antiserum, EDTA and an alternative substrate. E-selectin binding was not
affected. The levels of CD44 and CD45 on the cells remained constant whereas CD43
production was markedly diminished. Sutherland et al. (1992) carried on this work by
showing that five of the seven epitopes identified by CD34 antibodies were cleaved
by the protease. CD34 is important as its expression is restricted to 1-3% of normal
bone marrow leukocytes but these cells contain precursors of all blood lineages. Using
immunomagnetic beads coated with anti-CD34 antibody these cells could be released
from the beads using the protease. This technique produced a purity of CD34
expressing cells of 90-95% with no loss of viability. This was also achieved by Marsh
et al. (1992) who used the technique to isolate CD34 positive cells from
unffactionated normal human bone marrow mononuclear cells.
The importance of the protease in the human field has recently been exploited. Hu et
al. (1994) cleaved epitectin from H.EP 2 cells (human laryngeal carcinoma cells) and
other mucin type sialoglycoproteins implicated in malignancy. This selective
degradation of mucin glycoproteins on cancer cell surfaces has importance in the
detection and subsequent destruction of malignant cells. A plasmid containing most of
the glycoprotease gene was fused with the secretion signal of hly A of E. coll. The
recombinant plasmid expressed a fusion protein GCP-f which was secreted into the
medium when secretion functions hly B and Hly D were supplied. The protease was
readily recovered from other cellular material (Lo et al., 1994). A GCP probe
hybridises with genomic DNA from serotypes 5, 6, 8, 9, 11, 12 and weakly with A2.
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PCR amplification was positive for A13, 14 and 16 but not T15. Southern blot
hybridisation was also positive with the standard plasmid product pPHl.l with A7,
13, 14 and 16. The activity assay gave the same results. T biotypes are negative and
none of the 11 A1 nasal isolates showed activity (Lee et al., 1994a).
Lee et al. (1994b) also investigated the in-vivo production of the protease using calf
sera. Sera which recognised a band of 35.2 kDa on Western blots also neutralised
enzyme activity. When the specificity of immunoglobulin was investigated IgGl and
IgG2 both recognised the band. Correlation between neutralising activity of serum and
reduction in percentage pneumonic tissue observed, suggest a relationship between
the production of antibodies against the protease and protection.
1.12. Pathogen-Host Interactions
Although the use of single, purified virulence factors alone give some indication of
their potential in pathogenesis, infection is multifactorial and the effects of whole
bacteria whether live or dead are essential in the elucidation of the infectious process.
Systemic Interactions
Systemic interactions were investigated by Hodgson et al. (1993) where typical T
disease was identified in rapidity of onset of disease post challenge and gross
pathology at necropsy. The number of organisms isolated was higher in tissues than
blood. Plasma biochemistry described typical endotoxic shock, with glucose levels
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initially increasing then decreasing, maintained or increase in urea and lactacidaemia
and metabolic acidosis. Further work using P. trehalosi T15, treating one group (9
lambs) with antibiotics, showed clinical and biochemical endotoxaemia. PGE2
concentrations increased in fourteen out of sixteen lambs but significant levels of
TNFa occurred only in control lambs (Hodgson et al., 1994).
Mc Donald et al. (1983) showed that fresh serum from cattle killed P. haemolytica Al
log phase organisms. This effect was complement mediated by the classical pathway,
though agglutinating antibody was also present. Calf serum after colostrum feeding
killed only 30% of bacteria despite high anti P. haemolytica antibody. The amount of
IgA present in the colostrum was blamed for blocking the effects of IgG and IgM as
nasal secretions also had low indirect bactericidal agglutination. Blau et al., (1987)
reported that clinical isolates were resistant to serum killing whereas isolates from
asymptomatic cattle varied in susceptibility. This is in contrast to McDonald's study
which used mouse-passaged isolates and log phase bacterial cultures. These
methodologies have both been reported to decrease serum resistance, however, the
complement-mediated killing by the classical pathway was defined. Sutherland,
(1988) developed a microtitre plate assay for monitoring bactericidal activity. Sera
and lung washings from SPF lambs convalescent from a live P. haemolytica challenge
were shown to be bactericidal in the presence of complement. When IgG was purified
it was as bactericidal as whole serum and absorption with LPS abolished bactericidal
activity.
Cell populations in lamb blood were monitored after intratracheal inoculation of P.
haemolytica Al. After 24 hours a decrease of CD5+ and CD4+ T cells was observed
which returned to post inoculation levels after 5 days. Between 5-9 days there was a
significant rise in lymphocytes which were CD5+ but not CD4+ or CD8+. A
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depressed lymphocyte response to PHA was observed with 24 hour samples (Sharma
& Woldehiwet, 1991). Clarke et al., (1994) using chambers in calves measured
increases in IL-1, LTB4, TXB2, PGFla and PGE2 with neutrophils numbers
increasing. After 45 days, dexamethazone inoculation inhibited the chemotaxis of
neutrophils and the addition ofphenylbutazane reduced the inflammatory response as
measured by low concentrations of albumin. A similar experiment by Walker et al.,
(1994) measured the acute phase protein a 1-acid glycoprotein from chamber implants
containing bacteria. The levels of the glycoprotein were at the same levels as in serum
samples. Albumin in the chambers did rise but not in the serum reinforcing evidence
of its presence during inflammation response. In-vitro studies on the effects on
peripheral blood mononuclear leukocytes by P. haemolytica showed a significantly
greater bacterial killing than cells incubated with Staphylococcus epidermidis. Heat
killed bacteria did not cause cell death and the numbers of cells killed increased with
the increase in numbers of bacteria.
Lung Interactions.
Killing (31.9%) of P. haemolytica was observed when Al and A2 were incubated
with ovine lung surfactant. This was raised to 98.8% when serum was present. The P.
haemolytica surfactant complex was also deleterious to the bacteria when FCS,
gnotobiotic calf serum, rabbit or guinea pig serum were added. The effect was not
seen using bovine lung surfactant. Killing did not correlate with the presence of
complement, antibody or lysozyme, while the presence of LPS reduced the effect
(Brogden, 1992). P. haemolytica Al inoculated intratracheally into sheep showed an
increase in bacterial numbers until four hours which coincided with a marked rise in
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neutrophils. Macrophage numbers rose slowly but there was failure to clear bacteria
even in the presence of many neutrophils (>90% in lavage by 240 min). Davies et al.,
(1986) showed that prior infection with PI-3 virus increased the number of
macrophages but had no effect on bacterial infection and the bactericidal activity of
neutrophils was impaired considerably by dual infection. Investigations into the death
of pripheral blood mononuclear leukocytes from different species showed killing of
bovine cells was 41.7%, ovine 29.3%, goat 33.2%, horse 3.6%, swine 4% and humans
1.4%. Only live bacteria were cytotoxic, with E. coli as a control being cytotoxic for
all cell types but the ratios were very high at 106:1 (Kaehler et al., 1980a; 1980b).
In 1978 Benson et al. incubated P. haemolytica Al with bovine
bronchoalveolar macrophages and showed severe cytotoxic morphological changes
and a low rate of phagocytosis. This effect was the opposite to that of heat killed
bacteria. Maheswaran et al., (1980) followed the fate of P. haemolytica Al in bovine
bronchoalveolar macrophages. Ninety percent of the bacteria were phagocytosed in
the presence of normal or antiserum and were degraded within 60 minutes. Prolonged
incubation resulted in cytotoxic changes and destruction of the macrophages. With a
lower ratio of bacteria to macrophage at 10:1 or less, phagocytosis and bacterial
killing took place with no effects on the macrophages. In 1985 Dyer et al., also
reported on P. haemolytica and bovine bronchoalveolar macrophages. The viability of
macrophages was related to dosage and presence of opsonising antibody. Superoxide
varied with the dose of opsonised P. haemolytica but indirectly with macrophage
viability. Anion responses were dose dependent with all stimuli except unopsonised P.
haemolytica. Walker et al. (1980) isolated bovine bronchoalveolar macrophages from
calves aerosolised with P. haemolytica Al. These cells failed to phagocytose P.
haemolytica in vitro. The presence of whole serum, pulmonary IgA and IgG failed to
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enhance this, although calves not exposed to P. haemolytica by aerosol also failed to
clear the bacteria. In contrast, Czuprynski et al. (1987) working with bovine
neutrophils and P. haemolytica Al showed ingestion was serum dependent and P.
haemolytica was killed within 1-4 hours incubation depending on the number of
neutrophils present. At 100:1 bacteria to neutrophils a reduction in cell viability was
observed. After ingestion, a vigorous luminol enhanced chemiluminesance response
was observed indicating that oxygen intermediates were contributing to intracellular
killing ofP. haemolytica.
Bovine bronchoalveolar macrophages incubated with normal bronchoalveolar
washings (BAW) inhibited uptake of P. haemolytica. BAW from calves inoculated
with P. haemolytica also inhibited uptake in vitro although serum from these calves
had pronounced opsonising activity. Supernatants from the cultures of bovine
peripheral blood leukocytes, either stimulated or unstimulated, also inhibited
phagocytosis (Markham & Wilkie, 1980a). In 1982 Markham et al., also observed the
cytotoxic effects by P. haemolytica on bovine polymorphonuclear neutrophil
leukocytes resulting in 20% killing of PMNs. Pulmonary macrophages were
harvested from calves before and after exposure to P. haemolytica. In-vitro
macrophages were incubated with P. haemolytica in log and decline growth phases.
Those from decline phase were phagocytosed whereas log phase bacteria were not
phagocytosed by lavage cells pre- or post- P. haemolytica inoculation. The cells
showed altered morphologic features and were cytolytic (Walker et al., 1984).
With ovine bronchoalveolar macrophages Sutherland & Donachie, (1986) showed that
serotypesl-15 caused cytotoxic effects while those which fell into the untypable group
showed reduced toxicity. Wilkie et al., (1990) reported that P. haemolytica Al caused
deterioration of alveolar macrophages within 1 hour but effects on underlying
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parenchymal cells were not apparent until after 12 hours. The bacteria were rarely
ingested and the addition of culture supernatant accelerated macrophage deterioration
without apparent effects on parenchymal cells. This indicates that the severe tissue
destruction of fulminant pneumonic pasteurellosis is not a direct result of bacterial
infection. Bovine bronchoalveolar macrophages recovered from segmental lavage of
P. haemolytica affected calves were 30 times more procoagulant than cells from
unaffected lobes and 37 times more than controls. Total lung leukocytes
(macrophages and polymorphonuclear leukocytes) showed reduced profibrinolytic
activity. The imbalance between leukocyte-directed procoagulant and profibrinolytic
effects could lead to increased fibrin deposition and retarded removal (Car et al.,
1991).
Breider et al., (1991) monitored the effects of P. haemolytica Al on bovine
pulmonary arterial endothelial cells. Both live and killed P. haemolytica produced
extensive damage on the cells after 22 hours. This damage was prevented only by the
presence of both neutrophils and immune sera. Polymyxin B prevented the damage
suggesting a role for LPS which would account for the effect of killed organisms.
Ovine bronchoalveolar macrophages incubated with P. haemolytica Al caused release
of TNFa. This was also induced in the presence of killed P. haemolytica (Ellis et al.,
1991). When P. haemolytica was deposited into the lungs of calves and samples taken
TNFa and IL-ip mRNA levels were significantly increased in the lavage cells of
animals exposed to P. haemolytica than in those of the controls. Increased bioactive
levels of IL-1 and immunoreactive TNFa in lavage fluids were also demonstrated
(Yoo et al., 1995b).
65
1.13. Carriage and Colonisation
Pasteurella haemolytica is carried in the nasopharynx of apparently healthy sheep. A
study of 100 adult sheep heads from an abattoir in Scotland revealed that 64% of the
heads were colonised in the nasopharynx. Of these 38% were of the A biotype and
22% not typable (Gilmour et al., 1974). The lambs acquire infection soon after birth,
possibly due to contact with the dams (Shreeve & Thompson, 1970). Serotype A2 is
most commonly isolated (Gilmour & Gilmour, 1989) and this appears true for sheep
flocks in other countries (Frank, 1982; Prince et al., 1985; Mustafa, 1995). Biberstein
et al., in 1970 carried out a longitudinal survey and showed that the carrier rates
peaked in late spring and early summer and again in late autumn. This coincided with
increased incidence of disease, however there was no evidence this was the cause of
disease.
Contrary to the colonisation and disease pattern in sheep, cattle pasteurellosis is
caused mainly by serotype Al. Serotype A2, however, is more commonly isolated
from the nasopharynx in healthy calves. Studies have indicated that the ratio of A2 to
Al changes during the development of respiratory disease (Wray & Thompson, 1973;
Frank & Smith, 1983; Gonzalez & Maheswaran, 1993).
The tonsils are also a large reservoir for pasteurellae. In sheep this is mainly P.
trehalosi (T biotypes). The study by Gilmour et al. (1974) showed 95% of
pasteurellae were isolated from the tonsils, of which 40% were T biotype. Al-Sultan
& Aitken (1985) identified T biotype isolates from 60% of tonsils of young lambs
and from 90% by the age of 9 weeks. Of the ewes 78% carried T biotypes and the
authors concluded, in agreement with Shreeve & Thompson (1970), that lambs are
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colonised soon after birth. Again, in contrast, cattle tonsiliar carriage is not well
documented and experimental colonisation has not been successful (Frank & Briggs,
1992).
The mechanisms that pasteurellae possess to allow bacterial colonisation are not well
defined. There are many hypothesies presented which include the loss of fibronectin
on epithelial cell surfaces, loss of mucociliary apparatus, interactions with viral
infections and environmental stress. These links are putative and experimentally
unsubstantiated and outwith the scope of this thesis but are reviewed by Frank, 1988;
Whiteley et al., 1992; Confer et al., 1994). Those studies which have been carried out
include that of Marriassy et al. (1987) which showed that in sheep, infection with P.
haemolytica was associated with increases in airway secretory cells, gland
enlargement and that mucus cells showed increased binding to the lectins of Ulex
europus I (carbohydrate residue a-L-fuc) and Arachis hypogea (carbohydrate residue
a|3-Gal). Kaissi & Kaissi, 1983 showed ciliostasis of ovine tracheal organ cultures by
P. haemolytica. Epithelial damage was not observed until 24 hours after inoculation.
Ciliated cells were damaged more than non-ciliated. The exfoliation of ciliated
epithelial cells was found to occur by a process of extrusion rather than a
ciliocytophthonic process as found with damage by irritant chemicals and particles.
Cytopathic changes were also observed without intimate association with the
organism.
Muller et al., 1988 investigating Pasteurella multocida showed that some strains of P.
haemolytica were adherent to cells but that this was less than with the adherent P.
multocida. Muller & Mannheim (1995) showed the presence of sialidase and N-
acetylneuraminate lyase in P. trehalosi and the former enzyme in P. haemolytica.
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These were considered important as the removal of sialic acid residues from salivary
mucoprotein impairs the protective role of mucus against invading organisms. Botcher
et al., 1993 showed that untypables, Al, A2 and All outer membrane proteins and
capsule bound to preparations of epithelial cell wall fractions of trachea and tracheal
mucus of cattle. High binding capacity was observed with serovar Al strains. Uhlich
et al., 1993 reported that P. haemolytica Al adhered to bovine nasal mucus in vitro
and that this was altered by enzymatic degradation of both protein and carbohydrate
components of mucus. Vilela et al. (1992) investigating adherence to ovine
mammary gland epithelium found adherence and some internalisation in the epithelial
cells. A 70 kDa IRP was implicated in adherence. A more controversial result is the
production of fimbriae. Morck et al., 1987 using electron microscopy identified a vast
glycocalyx and rigid fimbrial structure on P. haemolytica Al. Potter et al., (1988)
purified fimbriae and showed them to be made up of a 35 kDa protein subunit but did
not rule out the possibility that it was conjugative pilus. Morck et al., (1989) also
identified the glycocalyx and fimbrial structure on the trachea of feedlot calves. Other
workers have reported failure to reproduce these results, although expression in vivo
and phase variation have not been ruled out (Confer et al., 1994). The need for
definitive studies in this area is urgent.
1.14. Disease Models
When investigating models for ovine pasteurellosis to test for the efficacy of vaccines
and treatments two main problems are encountered. The specificity of the bacteria for
the ruminant species excludes a large number of laboratory animals including cats,
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dogs, hens, pigeons, rabbits and guinea pigs (cited Sutherland, 1989). In contrast
Nocard (1892) (cited by Shoo, 1989) revealed that fowls, dogs and rats resisted all
modes of inoculation but that mice, rabbits, guinea-pigs and pigeons were susceptible
to intraperitoneal inoculation resulting in severe purulent peritonitis. Smith 1958
developed a mouse model by injecting mice intraperitoneally with mucin. This was
used by Evans & Wells 1979 to test the efficacy of P. haemolytica vaccines but this
does not resemble the natural infection in the lung and differing immunology between
murine and ovine hosts may play an important part in extrapolating efficacy between
species. The widespread natural colonisation amongst healthy conventional sheep and
the presence of antibodies against P. haemolytica causes problems when infecting
animals experimentally. This can work but high numbers of P. haemolytica are
required and is not always reproducible (Gilmour, 1980). Gilmour et al., (1975)
produced pasteurellosis in SPF lambs which was indistinguishable from natural
disease using aerosol. The percentage of lambs infected increased when PI-3 virus
was administered 7 days prior to the P. haemolytica aerosol. This system of PI-3
vims//3, haemolytica challenge is used frequently at Moredun due to its consistently
high reproduction of experimental infection (Sharp et al., 1978). Other combinations
to reproduce disease include M. ovipneumoniae and P. haemolytica which produced a
pathology more like atypical pneumonia (Gilmour et al., 1979; Jones et al., 1983).
Respiratory syncitial vims (RSV) and P. haemolytica produce disease histologically
similar to natural cases of acute pneumonia in lambs (Al-Darraji et al., 1982) and this
was also seen in conventionally reared lambs (Trigo et al., 1984) and Davies et al.,
(1982) used adenovims followed by P. haemolytica to produce disease successfully.
Systemic pasteurellosis was reproduced in sheep but used high numbers of bacteria at
~10I0cfu ml"1 intravenously administered. However, killed organisms caused the same
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effect (Smith, 1960). Using serotype T4 Gilmour et al., (1980) administered the
bacteria in agar but this was only partially successful in that low numbers of bacteria
were needed and deaths occurred but not all lesions were reproducible. Suarez
Guemes et al., (1987) reproduced systemic disease by hydrocortisone induced
immunosuppression and dietary changes. Inoculation of P. haemolytica was not
necessary so the source of infection was therefore endogenous. The hypothesis for this
event was that the bacteria invade through the gastrointestinal system. Hodgson et al.,
(1993) using T10 and T15 showed that subcutaneous injection of doses of
approximately 109 cfu ml"1 into SPF lambs reproduces disease. Endotoxic shock is the
main clinical manifestation and the roles of TNFa and PGE2 in disease have now
been evaluated (Hodgson et al., 1994).
Mouse and guinea-pig models have been suggested for bovine pneumonic
pasteurellosis. Initial experimental reproduction of disease in calves used preparations
from sick or dead animals using pleural fluid, blood, pneumonic lung suspension and
nasal exudate. Many of these failed to produce disease but some produced signs of
respiratory illness though P. haemolytica was either not isolated or lesions
characteristic of the disease were not produced (cited Shoo, 1989). The involvement
of viruses in the bovine respiratory disease complex led to experiments using P.
haemolytica in combination with viruses. Infectious bovine rhinotracheitis (IBR), PI-
3, bovine virus diarrhoea virus (BVD) or bovine herpes virus 1 (BHV1) all produce
disease with varying degrees of success. The best reproduction was given by aerosols
of BHV1 administered 4 days prior to P. haemolytica aerosol. Synergism was shown
with Mycoplasma bovis and P. haemolytica in calves (Houghton & Gourlay, 1983).
The main problem cited by Shoo, (1989) for unsuccessful challenge models was the
inoculum and state of the culture. Combination infections used low numbers of P.
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haemolytica whereas P. haemolytica alone caused fibrinous pneumonia when 5ml of
109cfu/ml was used (Panciera & Corstvet, 1984) and the culture was log phase (Ames
et al., 1985). This combination administered to susceptible calves either
intratracheally or intrathoracically consistently produced disease.
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1.15 Aims of Thesis
The aims of this thesis were to compare representative strains of the three main
serotypes responsible for causing pasteurellosis in ruminants. Ovine and bovine
serum, ovine and bovine tracheobronchial washings and media either iron-replete or
iron-restricted, were used as culture fluids to investigate the possibility that these
fluids would initiate changes in the virulence factors associated with Pasteurella spp.
Antiserum raised specifically against the serotypes was employed to define the
importance of the virulence factors in vivo and to identify any new antigens which
may be important for use in vaccine improvement. The same in-vivo fluids were also
used to assess the survival capability of the serotypes. Survival mechanisms have been
widely investigated in organisms found in the environment (Rozak and Colwell,
1987) but little research has focused on those organisms which are commonly found
colonising mucosal surfaces and which can proliferate to cause overwhelming disease.
Due to the ability of bacteria to adapt to their environments, many characteristics
essential for survival in a particular environment can be lost on sub-culture in
laboratory culture medium. As observations made in-vitro must be identified as being
present in-vivo there was a requirement for a method to isolate Pasteurella spp from
in-vivo tissues. These would then be compared observations made in in-vitro
studies.
Oxygen radicals cause irreparable damage to DNA, enzymes and other important
components of bacteria. They are generated by phagocytes and found in the mucosal
environment as a defence against invading micro-organisms. Superoxide dismutase is
an enzyme which neutralises the damaging effects of oxygen radicals. The
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investigation into the presence of superoxide dismutase in Pasteurella spp. is
important to define whether this enzyme plays a role in protection of the bacteria from
these essential defence mechanisms. This investigation leads onto the analysis of the
interaction that the bacteria have with resident alveolar macrophages. These cells are
regarded as the first line of defence against proliferation in the lower respiratory tract.
There has been substantial research into the interaction of bovine alveolar
macrophages and serotype Al. This study endeavours to investigate the interaction of
both ovine and bovine macrophages with the three important serotypes and to monitor
any apparent differences.
The significant feature of this research was to use, where possible, in-vivo fluids, in-
vivo bacteria and in-vivo host cells to attempt to relate any observations in-vitro to the
situation in vivo. The requirement to mimic in-vivo environments was necessary
firstly to ease the difficult problem of isolating in-vivo organisms. Secondly, to
identify components and adaptation mechanisms which may lead to enhanced






Bacteria and culture conditions
The strains used throughout this thesis are Pasteurella haemolytica serotypes A1
( strain M4/1/2, a bovine lung isolate), A2 ( strain 124/92, ovine lung isolate) and
Pasteurella trehalosi serotype T10 (152/94, an isolate from systemic pasteurellosis).
These are all standard challenge strains ofknown virulence.
Other strains of P. haemolytica and P. trehalosi used where stated are part of the
strain collection kept at Moredun Research Institute (MRI) and all were recovered
from cases of pasteurellosis at MRI or sent to MRI for serotyping. All strains were
stored at -70°C in nutrient broth No 2 (Oxoid ) or on beads (Prolab). Strains were
recovered from storage, thawed and plated onto 7% sheep blood agar and incubated at
37°C for 18 h. Further culture is as otherwise stated but most broth cultures of P.
haemolytica were carried out in tryptic soy broth with 1% yeast extract (TSB, YE,
Difco) and P. trehalosi was cultured in TSB alone. Escherichia coli was stored on
slopes and a loopful of culture was inoculated onto nutrient agar or into nutrient broth
(Oxoid). Listeria monocytogenes was also stored on slopes and cultured by
inoculation onto 7% sheep blood agar or into nutrient broth. Neisseria meningitidis
was stored at -70° C. Once thawed the culture was grown on GC medium (Difco)
containing 2% haemoglobin and vitox supplement (Oxoid), or in Muller Hinton broth
(Mast Diagnostics) with 10% glycerol. Haemophilus somnus was provided as a plate
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culture and was cultured on BHI agar (Difco) with 0.5% yeast extract and 7% bovine
blood or in BHIB with 0.05% sodium-L-aspartate, 0.1% tris and 0.001% thiamine
monophosphate. All bacteria mentioned were incubated at 37°C overnight with the
exception of N. meningitidis and H. somnus which on occasion were incubated for a
further 24 h.
Collection of lung washings
This was done as described by Sutherland, 1989. Ovine and bovine lungs were
collected from local abbatoirs or from animals at MRI. Phosphate buffered saline
(PBS pH 7.4, 400- 1200ml), depending on the size of the lungs, was poured into the
trachea. The lungs were briefly massaged and the fluid then poured into a container
through a gauze covered filter. The washings were centrifuged at 500 x g for 30 min
to pellet debris and cells and the supernatant collected. The supernatant was further
centrifuged at 2000 x g for 30 min to pellet any bacteria present. Supernatants were
then filtered through a 0.45pm filter. Samples were plated onto blood agar and
cultured at 37° C overnight to check for purity and stored at -20°C.
Production of convalescent lamb serum
P. haemolytica serotypes A1 and A2 and P. trehalosi serotype T10 were taken from a
blood agar plate and cultured in nutrient broth for 3 h at 37° C with shaking. The
bacteria were washed twice in PBS and resuspended in PBS to approximately 106
colony forming units (cfu) ml"1. 2ml of culture was given intratracheally (to SPF
lambs approximately 6 months of age) and subcutaneously (1ml) on days 1 and 20.
Any animal that showed signs of illness was given 2ml of tetramycin intramuscularly.
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Bleeds were taken before, and 10 days after each challenge in order to monitor
seroconversion. A final intra-nasal inoculation was given on day 34.
Production of rabbit antiserum
Cultures were grown overnight in TSB, YE at 37°C, washed in PBS and resuspended











At this stage rabbits given serotypes A1 and T10 seroconverted and showed high IHA
titres. The rabbit inoculated with A2 was given three further doses of 1ml of live A2
intravenously 25 days apart.
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Indirect Haemagglutination Assay
A loopful of bacterial culture was suspended in 1ml of PBS containing 0.03%
formalin (FPBS). The suspension was heated at 56°C in a water bath for 30 min, to
release the antigen from the cells. Glutaraldehyde-fixed (5%) ox red blood cell (RBC)
suspension (lOOpl) was added to the bacterial suspension and incubated for another
30 min at 37°C. The RBC complex was pelleted at 2,900 x g for 20 sec and washed
twice in 1ml of fresh FPBS. Rabbit antiserum 25pl belonging to each of the 12 P.
haemolytica and four P. trehalosi serotypes was added to a U-bottomed microtitre
plate. The RBC complex was then added at an equal volume and left to stand at room
temperature for 1-2 h or overnight. A positive result was indicated by an even mat of
RBCs over the bottom of the well and negative results were indicated by a small
button of RBCs in the centre of the well.
When testing antiserum a series of doubling dilutions from undilute to 1 in 2048 were
made in U-well microtitre plates. These were carried out in duplicate for each test
antiserum and for the positive control antiserum. The rest of the method was as
described except one lane of duplications contained sensitised RBCs (those
complexed to bacterial antigen) and the other contained unsensitised RBCs (diluted 1
in 10 in FPBS). The serum titre was the dilution at which the even mat of RBCs was
observed before RBC buttons were observed.
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2.2. Analysis of Strains Form Different Growth Conditions
Iron Restriction
Iron restriction and depletion was investigated using three methods (see Appendix I)
for chemically defined media (Jackson & Burrows, 1956; Wessman et al., 1966; Hu et
ai, 1986) and TSB with various molar concentrations of aa-dipyridyl and/or EDDA.
Envelope Preparation
Whole cells after culture were pelleted at 2000 x g, washed and resuspended in
250mM Tris (Tris [hydroxymethyl] amine-methane)-HCl. The suspension was then
sonicated (ultra sonic disintergrator, MSE) at 20 amp for 30 sec bursts (5-10 repeats)
whilst kept on ice. The suspension was then centrifuged at 2000 x g for 30 min to
pellet unbroken cells. The pellet was discarded and the supernatant was centrifuged
further at 30000 x g in a Ti 70 rotor (Beckman) for 1.5 h at 4°C. The supernatant was
stored at -70°C and the pellet washed twice in 250mM Tris-HCL, resuspended in PBS
and stored at -20°C.
SDS PAGE
Samples were dissolved in sample buffer (2% w/v sodium dodecyl sulphate (SDS),
5% w/v glycerol, 2% v/v 2-mercaptoethanol, 0.002% bromophenol blue and 125mM
Tris/HCl, pH 6.8) and heated in a boiling water bath for 5 min. Samples were then
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resolved by SDS-polyacrylamide gel electrophoresis (SDS PAGE) on a 10% (w/v) gel
using the discontinous buffer system of Laemmli (1970). Proteins were detected by
Coomassie blue and/or silver staining (all procedures detailed in Appendix I).
Western Blotting
SDS-PAGE gels were electroblotted onto nitrocellulose (Schleicher & Schuell) by the
method of Towbin et al. (1979). Nitrocellulose was blocked using lOmg/ml BSA in
blot wash buffer (BWB) for 1 h at 37°C or overnight at room temperature with gentle
agitation and was then was washed three times in BWB. For detection, the
nitrocellulose was incubated at 37°C for 1 h with a monoclonal antibody or an
antiserum diluted in BWB and then washed as described above. Nitrocellulose was
then incubated with horseradish-peroxidase conjugated to anti-mouse, anti-rabbit,
anti-sheep IgG (Scottish Antibody Production Unit) or anti-pig, anti-horse, anti
human and anti-dog IgG (Sigma) and again washed in BWB. Development was
carried out at room temperature in lOOmM Tris pH7.0, 0.5mg/ml diaminobenzidine
and 2pl/ml of 30% hydrogen peroxide. The reaction was terminated by the addition of
water (all procedures detailed in Appendix I).
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Cytotoxicity Assay ( Promega, Cell Titre 96 AQ Assay)
Bovine leukaemia derived cells (BL-3, 50pl) at 4x 106 /ml were added to a 96 well
flat-bottomed plate (Nunc) in Hanks/PBS (1:1). Toxin (50jul of a 20mg/ml freeze
dried preparation) was added and 50pl of Hanks/PBS. If neutralisation of the toxin
was being measured the toxin and antiserum were incubated for 20 min at room
temperature prior to addition to the cells. Controls consisted of cells alone, dead cells
(lOpl of Triton XI00) and toxin without cells. The toxin and cells were incubated at
37°C for 1 hour. After incubation, 20pl of MTS/PMS ( 2ml of 2mg/ml MTS + 100 pi
of 0.92 mg/ml PMS) was added to all wells except the first row (blank) and incubated
for up to 4 h at 37°C. The plate was then read at 490 nm on a MR5000 microplate
reader (Dynatech).
Visualisation of Capsule
The staining method of Maneval (1941) was used. Stock solutions of 1% aqueous
Congo red stain (BDH) and acid fuchsin (30ml of 5% aqueous phenol, 8ml of aqueous
glacial acetic acid and 4ml of 30% aqueous ferric chloride). A loopful of bacterial
suspension was mixed on a microscope slide with a loopful of congo red, spread
thinly and air dried. The smears were then counter stained with acid fuchsin for 2 min,
drained and blotted dry. Bacteria appeared as red stained bodies on a blue background
with capsules negatively stained, appearing as clear halos.
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Leukotoxin Preparation
A loopfull of culture from a blood agar plate growth was used to inoculate a 10ml
starter culture of brain heart infusion broth (BHIB). After incubation overnight at 37°
C this was added to 400ml of BHIB and further incubated at 37° C on a shaker for
three hours. Bacteria were pelleted by centrifugation (2000x g) and resuspended in 50
ml RPMI containing 7% (V/V) FBS. Incubation was for 30-45 mins at 37° C whilst
shaking. The bacteria were pelleted by centrifugation as above and the supernatant
collected. 1ml aliqouts were either freeze dried or stored at -70° C.
Lipopolvsaccharide (TPS) Preparation (Micro phenol method of Fomsgaard et al.,
1993,)
A loopful of bacterial culture was inoculated into 20ml of media and incubated
overnight at 37°C. The cells were pelleted at 2000 x g, washed twice and resuspended
in 500pl of pyrogen free water and transferred to an Eppendorf tube. Aqueous phenol
(500pl of 90% v/v) was added and the tube vortexed for 10 sec followed by placement
in a water bath at 70°C for 10 min with vortexing at intervals. The tube was
immediately placed on ice for a minimum of 2 min and centrifuged at 2900 x g for 4
min at room temperature. The upper clear layer was removed carefully with a pastette
and stored at -20°C.
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SDS PAGE for LPS
Using the method of Hancock & Poxton (1988) samples were boiled in sample buffer
(0.125M Tris/HCl pH6.8, 4% SDS, 20% glycerol, 2% 2-mercaptoethanol and 0.002%
bromophenol blue) for 5 min. The samples were resolved using 14% (w/v) gels using
the discontinous buffer system of Laemmli (1970). LPS was visualised using silver
stain (detailed proceedures in Appendix I).
LPS Stain
The gel was placed into a container with 200ml of 25% propan-2-ol and 7% acetic
acid overnight. The solution was discarded and replaced with 1.05g of periodic acid in
150ml of distilled water and 4 ml of the above solution for 5 min.
On discarding the above solution the gel was washed in at least 4 changes of distilled
water for over 4 h. The gel was then incubated for 15 min in a solution consisting of
21ml of 0.36% sodium hydroxide, 1.4ml of ammonia solution (0.88 SG), 4ml of
19.4% silver nitrate solution (which had been added slowly) topped up with 100ml of
water. The gel was again washed in 4 changes of distilled water for over 40 min. The
water was replaced with fresh 0.005% citric acid in 200ml of 0.019% formaldehyde
and left to develop. When the desired staining was reached, the gel was repeatedly
rinsed in large volumes of distilled water.
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Endotoxin analysis
The biological activity of LPS was determined in the Limulus amoebocyte lysate
(LAL) assay (reagents supplied by Associates of Cape Cod International, Inc.
Liverpool UK.). This was carried out by G.Moon, MRU
2.3. Survival
Survival Cultures
Bacteria were grown overnight at 37°C. The culture was washed in PBS and adjusted
to 105 cfu/ml. Bacterial suspension (20pl) was added per ml of fluid. The fluids were
used either undilute or diluted in PBS after it was shown that PBS alone did not
support growth or survival after 24 h. These were incubated at the designated
temperature and sampled after 24 h and again at various times after that depending
upon the experiment. Viable counts were assessed on sheep blood agar. When no
detectable colonies were present samples were inoculated into TSB and incubated at
37°C overnight.
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Analysis of survival cultures
Samples were stained using the methods of Gram or Maneval. Nutrient analysis of
protein, glucose and iron was carried out in The Biochemistry Dept, MRI by J. Small.
Transmission electron microscopy
Bacterial cultures were washed, placed onto copper grids and negatively stained with
0.1% ammonium molybdenum. Grids were observed at the Biochemistry Dept,
Edinburgh University and photos were taked by Mr Derek Notman.
2.4. Immunomagnetic Separation
Serum Adsorption
Brain Heart Infusion Broth (BHIB Oxoid, 1L) was inoculated with an overnight
culture of P. haemolytica or P. trehalosi grown at 37°C . The resulting cultures were
washed in PBS at 5500 x g for 1 h and the pellet resuspended in 0.5% formalin in
PBS. This was left overnight in the fridge and centrifuged at 2400 x g for 30 min and
the supernatant discarded. The pellet was washed in PBS and resuspended in 20ml of
PBS.
A total of 5ml of non-target bacteria were mixed together and centrifuged to obtain a
pellet. The pellet was resuspended in 2ml of antiserum raised against the target
bacteria and diluted 1 in 4 with sterile 0.9% saline. The suspension was incubated at
room temperature, while shaking for 2 h. The suspension was then centrifuged and the
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supernatant used to resuspend a fresh 5ml pellet of non target bacteria. This was
incubated at 4°C overnight. The room temperature step was repeated twice more and
10% BSA was added to the antiserum which was stored at -20°C. This procedure was
repeated for each target antiserum.
Dot Blots
Strips of nitrocellulose were wetted in BWB and allowed to dry at room temperature.
Formalin killed cells (2pl) used in the above experimental procedure were spotted
onto the nitrocellulose and allowed to dry at room temperature for 1 h. This was then
washed in BWB three times for 5 min each wash. The blots were then treated as
Western blots.
Immunomagnetic Separation (As described by manufacturer's instructions)
Direct Method
Dynabeads (Dynal) were washed three times in PBS/BSA (0.1%) with retrieval of the
beads carried out on a Dynal magnetic particle retriever. Beads (20pl) were added to
lml of monoclonal antibody hybridoma solution or absorbed antiserum containing 5-
20pg of antibody/ mg of dynabeads. This was incubated at 4°C for 2 h with gentle
mixing. The beads were then collected with the magnet and washed with PBS/ Tween
(0.005%) for 5 min three times. The beads were collected and resuspended in lml of
target cell suspension (104 cfu/ml as determined using McFarland standards,
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(Biomerieux) in PBS/BSA and the mixture incubated for 30 min at 4°C. The beads
were again collected and washed as previously described.
Indirect Method
The target bacteria were grown for 4 h at 37°C with shaking, washed and diluted with
PBS to 104 cfu/ml. The suspension (1ml in PBS/BSA) was incubated with 200pl of
antiserum for 30 min at 4°C. This was then centrifuged at 11600 x g for 10 min and
the supernatant discarded. The pellet was washed twice more and incubated with 20pl
of prewashed dynabeads and incubated in PBS/BSA for 2 h at 4°C. The beads were
collected with the magnet and washed three times in PBS/Tween. The beads were
plated onto sheep blood agar for detection of bacteria and, where required, an IHA test
was carried out on colonies to determine the serotype and hence the specificity of the
antibody-coated beads for the target organism. The specificity was also determined by
incorporating various mixtures of serotypes and other organisms together at the target
cell suspension stage.
Crosslinking
Dynalbeads (200pl) complexed to antibody were washed as normal then equilibrated
in 0.2 M triethanolamine pH 9.0. The beads were resuspended in 10ml of
triethanolamine and 52mg of dimethyl suberimidate was added to the suspension
which was then incubated for 45 min at room temperature with mixing. The beads
were recovered and resuspended in 10 ml of triethanolamine and incubated in the
same fashion for a further 2 h. The beads were again recovered and washed gently in
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PBS/Triton X100 for 10 min. The beads were washed three times in PBS and either
used immediately or stored at 4°C in PBS/ 0.02% sodium azide until required.
Isolation from tissues
Approximately lg of tissue was thawed at 37°C and macerated in a stomacher bag
with 10ml of PBS. This was centrifuged at 210 x g for 20 min in order to remove
cellular and tissue debris. The supernatant was retained and samples plated onto sheep
blood agar. The supernatant was centrifuged at 2400 x g for 30 min and the cell pellet
retained. This was resuspended in PBS/BSA with antiserum and the indirect method
followed or incubated with beads and the direct method followed. Detection was as
previously described.
Isolation from nasal swabs
Nasopharyngeal swabs were taken and the ends added to 3ml of PBS and vortexed
until a suspension was visible. The swab end was then removed and centrifuged at
2400 x g for 30 min. The pellet was resuspended in PBS and detection carried out by
the direct or indirect method.
87
2.5. Superoxide dismutase Detection
Preparation ofbacterial lvsates.
Colonies were scraped from a pure culture on a blood agar plate and suspended in
PBS. This was spread plated onto sheep blood agar and incubated overnight at 37°C.
The resulting bacterial lawns were scraped off by means of a bent glass rod and
suspended in lysate buffer (lOmM Tris, ImM EDTA, 0.5mM NADP, 0.005%DNAse,
pH 6.8). The bacterial lysates were prepared by disrupting the cells with 0.1mm
diameter zirconium beads in a mini beadbeater (Biospec Products Inc, Bartlesville,
Okla) for 2 min. The lysate was clarified by centrifugation (11000 x g) and stored at -
70°C. Protein concentration was determined using BCA protein assay (Pierce).
SOD detection using Polvacrvlamide gel electrophoresis (PAGE).
This was based upon the method of Beauchamp & Fridovitch (1971). Electrophoresis
was performed using Bio-Rad Mini Protean II system. Gels (0.75mm) were prepared
using a non-denaturing discontinous Tris-glycine buffer system, with the resolving gel
(7.5% acrylamide/bis) containing 1.5M Tris/HCL pH 8.8, and the stacking gel (4%
acrylamide/bis) containing 0.5M Tris/HCL pH 6.8. Electrophoresis was carried out
using chilled electrode buffer and run on ice at 200v for 45 min (detailed procedure in
Appendix I).
88
Staining for SOD activity.
Enzyme activity was visualised by soaking gels in 5mM nitro-blue tetrazolium (NBT)
for 15 min followed by 20 min in a working buffer (10ml 0.1M Tris-Base pH9, 42pl
TEMED, lOpl 28mM riboflavin). Gels were illuminated on a light box until the
development of colour was achieved and achromatic bands observed.
SOD assay.
This was carried out according to the manufacturer's instructions (RANSOD kit,
Randox, Co.Antrim,UK). Samples were mixed with substrate and xanthine oxidase
was added to start the reaction. Absorbance of samples and standards were read at a
wavelength of 500nm after 30 min incubation at room temperature.
Units of enzyme activity were calculated on the basis that 1 unit of SOD inhibits
maximum colour formation at 50% based on the standard curve.
Malate dehydrogenase tMDHl assay.
This was by the method outlined in the Worthington Enzyme Manual. The assay was
carried out by mixing 260pl of 0.1M phosphate buffer pH7.4, 20pl 0.00375 M
NADH, lOpl 0.006M oxaloacetic acid. Sample (lOpl) was added and the decrease in
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absorbance at 340nm over 1-5 min recorded. Units of activity were calculated using
the formula :
Units/ mg"1 protein = AA340/min x I x 1
6.22 mg protein ml reaction mixture
Inhibition studies of SOD.
These experiments were carried out to identify the type of SOD in the bacteria. EDTA
inhibits all SOD types whereas hydrogen peroxide inhibits Cu/Zn and Fe SODs and
potassium cyanide inhibits only Cu/Zn SOD. Prior to electrophoresis or assay,
samples were incubated for 30 min with final concentrations in aqueous solutions of
5mM potassium cyanide, 5mM hydrogen peroxide or 5mM EDTA. During gel
staining the inhibitors were also present in the NBT and riboflavin solutions.
Polymerase chain reaction (PCR)
The method of Lainson et al. (1996). Genomic DNA was obtained from an overnight
broth culture and prepared using the Genome DNA Kit (Bio 101). This was used as a
template in PCR. PCR was carried out using Taq polymerase and buffer (Boehringer)
and nested primers P6748 (AAGGTGGCAAGCTCACAGCAG) and P6749
(TTCAAGCGAGGGGCTAATAACT). Thermal cycling conditions were 30 cycles of
denaturation at 94° C for 1 min; annealing at 51°C for 1 min; extension at 72°C for 1
min followed by a single extension at 72°C for 10 min. Samples were checked for the
presence of a product by electrophoresis on a 2% agarose gel.
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Preparation of periplasmic and cytoplasmic fractions.
Osmotic shock method (based on the method of Stabel et al., 1994). Freshly harvested
bacteria were washed twice in cold TRIS (lOmM, pH8), NaCl (20mM). The bacteria
were resuspended in 2.5ml TRIS (30mM, pH8), 20% sucrose and a final
concentration of ImM EDTA. The suspension was shaken at room temperature for 10
min and the bacteria were then pelleted by centrifugation. The pellet was resuspended
in 2.5ml of cold distilled water and shaken for a further 10 min at 4°C. The bacteria
were pelleted and the supernatant collected.
CHAPS/lysozyme method (based on the method of Stabel et al., 1994). Bacteria were
adjusted to 1010 cfu ml"1 in PBS, using McFarland standards, and centrifuged to pellet
cells. The pellet was resuspended in 0.2M TRIS/HC1 and an equal volume of 0.2M
TRIS/HC1, 1M sucrose. 0.5% CHAPS and a final concentration of lOOg ml"1 of
lysozyme was added. Mild osmotic shock was carried out using an equal volume of
distilled water which was then incubated at room temperature for 2h and followed by
centrifugation. The supernatant was collected and concentrated using using Sephadex
G-100 coated dialysis tubing.
EDTA/lysozyme method (based on the method of Lainson et al., 1991). Bacteria were
adjusted to 1010 cfu ml"1 washed in PBS and resuspended in 1ml TRIS/HC1 (200mM,
pH8) and incubated for 10 min at room temperature. The above buffer (1ml)
containing 1M sucrose, 0.5mM EDTA and 120g ml"1 of lysozyme was added and
incubated for 5 min. This was then diluted 1:1 with distilled water, incubated at room
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temperature for 30 min with vigorous shaking. The suspension was then centrifuged
and supernatant collected and concentrated as described.
Chloroform method (based on the method of Stabel et al., 1994). Bacterial culture (20
ml) was washed in saline and the supernatant discarded. The pellet was resuspended
in the residual saline and 0.1 ml chloroform added and incubated at room temperature
for 15 min when 5 ml TRIS (lOmM pH8) was also added. After centrifugation the
upper portion was carefully removed for assaying.
Freeze thaw method. Bacterial cultures (20ml) were washed twice in PBS and
resuspended in 500pl of PBS. The cell suspensions were then frozen at -20°C and
thawed at 37°C at least 10 times. After centrifugation at 10000 x g the supematants
(periplasmic fraction) were removed for assaying. The remaining bacterial pellets
were lysed using the bead-beating method described previously in order to release
cytoplasmic contents. All periplasmic and cytoplasmic contents were assayed for
SOD activity and malic dehydrogenase.
Bactericidal Assay
Bacterial cultures (a loopful) were grown in nutrient broth at 37°C with shaking for
4.5 h. The bacteria were washed twice in PBS and resuspended in 0.1M phosphate
buffer pH 7.5. Using a serowell microtitre plate, control wells contained xanthine
(0.05mM), 2-(4-iodophenyl)-3-(4-nitrophenol)-5-phenyltetrazolium chloride (INT,
0.025mM) in 0.1M phosphate buffer pH 7.5 and 0.002 units of xanthine oxidase.
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Following mixing the production of visual formazan dye was monitored to show that
production of superoxide had occurred. INT is toxic to Pasteurella spp and was
omitted from the test wells. Controls contained xanthine, buffer and bacteria at 105
cfu/ml. Experimental wells contained xanthine, xanthine oxidase and the same
bacterial inoculum. The plate was incubated at 37° C and 10pl samples were removed
at times 0, 15 and 30 min. Samples were serially diluted, plated onto 7% sheep blood
agar in duplicate and incubated at 37° C overnight.
Reactivity with antiserum
This experiment was designed to show any interaction between the SOD and
antibodies which may have been raised specifically against the enzyme during
infection. The convalescent antiserum was incubated in equal volumes with the
sample for 30 min prior to electrophoresis. To determine whether specific IgG bound
to and inhibited SOD activity, lOpl of sample was mixed in a total volume of 100
mg/ml"1 of purified IgG in 0.1 M Tris/HCl pH8. This was incubated with mild
agitation at room temp for 1 h. Protein G (5ml Protein G immobilised on Sepharose
4B, Fast Flow, Sigma) was added and the incubation continued for a further 30 min.
Samples were centrifuged and the supernatant removed and assayed using the Ransod
kit. Negative control antiserum and purified IgG were obtained from an specific
pathogen free (SPF) lamb given orf virus.
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2.6. Macrophage Interaction
Collection and culture of alveolar macrophages (As described by Sutherland, 1989).
Collection was as previously described in collection of lung washings but instead of
discarding the pellet from the cell debris stage this was kept. If contaminating red
blood cells were present they were removed by resuspending the pellet in 10 ml of lx
PBS. Double distilled water (20 ml) was added and mixed quickly for 30 sec. lOx
PBS (2 ml) were added and centrifuged at 800 x g for 5 min and the supernatant
contained the cells. Cells were washed in Hanks' balanced salt solution (Hanks) and
resuspended in RPMI (detailed recipie in Appendix I).
Viability was determined with nigrosin (0.1%) and macrophages were counted using
an improved Neubauer haemocytometer. Macrophage concentration was adjusted to
lxlO7 cells/ml and lOOpl added to 96 well tissue culture plates. These were incubated
overnight at 39°C in 5% C02 until required.
Phagocytosis assay
Based on the method described by McNeil et al. (1994). Bacterial cultures were
adjusted to approximately lxlO6 cfu ml"1, washed and resuspended in RPMI without
antibiotics. The macrophage cultures were washed three times in Hanks, the bacteria
added and incubated at 37°C. After incubation macrophages were washed three times
in Hanks then RPMI containing 50ug/ml of gentamicin was added (to kill
extracellular bacteria) and this was incubated for a further 90 minutes. This medium
was then washed three times with Hanks and macrophages were lysed with the
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addition of 1 OOjj.1 of 1% saponin in Gey's balanced salt solution (GBSS) and 2% of
fetal bovine serum (FBS). From this serial dilutions were carried out on the lysate
and plated onto sheep blood agar to determine the numbers of surviving intracellular
bacteria.
Opsonisation of bacteria was carried out by incubating washed bacteria with a 1 in 10
dilution of antiserum.
Cytochalasin-D and monodansylcadaverine were used at 2pg/ml and 200pM
respectively and incubated for at least 1 hour with macrophages prior to infection.
Intracellular/ Extracellular bacterial Ratio.
This was based on the method described by Flondalus & Mosser (1994). Macrophages
(lxl07) and bacteria (lxlO6) were prepared as above except that culture was carried
out in 2 well glass slides (Chamber slide, Lab-Tek Napenville IL). After 1 h
incubation the slides were washed and to one chamber was added 100% methanol and
to the other was added 3% formaldehyde. The slides were incubated for 30 min and
washed with GBSS. The chamber slides were Gram stained and left to dry. Using
lOOOx magnification, the number of bacteria associated with 100 macrophages was
counted.
Macrophage cytotoxicity Assay (Promega Cytotox Kit).
Macrophages (lxl06) were cultured in 96 well tissue culture plates as previously
described. The medium was washed three times with Hanks/PBS (1:1) and bacteria
(1x10s) were added in Flanks/PBS. The plate was incubated for 30 min at 37°C with
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shaking. The plate was then centrifuged at 500 x g for 1 h. A 50pl sample was
removed from each well and added to a fresh plate. Substrate (50pl) was added to all
wells and the plate incubated for 30 min at room temperature in the dark. Stop
solution (50pl) was added and the absorbance read at 490nm on a microplate reader
(Dynatech). Controls were set up as per manufacturer's instruction
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Fig 3.1. Western blots of serotypes A1 (a), A2 (b) and T10 (c) envelopes probed with
sequential bleeds in the production of homologous convalescent lamb serum ( used in
chapters 3, 6 and 7) and rabbit antiserum (used in chapter 5).
(a) Molecular weight markers (lane 1), lamb 97 pre bleed (lane 2), lamb 97 second
bleed (lane 3), lamb 97 final bleed (lane 4), rabbit 439 pre bleed (lane 5), rabbit 439
final bleed (lane 6).
(b) Molecular weight markers (lane 1), lamb 268 final bleed (lane 2), lamb 268 second
bleed (lane 3), lamb 268 pre bleed (lane 4), lamb 127 final bleed (lane 5), lamb 127
second bleed (lane 6), lamb 127 pre bleed (lane 7), rabbit 0010 final bleed (lane 8),
rabbit 0010 second bleed (lane 9), rabbit 0010 pre bleed (lane 10).
(c) Rabbit 440 pre bleed (lane 1), rabbit 440 final bleed (lane 2), lamb 112 pre bleed
(lane 3), lamb 112 second bleed (lane 4), lamb 112 final bleed (lane 5), molecular



























Western blots probed with rabbit antiserum (Fig 3.1a-b) showed an equally strong
IgG response against bacterial envelopes of the serotypes when compared to the pre-
bleed serum. The IHA results, which can be seen in Table 3.1, did show higher titres
than the ovine antiserum except for serotype A2 which only agglutinated when the
antiserum was neat. The standard A2 antiserum used in the test was also of low titre.
SEROTYPE ANTISERUM SPECIES ANTIBODY
TITRE
A1 STD RABBIT 1/16
A2 STD RABBIT NEAT
T10 STD RABBIT 1/16
A1 97 OVINE 1/32
A2 268 OVINE NEAT
T10 112 OVINE 0
A1 439 RABBIT 1/128
A2 0010 RABBIT NEAT
T10 440 RABBIT 1/16
Table 3.1. IHA titres of rabbit (used in chapter 5) and sheep antiserum (used in
chapters 3, 6 and 7) raised against P. haemolytica and P. trehalosi serotypes and
tested on homologous strains.
STD, standard antiserum.
3.3. Iron Restriction
The approach to iron restriction was to obtain maximum growth under the maximum
stress of iron and/or divalent-cation restriction, as opposed to depletion. The first
methods applied used chemically defined media (CDM, see Appendix I). Three
different CDM which had been developed for P. haemolytica and closely related
organisms were used. The serotypes were grown in the CDMs prepared with and
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without the iron compound. Table 3.2 shows the effects of culture in the CDMs. The
serotypes either grew in all media or in the case of CDM C did not grow at all.
SEROTYPE CDM (A)
+ HAEMIN
CDM (A) CDM (B)
+ Fe, CI,
CDM (B) CDM (C)
+ Fe, S04
CDM (C)
A1 +++ +++ +++ +++ NG NG
A2 +++ +++ +++ +++ NG NG
T10 +++ +++ +++ +++ NG NG
+++ - Growth
NG - no growth
Table 3.2. The growth of serotypes using three different chemically defined media
(CDM), with and without an iron source. Results are the same for broth and agar plate
culture.
Divalent cation chelators were employed to restrict iron availability. Two widely
used chelators, namely act dipyridyl and ethylenediamine Di (o-Hydroxyphenylacetic
acid (EDDA), were screened using concentrations between 50 and 500pM. Table 3.3
shows the concentration of each chelator which arrested growth and also the
concentration of ferric chloride needed to overcome the cessation of growth.
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A1 500pM aadp lOOpM
400pM EDDA 200pM
TSB/YE A2 450pM aadp lOOpM
BROTH 450pM EDDA lOOpM
T10 500pM aadp lOOpM
400pM EDDA 150pM
A1 250pM aadp lOOpM
350pM EDDA 350pM
TSB/YE A2 250pM aadp lOOpM
AGAR 450pM EDDA 450pM
T10 350pM aadp lOOpM
200pM EDDA lOOpM
Table 3.3. Concentrations of chelator required for arresting growth of serotypes and
concentrations of the amount of iron needed to reverse the effect.
*MIC - minimum inhibitory concentration, ie the lowest concentration of chelator
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The concentrations of chelators employed in Table 3.3 were deemed unusually high
when compared to chelator concentrations used for other organisms and the variability
of different concentrations of chelator for each serotype was not practical when
making batches of media for screening iron compounds.
There was a possibility that iron was stored internally which has been shown for
Yersinia pestis (Perry et al, 1993) and that the chelators were having a toxic effect
rather than restricting growth, with subsequent repletion being neutralisation of the
chelator. Lower concentrations of the chelators were used and the serotypes passaged
from culture to culture which has been used for the oral pathogen Bacteroides
gingivalis (Bramanti & Holt, 1990) thus utilising any possible internal storage of iron.
Table 3.4 shows that passaging into iron-restricted broths did not affect growth of the
serotypes with aa dipyridyl at the stated concentrations. EDDA, however, in both
broth and agar would not allow growth as early as passage 2 and so was successful at
preventing growth at the same (low) concentration of chelator. The system was tested
by adding iron compounds to see if growth could be initiated. Table 3.5 shows that
under these iron-depleted conditions, all serotypes were able to utilise hemin, hematin
and ovine, bovine and porcine haemoglobin. This defined that 200pM EDDA
produced iron restriction in all serotypes and if subcultured into 150pM EDDA the
serotypes were thereby depleted of iron and if no iron source was available growth did
not occur. This worked well with broth culture but agar culture combining chelators
was not reproducible and with differing chelator concentrations between serotypes,
the screening of iron compounds could be deemed impractical.
103
3.4. SDS PAGE
Bacterial envelopes were prepared from overnight cultures of serotypes Al, A2 and
T10 in various media and in-vivo fluids. Fig 3.2 shows the Coomassie blue stained
protein profiles of Al. Lane 1 which contains envelope preparations from NCS
culture shows two extra protein bands at approximately 53 and 17 kDa, similar
proteins are apparent in LS (Lane 2) growth but are at a slightly less molecular weight
at 50 and 16 kDa. There were only two differences in iron-restricted culture with the
loss of a 90 kDa protein and the appearance of a 70 kDa protein. No differences were
observed in the envelope profiles of PBS and otbw cultures. Serotype A2 bacterial
envelopes (Fig 3.3) showed an increase in a protein band at approximately 50 kDa in
LS and a similar protein in NCS culture at 53 kDa. Proteins in A2 at 40 and 29 kDa
are apparent in all samples and appear to be major OMPs in this serotype. Iron-
restricted culture produced a protein profile very similar to that observed in LS with
the exception of the appearance of a unique 70 kDa protein. Envelope profiles from
PBS and otbw culture were also similar and shared profiles observed for NCS. T10
envelope profiles also showed many differences. Iron-restricted culture and PBS
culture produced proteins of 80 and 100 respectivley both of which are present in LS,
and no change was apparent in otbw. Similar increases in the proteins from serum
cultures at 50 and 30 kDa are apparent (Fig 3 .4). Table 3.6 summarises the main
envelope protein differences of the three serotypes.
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Fig 3.2. Coomassie blue stained SDS PAGE profiles of serotype A1 bacterial
envelopes prepared from different culture fluids. Approximately 20pg loaded per
well.
Growth in NCS (lane 1), LS (lane 2), otbw (lane 3), PBS stressed (Lane 4), TSB with
200pM EDDA (lane 5), TSB with 50pM iron (lane 6), TSB (lane 7) and molecular
weight markers (lane 8). > denotes missing band, ► denotes extra band when
compared to TSB culture.
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Fig 3.3. Coomassie blue stained SDS PAGE profiles of serotype A2 bacterial
envelopes prepared from different culture fluids. Approximately 20pg loaded per
well.
Growth from NCS (lane 1), LS (lane 2), otbw (lane 3), PBS stressed (Lane 4), TSB
with 200pM EDDA (lane 5), TSB with 50pM iron (lane 6), TSB (lane 7) and
molecular weight markers (lane 8). > denotes missing band, *- denotes extra band
when compared to TSB culture.
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Fig 3.4. Coomassie blue stained SDS PAGE profiles of serotype T10 bacterial
envelopes prepared from different culture fluids. Approximately 20pg loaded per
well.
Molecular weight markers (lane 1), growth in TSB ( lane 2), TSB with 50pM iron
(lane 3), TSB with 200pM EDDA (lane 4), PBS stressed (lane 5), otbw (lane 6), LS
(lane 7) and NCS (lane 8). > denotes missing band, ► denotes extra band when
compared to TSB culture.
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Table 3.6. Summary of missing (denoted by *) and extra proteins based on proteins
present in TSB culture observed on Coomassie stained SDS PAGE of Al, A2 and
T10 envelope preparations from different culture fluids.
Serotype Al, A2 and T10 cell contents ( all other components left over after the
envelope fraction has been removed) are shown in Fig 3.5, 3.6 and 3.7 respectively.
Serotype Al (Fig 3.5) showed a missing protein of 97 kDa in iron-restricted, otbw and
LS cultures. Many extra proteins were observed from iron-restricted culture all in the
25-50 kDa range. All culture conditions showed an extra 30 kDa protein. A2 (Fig 3.6)
shows proteins >205 kDa approximately and between 30 and 55 kDa in both serum
cultures. Proteins of 90 and 55 kDa were missing from iron-restricted culture and no
change in protein profiles were apparent in PBS and otbw cultures. T10 showed extra
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Fig 3.5. Coomassie blue stained SDS PAGE profiles of serotype A1 bacterial cell
contents prepared from different culture fluids. Approximately 20pg loaded per well.
Molecular weight markers (lane 1), TSB (lane 2), TSB with 50|aM iron (lane 3), TSB
with 200pM EDDA (lane 4), PBS stressed (lane 5), otbw (lane 6), LS (lane 7) and
NCS (lane 8). > denotes missing band, ► denotes extra band when compared to TSB
culture
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Fig 3.6. Coomassie blue stained SDS PAGE profiles of serotype A2 bacterial cell
contents prepared from different culture fluids. Approximately 20pg loaded per well.
Growth in NCS (lane 1), LS (lane 2), otbw (lane 3), PBS stressed (lane 4), TSB with
200pM EDDA (lane 5), TSB with 50pM iron (lane 6), TSB (lane 7) and molecular
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Fig 3.7. Coomassie blue stained SDS PAGE profiles of serotype T10 bacterial cell
contents prepared from different culture fluids. Approximately 20pg loaded per well.
Molecular weight markers (lane 1), TSB (lane 2), TSB with 50pM iron (lane 3), TSB
with 200pM EDDA (lane 4), PBS stressed (lane 5), otbw (lane 6), LS (lane 7) and
NCS (lane 8). > denotes missing band, ► denotes extra band when compared to TSB
culture.
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Many proteins were missing, notably the 60 kDa from iron-restricted, PBS and LS
culture. The protein profile of PBS and NCS cultured organisms was similar and no
differences were observed for proteins from otbw cultures. Table 3.7 provides a
summary ofprotein profiles observed of the three serotypes.
Molecular weights (kDa) of missing and extra proteins when cultured in:
Serotype TSB/EDDA PBS otbw LS NCS
116
A1 100




















35 35 35 35
32 * 32 *
30 30 30 30
29* 29 *
17 17
Table 3.7. Summary of missing (denoted by *) and extra proteins (based on proteins
present in TSB culture) observed on Coomassie stained SDS PAGE of Al, A2 and
T10 cell contents from different culture fluids.
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3.5. Western blotting
Ovine convalescent serum used as a probe on envelope fractions of the serotypes are
seen in Figs 3.8, 3.9 and 3.10 shows Al, A2 and T10 respectively. Serotype A1
showed the lack of recognition of a 90 kDa band in PBS culture. A 55 kDa band was
however recognised from all culture conditions. A2 showed 110 kDa band recognised
in all ruminant fluids but not the envelopes of in-vivo isolated organisms (these
organisms were from freeze dried stocks of pleural fluid collected cells, Donachie and
Gilmour, 1988). The 77 kDa band was present in all culture conditions as was the 30
kDa band (except PBS). T10 showed no responses which were different from broth
culture in iron-restricted and PBS. The serum cultures showed extra bands recognised
at 200 and 100 kDa. A LMW (low molecular weight) protein was missing from
recognition in otbw and a 70 kDa in LS. Table 3.8 summarises the recognition of
antigens of the three serotypes by their respective homologous antiserum.
Molecular weights (kDa) ofmissing and extra bands when cultured in:
Serotype TSB/EDDA PBS otbw LS NCS In-vivo
Al 90*
55 55 55 55 55
A2 110 110 110











Table 3.8. Summary of missing (denoted by *) and extra proteins (based on proteins
present in TSB culture) observed on Western blots of Al, A2 and T10 envelope
preparations from different culture fluids and probed with homologous convalescent
lamb serum.
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Figs 3.11-3.13 shows the recognition of cell content antigens by homologous
antiserum. A1 showed an extra band recognised in cultures with extra iron at 140
kDa. With iron-restricted culture bands are not recognised at 85 and 60 kDa and extra
bands are observed having the same molecular weights as NCS culture. There was no
change in PBS or otbw culture. A2 showed an extra band recognised at 50, 40 and 70
kDa the latter was also present in both serum cultures. The 35 kDa band was missing
from all cultures except PBS. T10 showed a 40 kDa extra band present in broth with
extra iron culture and PBS. Whereas in iron-restricted and otbw culture an extra band
was observed at 46 kDa. All ruminant fluids showed extra bands in the 10-20 kDa
range and both serum cultures produced recognition of a 100 kDa band.
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Fig 3.8. Western blot of serotype A1 envelopes prepared from different culture fluids
and probed with homologous convalescent lamb serum (this chapter).
Molecular weight markers (lane 1), TSB (lane 2), TSB with 50pM iron (lane 3), TSB
with 200pM EDDA (lane 4), PBS stressed (lane 5 ), otbw (lane 6), LS (lane 7) and
NCS (lane 8). > denotes missing band, ► denotes extra band when compared to TSB
culture.
Fig 3.9. Western blot of serotype A2 envelopes prepared from different culture fluids
and probed with homologous convalescent lamb serum (this chapter).
In-vivo isolated (lane 1), NCS (lane 2), LS ( lane 3), otbw (lane 4), PBS stressed
(lane 5 ), TSB with 200pM EDDA (lane 6), TSB with 50pM iron (lane 7), TSB (lane
8) and molecular weight markers (lane 9). > denotes missing band, ► denotes extra
band when compared to TSB culture.
Fig 3.10. Western blot of serotype T10 envelopes prepared from different culture
fluids and probed with homologous convalescent lamb serum (this chapter).
NCS (lane 1), LS (lane 2), otbw ( lane 3), PBS stressed (lane 4), TSB with 200pM
EDDA (lane 5 ), TSB with 50pM iron (lane 6), TSB (lane 7) and molecular weight
markers (lane 8).










Fig 3.11. Western blot of serotype A1 cell contents prepared from different culture
fluids and probed with homologous convalescent lamb serum (this chapter).
NCS (lane 1), LS (lane 2), otbw ( lane 3), PBS stressed (lane 4), TSB with 200pM
EDDA (lane 5 ), TSB with 50pM iron (lane 6), TSB (lane 7) and molecular weight
markers (lane 8). > denotes missing band, ► denotes extra band when compared to
TSB culture.
Fig 3.12. Western blot of serotype A2 cell contents prepared from different culture
fluids and probed with homologous convalescent lamb serum (this chapter).
In-vivo isolated (lane 1), NCS (lane 2), LS ( lane 3), otbw (lane 4), PBS stressed
(lane 5 ), TSB with 200pM EDDA (lane 6), TSB with 50pM iron (lane 7), TSB (lane
8) and molecular weight markers (lane 9). > denotes missing band, denotes extra
band when compared to TSB culture.
Fig 3.13. Western blot of serotype T10 cell contents prepared from different culture
fluids and probed with homologous convalescent lamb serum (this chapter).
NCS (lane 1), LS (lane 2), otbw ( lane 3), PBS stressed (lane 4), TSB with 200pM
EDDA (lane 5 ), TSB with 50pM iron (lane 6), TSB (lane 7) and molecular weight
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The major differences of IgG recognition of each of the serotype grown in different
culture conditions are summarised in Table 3.9.



































Table 3.9. Summary of missing (denoted by *) and extra proteins (based on proteins
present in TSB culture) observed on Western blots of Al, A2 and T10 cell contents
from different culture fluids and probed with homologous convalescent lamb serum.
Due to some of the culturing being carried out in "in-vivo" fluids, Western blots
using anti-sheep conjugate as a probe to assess the presence of host proteins bound to
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the bacterial proteins, were carried out. Fig 3.14 a-c shows the envelopes of the three
serotypes. In A1 lanes containing samples from in-vivo fluid culture have recognised
bands only at molecular weights of approximately 112, 50 52 and 29 kDa. In A2
envelopes bands at 53, 52 and 30 kDa are recognised. T10 also had bands of
approximately the same molecular weights at 53, 52, 28 and 25 kDa. The cell contents
of the three serotypes (Fig 3.15 a-c) show A1 had bands of 53, 52 and 28 kDa. A2 had
approximate bands at 112, 52, 50 and 20 kDa whilst those of T10 were present also at
52, 50 and 28 kDa.
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Fig 3.14. Western blots of envelopes of serotypes A1 (a), A2 (b) and T10 (c) grown in
different culture fluids and probed with donkey anti-sheep conjugate to identify host
bound protein.
(a) TSB (lane 1), TSB with 50pM iron (lane 2), TSB with 200pM EDDA (lane 3),
PBS stressed (lane 4), otbw (lane 5), LS (lane 6), NCS (lane 7) and molecular weight
markers (lane 8).
(b) Molecular weight markers (lane 1), In-vivo (lane 2), NCS (lane 3), LS (lane 4),
otbw (lane 5), PBS stressed (lane 6), TSB with 200pM EDDA (lane 7), TSB with
50pM iron (lane 8) and TSB (lane 9).
(c) TSB (lane 1), TSB with 50pM iron (lane 2), TSB with 200pM EDDA (lane 3),































Fig 3.15. Western blots of cell contents of serotypes A1 (a), A2 (b) and T10 (c) grown
in different culture fluids and probed with donkey anti-sheep conjugate to identify
host bound protein.
(a) TSB (lane 1), TSB with 50 pM iron (lane 2), TSB with 200pM EDDA (lane 3),
PBS stressed (lane 4), otbw (lane 5), LS (lane 6), NCS (lane 7) and molecular weight
markers (lane 8).
(b) Molecular weight markers (lane 1), In-vivo (lane 2), NCS (lane 3), LS (lane 4),
otbw (lane 5), PBS stressed (lane 6), TSB with 200pM EDDA (lane 7), TSB with
50pM iron (lane 8) and TSB (lane 9).
(c) Molecular weight markers (lane 1), NCS (lane 2), LS (lane 3), otbw (lane 4), PBS



































The cell contents were probed with a monoclonal antibody raised against an A2
serotype 35 kDa IRP (Lainson et al 1991). Fig 3.16 (a) shows that all growth
conditions produced a protein in A2 with which the Mab reacted with the exception
(Lane 8) of in-vivo isolated bacteria. All growth conditions with serotypes Al and
T10 were negative for recognition with the 35 kDa Mab. When the envelope fractions
were probed (Fig 3.16 b) the results for A2 were the same as the cell contents where
no recognition of the protein in in-vivo bacteria was observed. The envelopes of Al,
however, showed recognition of a band at the correct molecular weight from TSB,
TSB with iron and restricted, LS and NCS culture only (Fig 3.16c). T10 also
possessed one band of the correct molecular weight in the sample from otbw culture
(results not shown).
A rabbit polyclonal antiserum raised against a 100 kDa protein, proposed as a
haemopexin receptor (Davies et al 1996), was used to probe A2 envelopes. A reaction
( Fig 3.17) was observed in iron-restricted and LS growth conditions with a slight
reaction in TSB and in-vivo growth conditions. No reaction was observed in Al or
T10 fractions.
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Fig 3.16. Western blot of serotype A2 cell contents and A2 and A1 envelopes from
different culture fluids and probed with a monoclonal antibody raised against an A2
35 kDa IRP (Lainson et al, 1991).
(a) A2 cell contents of: TSB (lane 1), TSB with 50pM iron (lane 2), TSB with 200pM
EDDA (lane 3), PBS stressed (lane 4), otbw (lane 5), LS (lane 6), NCS (lane 7), in-
vivo isolated (lane 8) and molecular weight markers (lane 9).
(b) A2 envelopes: molecular weight markers (lane 1), in-vivo isolated (lane 2), NCS
(lane 3), LS (lane 4), otbw (lane 5), PBS stressed (lane 6), TSB with 200pM EDDA
(lane 7), TSB with 50pM iron (lane 8), and TSB (lane 9).
(c) Al envelopes: molecular weight markers (lane 1), NCS (lane 2), LS (lane 3), otbw
(lane 4), PBS stressed (lane 5), TSB with 200pM EDDA (lane 6), TSB with 50pM
iron (lane 7), and TSB (lane 8).
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Another polyclonal rabbit antiserum was raised against the two transferrin binding
proteins at 100 and 70 kDa ( tbpl and tbp2 respectively). Fig 3.18 a-c shows in
serotype A1 that the 100 kDa was recognised in all lanes except from growth in LS.
The 70 kDa protein was also in all lanes except from otbw growth. The A2 serotype
had a reaction with the 100 kDa protein in lanes when the bacteria were grown in
TSB, LS, NCS and in-vivo isolation. The 70 kDa was present with all growth
conditions except PBS-stressed bacteria. Although T10 has been shown to possess
different IRPs (Murray et al 1992) the 70 kDa protein was shown to be present in
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Fig 3.17. Western blot of serotype A2 envelope preparations from different culture
fluids and probed with a rabbit antiserum raised against an A2 100 kDa haemopexin
receptor (Davies et al, 1996).
TSB (lane 1), TSB with iron (lane 2), TSB with EDDA (lane 3), PBS stressed (lane
4), otbw (lane 5), LS (lane 6), NCS (lane 7), in-vivo isolated (lane 8) and molecular
weight markers (lane 9).
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Fig 3.18. Western blot of serotype A1 (a), A2 (b) and T10 (c) envelope preparations
from different culture fluids and probed with a rabbit antiserum raised against A1 100
kDa and 70 kDa transferrin binding proteins.
(a) Molecular weight markers (lane 1), TSB (lane 2), TSB with 200pM EDDA (lane
3), PBS stressed (lane 4), otbw (lane 5), LS (lane 6) and NCS (lane 7).
(b) Molecular weight markers (lane 1), TSB (lane 2), TSB with 200pM EDDA (lane
3), PBS stressed (lane 4), otbw (lane 5), LS (lane 6), NCS (lane 7) and in-vivo (lane
8).
(c) Molecular weight markers (lane 1), TSB (lane 2), TSB with 200pM EDDA (lane
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3.6. Lipopolysaccharide analysis
Lipopolysaccharide (LPS) was extracted from overnight cultures of all three serotypes
using a rapid hot-phenol method. Fig 3.19 shows the LPS from all serotypes grown
under all the different culture conditions. All three serotypes show reduced presence
of core polysaccharide when grown in otbw, whereas in btbw no LPS can be
observed in any serotype using this extraction method even though growth was
substantial. Serotypes A1 and A2 have similar LPS profiles with reduced core
polysaccharide, from LS cultures. There is more core present in the NCS grown
samples and TSB with or without iron restriction produced the largest amount of
observable LPS. T10 LPS was similar in serum cultured samples and TSB cultures
with core and O-antigen visible.
The same samples were Western blotted with antiserum raised against A1 (Fig 3.20)
and recognition of A1 LPS from NCS, TSB and iron-restricted culture were
recognised. These samples also recognised some O-antigen which was not previously
visible on the stained gel and indicates that under certain growth conditions this A1
strain can possess O-antigen. The A1 antiserum cross-reacted with A2 core LPS from
the same growth conditions as the A1 serotype and there was no recognition of T10
LPS.
A2 antiserum ( Fig 3.21) recognised all the core LPS of A2 samples except the btbw
grown samples. The antiserum cross-reacted with A1 grown in NCS, TSB and iron-
restricted culture but recognised only core LPS. Again, no cross-reaction was
observed with T10.
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Fig 3.19. Silver stained PAGE gel of LPS samples of A1 (lanes 1-6), A2 (lanes 7-12)
and T10 (lanes 13-18) from different culture fluids.
Various amounts were loaded onto the gel based on previous gels.
A1 from otbw (lane 1), btbw (lane 2), LS (lane 3), NCS (lane 4), TSB with 50pM iron
(lane 5), TSB with 200pM EDDA (lane 6), A2 from otbw (lane 7), btbw (lane 8), LS
(lane 9), NCS (lane 10), TSB with 50p.M iron (lane 11), TSB with 200pM EDDA
(lane 12), T10 from otbw (lane 13), btbw (lane 14), LS (lane 15), NCS (lane 16), TSB
with 50(aM iron (lane 17) and TSB with 200pM EDDA (lane 18).
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Fig 3.20. Western blot of LPS samples of A1 (lanes 1-6), A2 (lanes 7-12) and T10
(lanes 13-18) from different culture fluids and probed with convalescent lamb serum
raised against A1 (this chapter).
A1 from otbw (lane 1), btbw (lane 2), LS (lane 3), NCS (lane 4), TSB with 50pM iron
(lane 5), TSB with 200pM EDDA (lane 6), A2 from otbw (lane 7), btbw (lane 8), LS
(lane 9), NCS (lane 10), TSB with 50pM iron (lane 11), TSB with 200pM EDDA
(lane 12), T10 from otbw (lane 13), btbw (lane 14), LS (lane 15), NCS (lane 16), TSB
with 50p,M iron (lane 17) and TSB with 200pM EDDA (lane 18).
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Fig 3.21. Western blot of LPS samples of A1 (lanesl3-18), A2 (lanes 7-12) and T10
(lanes 1-6) from different culture fluids and probed with convalescent lamb serum
raised against A2 (this chapter).
T10 from TSB with 200pM EDDA (lane 1), TSB with 50pM iron (lane 2), NCS (lane
3), LS (lane 4), btbw (lane 5), otbw (lane 6), A2 from TSB with 200pM EDDA (lane
7), TSB with 50pM iron (lane 8), NCS (lane 9), LS (lane 10), btbw (lane 11), otbw
(lane 12), A1 from TSB with 200pM EDDA (lane 13), TSB with 50pM iron (lane
14), NCS (lane 15), LS (lane 16), btbw (lane 17) and otbw (lane 18).
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Fig 3.22. Western blot of LPS samples of A1 (lanes 13-18), A2 (lanes 7-12) and T10
(lanes 1-6) from different culture fluids and probed with convalescent lamb serum
raised against T10 (this chapter).
T10 from TSB with 200pM EDDA (lane 1), TSB with 50pM iron (lane 2), NCS (lane
3), LS (lane 4), btbw (lane 5), otbw (lane 6), A2 from TSB with 200pM EDDA (lane
7), TSB with 50pM iron (lane 8), NCS (lane 9), LS (lane 10), btbw (lane 11), otbw
(lane 12), A1 from TSB with 200pM EDDA (lane 13), TSB with 50pM iron (lane
14), NCS (lane 15), LS (lane 16), btbw (lane 17) and otbw (lane 18).
Using T10 antiserum ( Fig 3.22) there was recognition of LPS in all T10 samples
except those from btbw culture. Only the O- antigen was recognised on the blots and
no cross-reaction with A1 and A2 was observed.
Table 3.10 shows the endotoxin unit measurements of the extracted LPS. This is
essentially a measurement of the toxicity of the Lipid A portion of LPS.




A1 LS 1/1000000 23
NCS 1/1000000 90




A2 LS 1/1000 1.8
NCS 1/1000000 31





T10 NCS 1/1000000 576
TSB + Fe 1/1000000 436
EDDA 1/1000000 467
Table 3.10. The amounts of endotoxin present in serotypes grown in different media.
The endotoxin measurements correspond to the relative amounts of LPS observed on
the stained gel. This indicates that the culture conditions can affect the amounts and
therefore the subsequent toxicity of the bacterial LPS molecule.
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3.7. Capsule polysaccharide analysis
Capsular polysaccharide was observed using the Maneval stain. Table 3.11 shows the
variation seen in capsule size. Fig 3.23 a-e shows the observed capsules in relation to
the tabulated grouping.





TSB/YE / EDDA A2 +
T10 ++
Al +














+/- small, partial and no obvious capsule
+ medium capsule
++ large capsule
++ * largest capsule
Table 3.11. Capsule presence in serotypes Al, A2 and T10 from different growth
conditions.
132
The largest capsule was that belonging to serotype A1 grown in btbw. The other
capsules were divided into three categories namely, large, medium and small, partial
and no observable capsule.
There was no pattern to the presence of capsular size and the culture medium. There
was a trend towards less capsular material present on bacteria from in-vitro cultures.
There was no relationship with a serotype and any particular capsule size.
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Fig 3.23. Photographic examples of capsular polysaccharide sizes from different
culture fluids and stained with Maneval's stain and observed at lOOx magnification.
(A) A1 from otbw the largest capsule observed, (B) A2 from btbw showing large
capsule, (C) A2 from otbw showing medium capsule, (D) T10 from btbw showing
small and partial capsule present and (E) T10 from LS shows what was regarded as




Culture supernatants from four hour cultures (overnight for broth containing hemin)
of the three serotypes grown in various fluids was analysed for the presence of


























Table 3.12. The effects of culture supernatant on the viability of BL-3 cells.
Percentage viability is based on cells with culture supernatant alone (100% viable)
and Triton X100 killed cells (100% dead cells). EDDA at 200p,M and Haemin at
50pM.
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Table 3.12 shows that with all serotypes only culture supernatants from TSB, iron-
restricted broth and broth containing hemin were toxic for BL-3 cells. This indicates
that leukotoxin was actively toxic only in these cultures. The in-vivo fluid cultures
showed no cytotoxicity for BL-3 cells although different growth rates may have meant
that leukotoxin was produced at a different time other than that tested .
Leukotoxin was prepared from each of the three serotypes and compared. Leukotoxin
preparations were run on SDS PAGE and Western blotted. A polyclonal rabbit
antiserum raised against PAL2 leukotoxin (recombinant A1 leukotoxin) was used to
probe the preparations as this is the only serum which recognised the leukotoxin
protein from all three serotypes. Fig 3.24 shows the Western blot with recognition of
all the serotypes' leukotoxin at relatively similar levels. The protein present in the
preparations was 10.8 mg, 10.6 mg and 10.9 mg for Al, A2 and T10 respectively.
This suggests that there was equal amounts of leukotoxin present in the preparations.
Table 3.13 shows that the cytotoxicity for BL-3 cells of the leukotoxin preparations of
Al and A2 was similar with 93% and 88% killing respectively. T10 leukotoxin
showed only 35% killing and so appeared significantly less toxic. This may indicate
that the T10 leukotoxin is not as potent as the toxin from the other two serotypes.
Using ovine convalescent serum, Al leukotoxin was neutralised (74%) by
homologous antiserum at 1/200 dilution. The ability to neutralise Al leukotoxin with
the heterologous antiserum of A2 and T10 was only 30% and 41% respectively when
those antisera were at 1/50 dilution. The comparative neutralisation, at 1/200 dilution
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Fig 3.24. Western blot of serotypes Al, A2 and T10 leukotoxin preparations probed
with rabbit antiserum raised against recombinant leukotoxin.
lOpl were loaded into each well. T10 leukotoxin (lane 1), A2 leukotoxin (lane 2), Al
leukotoxin (lane 3) and molecular weight markers (lane 4).
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of the antiserum, of A1 was 4% and 2% for A2 and T10 respectively. Serotype A2
leukotoxin was neutralised by homologous antiserum (1/200 dilution) at 55%,
whereas the heterologous antiserum of A1 and T10 neutralised at 62% and 65%
respectively, all at the same dilution.
SAMPLE ANTISERUM
(DILUTION)
% VIABLE CELLS % NEUTRALISATION
At NA 7 NA
At A1 (1/50) 71 69
At A1 (1/100) 74 72
At A1 (1/200) 76 74
At A2 (1/50) 35 30
At A2 (1/100) 14 8
At A2 (1/200) 10 4
At T10 (1/50) 45 41
At T10 (1/100) 33 28
At T10 (1/200) 9 2
A2 NA 12 NA
A2 A1 (1/50) 71 67
A2 A1 (1/100) 41 34
A2 A1 (1/200) 66 62
A2 A2 (1/50) 77 74
A2 A2 (1/100) 74 71
A2 A2 (1/200) 61 55
A2 T10 (1/50) 67 63
A2 T10 (1/100) 69 64
A2 T10 (1/200) 73 65
T10 NA 65 NA
T10 A1 (1/50) 73 73
T10 A1 (1/100) 65 70
T10 A1 (1/200) 62 55
T10 A2 (1/50) 23 63
T10 A2 (1/100) 70 64
T10 A2 (1/200) 36 64
T10 T10 (1/50) 65 69
T10 T10 (1/100) 70 60
T10 T10 (1/200) 72 56
NA, not applicable
Table 3.13. Cytotoxicity of leukotoxin preparations from serotypes and the
neutralising capacity of homologous and heterologous antiserum.
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T10 leukotoxin was similar to A2 leukotoxin in that 1/200 dilution of the antiserum
resulted in 56%, 55% and 64% neutralisation when Al, A2 and T10 antiserum were
reacted against T10 leukotoxin.
Although cell lines (in this case BL-3 cells) are useful to compare effects of different
treatments, they do not represent the in-vivo cells which are affected by interactions
with Pasteurellae toxins or other cell products. Ovine and bovine macrophages were

















Al NA 37 63 55 NA
A2 NA 34 66 46 NA
OVINE T10 NA 26 74 68 NA
Al Al 73 27 NA 80
A2 A2 80 20 NA 95
T10 T10 64 36 NA 67
Al NA 25 75 59 NA
A2 NA 48 52 21 NA
BOVINE T10 NA 45 55 26 NA
Al Al 58 42 NA 91
A2 A2 61 39 NA 100
T10 T10 59 41 NA 87
NA - Not applicable.
Table 3.14. The effect of leukotoxin on ovine and bovine macrophages and the
subsequent effects of homologous antiserum.
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Table 3.14 shows that the percentage killing of ovine macrophages was similar at 55,
46 and 68% for Al, A2 and T10 respectively. Although the killing of ovine
macrophages as compared to BL-3 cells was increased with T10 leukotoxin, killing by
Al and A2 leukotoxin was lower. Neutralisation was much higher than with BL-3
cells as: Al gave 80%; A2 gave 95% and T10 gave 67% neutralisation with
homologous antiserum.
The bovine macrophages showed a slight increase in killing by Al leukotoxin when
compared to ovine macrophages but the effects of A2 and T10 leukotoxin are greatly
reduced at 21% and 26% respectively. Again, the neutralising capacity of homologous
antiserum was higher than that for BL-3 cells and ovine macrophages with 91, 100
and 87% neutralisation for Al, A2 and T10 respectively.
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3.9. Discussion
The production of antiserum against the three serotypes was successful. IgG responses
increased over time and a number of antigens were recognised. The ovine antiserum
also possessed leukotoxin neutralising antibody and bactericidal activity (latter work
not in this thesis, M.Maley, pers comm). When the serum was tested in the IHA (a
measure of anti-capsule antibodies) against the standard antiserum used for typing
Pasteurellae serotypes differences were observed. The rabbit antisera was similar to
the standard antisera except for the presence of a higher titre in the case of anti-Al
serum. Antibodies against the A2 serotype in all the sera tested were poor and in the
standard antiserum even though when previously tested the titres were much higher.
There is a possibility that prior to necropsy the high titre present was due to the
presence of IgM antibodies which were susequently lost, with the result that the serum
taken at post mortem does not possess a high titre. A2 has been shown to possess a
capsule which does not induce a good immune response. However, antibodies
against A2 capsular antigen correlate with protection against pasteurellosis (Adlam et
al., 1987; Mustafa, 1995). Recovery from, or resistance to, pasteurellosis challenge
during the production of antibodies in this study, appears not to correlate with
antibodies to the capsule antigen. This may be the reason why the ovine anti-capsular
antibodies are low in comparison to the rabbit antibody titre as pasteurellosis is not a
disease of the latter although the rabbits are usually hyperimmunised.
Although the serotypes were successfully grown in iron-restricted conditions the use
of chemically defined medium was not successful due possibly to trace amounts of
divalent cations present in some of the other constituents of the medium. These could
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possibly have been removed by passing the medium down a Chelex 100 column
(which removes iron) or even by passage of the strains in successful iron-restricted
media, treatment that was eventually adopted for depletion of intracellular iron and
which appears to have stimulated iron regulated protein expression.
For this study chemical chelators aa dipyridyl and EDDA were used. There was a
general trend towards growth of the serotypes in broth at higher concentrations of aa
dipyridyl than EDDA and the aa dipyridyl allowed sequential passage up to seven
times. It appears from this study that there may be internal storage mechanisms
available for iron in Pasteurellae as evidenced by the ability to deplete completely on
passage of the cultures through successive chelated broths. The differences between
the mechanisms of the chelators, aa dipyridyl chelates internally and EDDA chelates
externally may explain some of the results. As aa dipyridyl is internalised in the
bacteria, some of the earlier concentrations could have been toxic or may not be as
efficient in chelating from an intracellular position. Conversely EDDA has the iron
bound before it has a chance to be delivered to the bacteria and is a better chelator
for this type of study as shown in the results. The passage experiment allowed a level
of iron restriction to be achieved to the point where the bacteria could no longer live
without an additional iron source present. This allowed the screening of some iron
compounds not previously shown to be able to replete the growth of Pasteurellae
under restriction. Although haemoglobin and haem containing compounds have been
shown to enhance infection and toxicity with Pasteurellae ( Chengappa et a., 1983;
Gentry et al., 1986) they have not been tested in vitro as the sole sources of available
iron. It is interesting that unlike the situation with the acquisition of iron from
transferrin, which is host specific, it appears that all serotypes can utilise any species'
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haemoglobin. The haem molecule alone which in-vivo probably comes from
haemoglobin can also support the growth of all three serotypes. Leukotoxin which
shows a broader target cell specificity than previously thought has been implicated in
the haemolysing effect on red blood cells (Murphy et al., 1995). However, leukotoxin
activity was low, and haemolysis of red blood cells was observed in the uninoculated
media controls. The results implicate leukotoxin involvement of the lysis of red blood
cells was based upon examination of P-haemolysis. This link with haemolysis,
however, needs more attention as other authors (Chidambaram et al., 1995) have
shown haemolytic activity by leukotoxin-negative mutants to be similar to the wild
type strain. The acquisition of iron by utilising haem compounds needs more
attention as different mechanisms from those previously described for transferrins are
being employed.
The SDS PAGE protein profiles of all the serotypes differed depending on the fluid
which sustained growth. Iron-restricted cells from the serotypes showed the presence
of IRPs at the correct molecular weight described previously (Donachie & Gilmour,
1988; Deneer & Potter, 1989; Davies et al., 1992; 1994a), T10 possesses an IRP at
approximately 80kDa which could be the 78 IRP described by Murray et al. (1992).
Al possessed proteins of approximately 70, 50, 40, 35, 30 and 25 kDa while with A2
proteins 77, 70 and 65 kDa were identified T10 proteins of approximately 80, 40, 35
and 30 kDa were identified. Most of the IRP proteins were present in the serum
cultures especially those grown in NCS. The similarity of protein profiles from NCS-
grown bacteria and in-vivo isolated bacteria has been described by Davies et al.
(1994a) with growth conditions in both cases also stimulating previously described
IRPs. He also found the the expression of IRPs from in-vivo cells was not as strong as
those from iron-restricted culture which may explain why most differences are
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observed in the iron-restricted cultures. It may be the case that, due to the iron
acquisition mechanisms which are present in Pasteurellae serotypes, in-vivo fluids or
natural in-vivo growth does not constitute a growth restriction and the expression of
IRPs is therefore lower. Another possibility is that the in-vivo environment is
extremley complex and iron restriction is just one variable which initiates the
expression of new proteins. Both A1 and A2 had obvious proteins missing from iron-
restricted culture in comparison to iron replete media (TSB) at approximately 97 and
45 kDa in A1 and 90 and 55 kDa in A2. The precise nature of these proteins is
unknown but they may not be required during the process of scavenging for iron but
are expressed again once the cells are iron sufficient.
Most of the information on IRPs present came from Western blots using convalescent
sera. Only the 70 kDa protein was recognised in serotype A1 whereas in A2 proteins
at 77 kDa which were also identified in in-vivo isolated cells were apparent and those
70, 50 and 40 kDa proteins were also recognised. T10 possessed IRP bands which
were recognised at 100, 70, 35 and 46 kDa some of which were present in serum and
tbw cultured samples. Monoclonal antibodies and specific antiserum helped to
determine which proteins are expressed in certain fluids. The 35 kDa IRP was present
in all A2 samples in envelopes and cell contents except in in-vivo isolated cells. This
suggests that the 35 kDa protein is not necessarily iron restricted ( in contrsat to
Lainson et al, 1991) but may well be an iron regugulated protein. The same result was
also observed in Western blots with convalescent serum failing to recognise a protein
of approximately 35kDa in iron-restricted, serum cultures and in-vivo isolated cells. It
may be that in-vivo conditions modify slightly the protein so that it becomes
unrecognisable to antibodies. It may also be that the protein is not expressed in vivo
and that previous recognition by convalescent serum (Lainson et al., 1991) may be
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due to other 35 kDa proteins present at the same molecular weight. The protein was
also observed in A1 envelopes samples and in T10 grown in otbw. The presence of
the protein has not previously been shown in other serotypes. This may be due to the
culture conditions and hence variation in the epitopes present on the proteins resulting
in recognition by antibodies. The position as the protein is present in the envelopes, is
also different to the proposed position by Lainson et al. (1991) for A2, so that the
mechanisms of iron acquisition may differ slightly between serotypes.
The difference in iron acquisition mechanisms is also observed with the presence of
the haemopexin receptor which has been shown only in ovine strains and so is not
present in the Al serotype as this is a bovine isolate. T10 expresses different IRPs
and does not appear to possess this protein. The receptor was present in iron-
restricted, LS and in-vivo A2 cells, highlighting the similarity of iron-restricted and
serum cultures with in-vivo cells (Davies et al., 1992). The reason why the protein is
not expressed in NCS may be due to the species specificity reported for the protein.
The receptors are found in strains isolated from ovine cases only, so it appears there
is no requirement for a receptor of that kind for strains growing in a bovine
environment and is therefore not expressed in bovine serum-grown cells. The
transferrin binding proteins were also present in differing combinations in all
serotypes. As the antibodies were raised against the A2 proteins slight serotype
differences in epitopes may indicate that the protein is not present when it actually is.
All serotypes possessed high molecular weight proteins, especially in bacteria from
serum cultures. Proteins at this molecular weight have been described in serotype Al
from in-vivo grown cells (Confer et al., 1992). A2 envelope proteins of 40 and 29 kDa
could be similar to the 41 and 29.5 kDa major OMPs described by Morton et al.,
1996. Another two A2 proteins at 100 and 65 kDa were described also by Sutherland
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et al., (1990) in in-vivo cells. A 116 kDa protein present in preparations of A1
bacteria could be the Al specific protein described previously ( Gonzales-Rayos et al.,
1986).
The main proteins expressed during growth of all serotypes in serum appeared to
differ by approximately 2kDa. This indicates that the environment of growth may
change the proteins slightly possibly by glycosylation, which then affects the
molecular weight of the protein which can then be identified wrongly as a new
protein. Another problem of protein identification and comparisons with other studies
is those proteins which reside at the same molecular weight. In A2 there are three
proteins present at 70 kDa and two at 100 kDa ( Donachie, 1994; Davies et al., 1996).
This may interfere with antibody recognition and shows the need to separate these
proteins and produce specific antibodies to use as tools before screening for their
presence in in-vivo cells.
This study is in agreement with Sutherland et al. (1990) and Davies et al. (1992) in
the identification of host proteins bound to the surface of the bacteria. The bands
between 50-52 and 20-28 kDa present in all serotypes are probably the IgG light and
heavy chains. Other host proteins were also bound. This observation may be important
as the host proteins may be bound to important antigens. In contrast, the bacterial
proteins may not be important antigenically and divert antibody responses away from
the impotant antigens. Only with direct comparison with in-vivo grown cells can an
indication of an in-vivo fluid representing bacteria in-vivo be made. Serum-grown
bacteria possessed proteins which appeared to resemble those proteins which have
been described previously as belonging to in-vivo bacteria. Growth of serotypes in
otbw did not produce unique protein profiles. PBS-stressed cells appeared to produce
less of most proteins but there appeared no induction of stress proteins, although
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further separation was not carried out beyond identifying envelope and cell contents.
A2 bacteria from isolation in vivo also had little reaction with antibody on Western
blots, which may indicate changes in vivo which helps to evade immune recognition.
Morton et al. (1996) indicated that the variations in strains, extraction procedures, gel
densities and molecular weight standards can make large differences in comparisons
with previously described proteins.
Growth in btbw was shown to disrupt production of LPS dramatically in all serotypes.
This may be due to the presence of antibodies interfering with the development of the
LPS or to a nutritionally deficient medium, which would prevent synthesis of the
molecule. Al LPS has been identified in-vivo in the bovine respiratory environment
(Whiteley et al., 1990) so the absence of LPS could be a unique feature of growth in
this particular tbw. It was thought that the LPS could not be observed on silver stained
gels due to changes on the molecule to adapt to a different growth environment. The
endotoxin amounts show that endotoxicity was present, although low, and so this was
probably not the case. It is more likely there was an overall reduction in total LPS
molecules on the bacteria and that the method employed may have added to the lack
of observation. Western blotting showed previously unseen O-antigen on the Al LPS
molecule. In certain media Al will produce an O- antigen side chain. O-antigen was
also observed in the T10 samples which has been shown to be of smooth type LPS. O-
antigens are important as they have been shown to reduce the accessibility of
antibodies to the core region (where the endotoxic Lipid A is present) (Nelson et al.,
1991). This may account for the differences observed in reported bactericidal
activities of antibodies. LPS of P. haemolytica has been shown to be the binding site
for bactericidal antibodies (Sutherland et al., 1988; Brogden et al., 1992). The
antibodies work probably by destabilising the LPS. This effect as described by
147
Sutherland et al. (1989) does not happen in P. trehalosi due probably to the diversion
of antibodies away from the core towards the O- antigen. The lack of recognition by
homologous and heterologous antiserum of the core of T10 LPS may give some
indication of the differences between disease syndromes, although O-antigen
specificity is well documented (Rietschel et al., 1990). Systemic T disease has been
shown to be a classic endotoxaemia (Hodgson et al., 1993), therefore the raising of
antibodies to the core may be important in protection. LPS has been shown to bind
host proteins (Morrison, 1990) and although this was not apparent from the gel
profiles it may explain the O-antigen presence only on the Al serotype in certain
growth fluids. Confirmation of the presence of different serum constituents attached to
the molecule would need chemical analysis of the structures especially of isolated in-
vivo bacteria.
Confer et al. (1992) and Sutherland et al. (1990) both reported no differences
between in-vitro and in-vivo LPS. The two authors reported also that there was no
difference between capsule sizes. Gatewood et al. (1994) found that capsule size
differed depending on the growth conditions with Al and suggested the capsule was
changing in response to growth conditions. It is possible that large capsules observed
in this study were due to the presence of antibodies which may have initiated capsular
swelling. Gilmour et al. (1985) reported that Al could possess an irregular capsule.
This study reported that there appeared no degradation of capsule in 18 hour cultures
as reported by Corstvet et al. (1982). Gilmour et al. (1985) also reported that P.
haemolytica capsules may appear in different forms, either as aggregations or as a
discrete continuous envelope and this may reflect the differences observed here in
different media. P. trehalosi were reported to possess thinner capsules which may be
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why capsules in this study were relatively poor in most media in comparison to A1
and A2.
The relevance of these different size capsules would have to be evaluated in
experiments where capsules are thought to be important such as phagocytosis
experiments. Although capsules can enable bacteria to resist phagocytosis the process
may be enhanced by deposition of C3b complement component. Some capsules such
as meningococcal group b, with which A2 shares a capsule structure, fail to activate
complement (Adlam et al., 1987; Moxon & Kroll, 1990). In vivo, however,
Sutherland et al. (1990) observed that A2 were aggregated together with glycocalyx
type structures and these may have been important in resistance to phagocytosis.
There is generally much more investigation required into the functions of bacterial
capsules as the presence of capsules can be contradictory to generally held ideas of
capsule function as discussed by Moxon & Kroll ( 1990 ). The evidence that capsules
impair phagocytosis, interfere with complement and reduce the immunogenicity of an
organism are known. However, the majority of infections which occur through
contiguous spread of Haemophilus influenzae (otitis media, sinusitis and pneumonia)
are caused by capsule deficient strains.
The identification of leukotoxin in the supernatants of different growth conditions was
variable. Broth cultures at four hours incubation produced evident cytotoxicity for
BL-3 cells, but cytotoxicity was also present in 18 hour cultures which contained
hemin. Iron compounds have enhanced the cytotoxicity of P. haemolytica
(Chengappa et al., 1983; Al-sultan & Aitken, 1984; Gentry et al., 1986). However,
little data is available on the amounts of leukotoxin produced in iron-restricted cells. If
leukotoxin is responsible for the haemolytic effect observed in Pasteurellae it would
make sense that leukotoxin production is increased under iron-restriction in-vivo to
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acquire an iron source in the form of haem from red blood cells. Gatewood et al.
(1994) established that production of leukotoxin was relatively independent of growth
conditions and more closely associated with growth rate. There was no cytotoxicity
present in any of the in-vivo fluids in any of the serotypes. This may be due to the
presence of neutralising antibodies although a neutralisation assay combining these
fluids suggested that this may be true only for lamb serum. Other in-vivo components
may bind and inactivate the leukotoxin or the conditions may not have stimulated
leukotoxin production. Whiteley et al. (1990) showed the presence of leukotoxin in-
vivo and studies at MRI have shown that leukotoxin is present and active in pleural
fluid, so inactivation is the most probable explanation.
Protein content and Western blots indicated similar amounts of leukotoxin present in
preparations from the three serotypes. Although Al and A2 possessed similar
cytotoxic activity against BL-3 cells the activity of T10 leukotoxin was comparatively
low. Neutralisation of leukotoxin revealed that Al possibly possesses a unique major
neutralising epitope as evidenced by the lack of cross neutralisation by A2 and T10
antiserum. Heterologous neutralisation of A2 and T10 leukotoxin was similar to
homologous neutralisation. This indicates that antibodies raised against Al leukotoxin
are probably important in infection as they will cross-react with other serotypes, but
antibodies to other serotype leukotoxins will not protect against Al leukotoxin. As Al
is the most prevalent serotype in bovine pneumonic pasteurellosis and as much of the
pathology of the disease is due to leukotoxin and other excreted products it is clear
why the vaccines which contain leukotoxin in a supernatant mixture appear to be so
effective.
BL-3 cells are useful for toxicity assays but tell us little about the interactions of P.
haemolytica and P. trehalosi with cells in-vivo. Macrophages of both ovine and
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bovine origin were less affected by the leukotoxin of all three serotypes in comparison
to BL-3 cells. Killing of ovine macrophages and neutralisation were similar in all
three serotypes although heterologous antiserum neutralisation was not carried out. In
bovine macrophages A1 leukotoxin killing was markedly higher than A2 and T10
which indicates some species specificity of serotype A1 for bovine macrophages. This
may explain the high incidence of A1 in bovine cases of pasteurellosis. One of the
important observations is that although the killing was lower in macrophages than
BL-3 cells, the neutralising capacity of the antiserum was much higher, indicating a
possible interaction between macrophage and antibody which enhances protection
from the effects of leukotoxin.
The fluids used are, however, not applicable unless they are representative of the
organism in-vivo. Many differences have been identified during the analysis of these
serotypes grown in "in-vivo" fluids they do appear to resemble in vivo organisms
especially when grown in serum. This would increase the knowledge of Pasteurellae




SURVIVAL OF P. HAEMOLYTICA AND P. TREHALOSI IN 'IN-VIVO'
FLUIDS
4.1. Introduction
Iron-restricted proteins produced by bacteria in-vivo provide an understanding into the
situation whereby nutrients are present but not readily utilisable. This may well be the
normal situation for bacteria in-vivo with respect to their requirement for many types
of nutrients. Bacteria which colonise tissue surfaces in a host will no doubt be under
stress not only from defence mechanisms but also from low nutritient availiability.
The nutrients may be restricted by host mechanisms or through competition from
other bacterial species present. Pathogens such as Pasteurellae spp, which commonly
colonise the tonsils and nasopharynx of ruminants, survive in this environment in low
numbers. Bacteria are not always found and their appaerence during nasal swabbing
fluctuates. Little is known about the bacteria in this state. Due to the differences
observed in the protein profiles detailed in the last chapter, it may be that some
proteins are important in survival in those particular fluids. This study will monitor
whether the use of "in-vivo" fluids, which would naturally be present in vivo, would
enable the serotypes to withstand nutritional stress and aid recovery on the addition of
nutrients.
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4.2. Growth and survival monitoring by viable counts
Serotypes Al, A2 and T10 were inoculated into various 'in-vivo' fluids, incubated at
37° C and sampled at selected time periods to determine viable counts on blood agar.
The growth and survival graphs (Fig 4.1. a-d, for raw data see Appendix II) indicate
the ability of the serotypes to grow in such fluids. In ovine tracheobronchial washings
(otbw, Fig 4.1a) all serotypes showed initial growth equal to that observed in
laboratory media.
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Fig 4.1a-d. Graphs showing the growth and survival of serotypes Al, A2 and T10 in
ruminant fluids at 37° C. Bacteria were inoculated into 5ml of the fluids and sampled
at various times (from duplicate cultures), diluted and plated (in triplicate) onto 7%
sheep blood agar for viable counts (counts are expressed as the mean). Fresh media
was added on days 244 and 247 in otbw and days 153 and 154 in btbw.
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The appearance of micro-colonies with serotype T10 was apparent at day 14 and
lasted until day 264. As micro-colonies could not accurately be counted by eye, and
there was no obvious loss of viability, the last viable count was deemed not to have
altered. A1 and A2 showed a periodic rise and fall in viability (which is probably what
T10 actually did) with A1 then showing extended micro-colony appearance after 244
days. There was a requirement to assess whether the addition of fresh fluids (the same
fluid which was already present) would have any effect (increase viability, change in
colony morphology and/or result in a decline in viability). The addition of fresh media
(approximately lOOpl/ ml of fluid present) on days 244 and 247 resulted in a lag phase
before any reaction was observed. T10 declined rapidly and A1 did not change, apart
from a brief return to 'normal' colony morphology. A2, however, increased in
viability. The lack of viability of T10 is attributed to the loss of growth on sheep
blood agar plates. It was still viable when inoculated into nutrient broth. In bovine
tracheobronchial washings (btbw, Fig 4.1b) no initial growth was observed and all
three serotypes had similar viability patterns with a rise and fall in viability between
106 and 104 cfu/ml. The addition of fresh serum on days 153 and 154 caused a rise in
viable counts with all serotypes and this rise was higher than the original inoculum
(which was not observed at 24 hours incubation). Growth in lamb serum (LS) or
newborn calf serum (NCS) was relatively steady over 314 days with all serotypes.
The lack of micro-colony formation and the consequent ease of counting colonies
meant that fresh serum was not required to see if the bacteria were capable of
resuscitation to normal colony morphology.
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Fig 4.2a-d. Graphs showing the survival of serotypes Al, A2 and T10 in ruminant
fluids at 37° C. Bacteria were inoculated into 5ml of the fluids at a higher inoculum
than the growth and survival experiment and sampled at various times (from duplicate
cultures), diluted and plated (in triplicate) onto 7% sheep blood agar for viable counts
(counts are expressed as the mean). Fresh fluids were added on days 337 and 340 in

















The survival experiments (Fig 4.2. a-d, for raw data see Appendix II) dealt with a
higher initial inoculum to see if survival over a long period of time was inoculum
dependent. In otbw (Fig 4.2a) an initial drop in viability was observed followed by a
pattern of rise and fall in viability as seen with the growth experiments. T10 again had
micro-colony morphology on days 107- 342, and 379-407, A1 had micro-colony
morphology on days 340 and 357-407. The addition of fresh serum on days 337 and
340 caused a brief return to 'normal' colony morphology with A1 and T10 and an
increase again in viability for A2. The survival pattern in btbw (Fig 4.2b) was again
similar to that observed previously with a large slow decline in viability over time
with T10 micro-colonies on days 156-173 and 195-203. This time however both A1
and A2 showed an increase in viability on the addition of fresh media on days 153 and
156 whereas T10 appeared to diminish with only micro-colonies observed and
'normal' colony type observed only on day 173 which was 17 days after the last
addition of fresh media. The serum cultures were no different from those observed in
the growth and survival graphs.
When representative nutrients were analysed (Table 4.1) it was found that the
nutritional contents differed between the sera and tbws.
Nutrient Bovine tbw Ovine tbw Newborn Lamb
calf serum serum
Protein g/L 0.07 0.84 71 81
Glucose mmole/L 0.02 0.07 4.03 2.2
Iron pmole/L 1.38 1.59 14.7 27.9
Table 4.1. Representative nutrient levels of 'in-vivo' fluids used in growth and
survival of serotypes.
The survival behaviour of the serotypes is not easily comparable between the different
fluids because of nutritional differences. The high levels present in serum may be the
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reason why replenishment was not required. Although the levels of glucose and iron
in the tbws are not dissimilar, protein levels were much higher in otbw than btbw and
probably account for the inability to support growth and extended survival.
4.3. Survival in fluids from other species
To address the question of species specificity of survival in in-vivo fluids tbw and
serum from a number of different species were used, along with control bacteria. The
fluids were all adjusted to approximately the same levels based on protein
measurements (Table 4.2).
Fluid Protein mg/ml Glucose mmole/L Iron pMole/L
LS (Lamb serum) 0.10 0.009 1.07
NCS (Newborn calf 0.06 0.009 2.30
serum)
PS (Porcine serum) 0.13 0.023 0.67
FIS (Horse serum) 0.08 0.010 7.33
otbw (Ovine) 0.13 0.006 5.51
btbw (Bovine) 0.11 0.011 0.75
ptbw (Porcine) 0.04 1.068 3.13
ltbw (Laprine) 0.06 0.029 3.19
mtbw (Murine) 0.12 0.079 2.44
etbw (Equine) 0.13 0.067 4.11
ctbw (Canine) 0.08 0.028 1.68
hutbw (Human) 0.04 0.009 0.66
TSB <0.01 0.729 5.16
Table 4.2. Nutrient values of all tbws and sera used in an experiment to investigate
species specificity role in survival in in-vivo fluids.
Fig 4.3 shows survival in otbw (A2 and T10), btbw and mtbw (A1 and A2), ptbw (A1
and T10), A1 in hutbw and all three serotypes in diluted TSB. Serum at this level
would not support any survival. Control organisms, Neisseria meningitidis and
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Haemophilus somnus did not survive for 24 hours in any fluid at any temperature. E.
coli 0157 survived in all fluids at 37°C and 4° C for at least 65 days.
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Fig 4.3. Survival of serotypes Al, A2 and T10 in tbws and serum from different
species at 37°C. Fluids were adjusted to approximately the same protein concentration
then inoculated with the bacteria and sampled as previously described (Fig 4.1).
Viability was identified by inoculating 10pl into 10ml of nutrient broth and















FLUID SEROTYPE ROOM TEMP 4°C
A1 1 1
otbw A2 0 9
T10 0 1
A1 1 1
btbw A2 1 9
T10 0 9
A1 1 1
ptbw A2 1 9
T10 0 1
A1 0 1
ltbw A2 0 9
T10 0 1
A1 0 0
mtbw A2 0 1
T10 0 9
A1 1 1
etbw A2 1 9
T10 0 1
A1 0 0
ctbw A2 0 1
T10 0 1
A1 0 1
hutbw A2 0 9
T10 0 1
A1 0 0
TSB A2 0 1
T10 0 1
A1 0 0
LS A2 0 1
T10 0 1
A1 0 1
NCS A2 1 9
T10 0 1
A1 0 1
PS A2 1 9
T10 0 1
A1 0 0
HS A2 0 9
T10 0 1
Table 4.3. Table showing days survival of serotypes inoculated into different tbw and
sera and incubated at room temperature (approximatley 25°C) and 4° C. Viability was
identified as in Fig 4.3.
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When the incubation temperature of the fluids was lowered (Table 4.3) however, A1
survived at room temperature in otbw and A2 survived in NCS and PS which gave no
indication of viability when incubated at 37° C.
The results for the 4°C culture were even more dramatic and showed increased
survival time for serotypes in fluids they previously did not survive in, especially
serotype A2. This supports the evidence from Western blots that the serotypes were
inhibited by something other than IgG bactericidal activity. The blots (Figs 4.4-4.6)
show that there is no correlation between the ability to grow and/or survive and IgG
recognition.
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Fig 4.4. Western blots of envelope preparations of serotype A1 and probed with
different tbws and serum to assess IgG recognition of proteins, (conjgates used at
1/200 dilution)
LS (lane 1), NCS (lane 2), PS (lane 3), HS (lane 4), otbw (lane 5), btbw (lane 6), ptbw
(lane 7), etbw (lane 8), mtbw (lane 9), ltbw (lane 10), hutbw (lane 11), ctbw (lane 12)
and molecular weight markers (lane 13).
Fig 4.5. Western blots of envelope preparations of serotype A2 and probed with
different tbws and serum to assess IgG recognition of proteins.
Molecular weight markers (lane 1), LS (lane 2), NCS (lane 3), PS (lane 4), HS (lane
5), otbw (lane 6), btbw (lane 7), ptbw (lane 8), etbw (lane 9), mtbw (lane 10), ltbw
(lane 11), hutbw (lane 12) and ctbw (lane 13).
Fig 4.6. Western blots of envelope preparations of serotype T10 and probed with
different tbws and serum to assess IgG recognition of proteins.
LS (lane 1), NCS (lane 2), PS (lane 3), HS (lane 4), otbw (lane 5), btbw (lane 6), ptbw
(lane 7), etbw (lane 8), mtbw (lane 9), ltbw (lane 10), hutbw (lane 11), ctbw (lane 12)
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4.4. Survival in natural water
Survival has been shown in very low nutrient conditions and at low temperatures
suggesting that pasteurellae may survive in natural water. Natural water was collected
(Loch Etive, Scotland) and filtered through a 0.2pm filter. The serotypes were
inoculated into the water as in previous survival experiments and after incubation at
different temperatures were sampled for viability. As with the previous experiment the
low nutrient levels resulted in loss of colonies on agar and broth inoculation was
therefore used to identify viable organisms. Fig 4.7 shows that survival of up to 4 days
for serotype A2 was possible in lake water which contained no detectable protein. The
lower the temperature that the cultures were incubated at the longer the survival.
Inoculation and growth in broth also shows the ability to resuscitate quickly in the
presence of a nutrient influx and raised temperature.
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Fig 4.7. Survival in fresh water of serotypes Al, A2 and T10 at different temperatures.
Cultures were set up as previously described (Fig 4.1) and sampled daily for viable
counts and for growth in broth at 37° C.
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4.5. Analysis of bacterial morphology
One of the most important observations during survival was the change in colony
morphology from 'normal' to micro-colonies (Fig 4.8). The difference in size and
numbers present is quite different and these colonies did not grow when diluted and
were only observed on agar when plated straight from the culture. These colonies
when subcultured onto blood agar regained their normal colony morphology. Gram's
stain was used to compare micro-colonies to 'normal' colonies. Fig 4.9 shows that
serotype A2 micro-colonies were only slightly different when compared to 'normal'
colonies but they were less pleomorphic in size and shape. Figs 4.10 and 4.11 show
A1 and T10 respectively forming long chains of elongated bacteria with small
pleomorphic bacteria apparent in the background. When examined using electron
microscopy with negative staining A1 and A2 (Fig 4.12 a and b) four hour cultures
show typical pleomorphism of the bacteria. At higher magnification all three
serotypes show the typical differences (Fig 4.13 a-f), which were also observed using
light microscopy , in the size and shape of the bacteria when three hour cultures and
micro-colony bacteria are compared.
When bacteria taken straight from starvation fluids were examined they would not
take up Gram's stain and could not be observed. However, the use of Maneval's stain
overcame this problem and Fig 4.14 shows very small bacteria closely associated and
enclosed in what appears to be a glycocalyx of biofilm type structure. If this structure
contained capsular polysaccharide this may explain how samples straight from culture
and micro colonies still serotyped in the IHA.
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Fig 4.8. Example of micro-colonies. This sample is serotype T10 from long term
culture next to an overnight culture from TSB. Samples were dropped neat (10 pi)





Fig 4.9. Serotype A2 from (A) 'normal' colonies and (B) from micro-colonies. The








Fig 4.10. Serotype A1 from (A) 'normal' colonies and (B) from micro-colonies. The











Fig 4.11. Serotype T10 from (A) 'normal' colonies and (B) from micro-colonies. The
samples were Gram stained.
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Fig 4.12. Negative stained electron microscopy of A1 (A) and A2 (B) four hour
cultures in TSB showing typical polymorphism with long bipolar stained bacteria and
small dividing cocci shaped bacteria.
171
Fig 4.13. Negative stained electron micoscopy comparing bacteria from four hour
cultures with micro-colony bacteria. A1 four hour (A), A1 micro colony (B), A2 four
hour (C), A2 micro colony (D), T10 four hour (E), T10 micro colony (F). All bacteria
were typical of those which were present on the grids. The micro-colony samples
however did have a tendancy to be present in long chains with no obvious joins which
has been observed in the light microscopy photographs. These chains were too long





Fig 4.14. Maneval's stain of serotypes A1 (A) and T10 (B) directly from long term
cultures without subculture. The pictures show the bacteria are much smaller and
closely associated in what appears to be a glycocalyx type structure.
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4.6. Discussion
The results of this study show that P. haemolytica and P. trehalosi have the ability to
survive for long periods of time in relatively low nutrient 'in-vivo' fluids. Unlike
most other bacteria, shown to have this capacity, the Pasteurellae spp are not
regarded as being prevalent in the environment. Bacterial survival has been
demonstrated in different environments such as soil, natural and marine waters
(Morita, 1988). Stored soil samples analysed after 54 years showed bacteria oxidising
sulphur and producing CO2 Bacillus spp, Coryneforms and Streptococcus spp from 70
year old soil have been isolated. Ant-300 a marine vibrio survived 2.5 years in a
starvation menstrum but would possibly have remained viable much longer. Also a
marine pseudomonad remained viable at ~105 cfuml"1 for over 1 year (Novitsky &
Morita, 1976). Morita (1993) cited an experiment by Iacobellis and DeVey who
showed that 14 isolates of Pseudomonas syringae subsp. syringae survived in distilled
water for 24 years. The bacterial viable counts averaged 108cfuml"1 and dropped only
two or three logs over the time period and also retained their antigenic properties.
Few studies have investigated the capacity of bacteria (especially those which are
pathogenic for humans and animals) to survive in body fluids. However, Blasser et
al., (1980) studied the growth of Campylobacter fetus subsp. jejuni in HC1 (to mimic
gastric juice), human bile, urine, bovine milk and stream water. The organism
survived for 30 minutes (pH dependent), 2 months, 5 weeks, 22 days and 4 weeks
respectively. Porter & Wardlaw (1994) used tbws from different species and showed 7
days survival for Bordetella bronchiseptica and B. avium in all species' tbw tested. In
contrast, the survival ofB. pertussis was less than 2 days in human, mouse, sheep and
chicken tbws whereas the bacteria were detectable in horse, dog and rabbit tbws after
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2 days but not at 7 days. Growth did not occur with B. pertussis whereas prior to
survival B. bronchiseptica grew in sheep, human, mouse, rabbit and chicken tbws.
There may have been some effect of individual fluids as one human tbw tested did not
allow growth or survival beyond day 2 for all species of bordetellae tested.
Morita (1985) produced a model graph showing four patterns of survival: a) increase
in numbers followed by decline; b) rapid dying; c) increase of viable cells followed by
a constant level; d) no dying or increase. These patterns however may depend on the
nutrients available, state of the organism and the inoculum. In this study the growth
and survival experiment would fit comfortably into Morita's classification 'a' except
in the case of btbw, whose low nutrient content could not sustain growth of P.
haemolytica and P. trehalosi. Roszak & Colwell (1987a) explained that laboratory
media maintains organisms at 72g of carbon/litre compared to oligotrophic conditions
found in the natural environment of 1-15mg carbon/litre. Morita (cited 1993)
presented work carried out by Zobell and Grant in 1942 who studied growth using
only 0.1 mg glucose/litre for the marine bacteria Staphylococcus citreus, Proteus
vulgaris, E. coli and Lactobacillus lactis. However, 10-25 pg carbon/litre was needed
for Aeromonas hydrophilia and Pseudomonas aeruginosa and this highlights the
differences between bacteria and their specific minimal growth requirements. The
survival experiment described here did produce a decline from the high inoculum, but
this was not rapid and the viability settled out to between 105 - 107 cfu mf1 for all
serotypes in all fluids.
The survival patterns of the graphs were not constant with regard to viable counts. P.
haemolytica and P. trehalosi isolates tested showed the characteristic rise and fall in
viability. This has been termed cryptic growth where dead cells supply nutrients for
the viable cells that remain and hereby induce a growth spurt (Roszak & Colwell,
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1987a). Postgate & Hunter (1962) calculated that at least 50 bacteria which have died
and leaked their nutrients are needed to support the growth of one bacterium.
Sporadic or long term loss of 'normal' colony morphology and the inability to culture
on agar or in broth was a feature of starvation especially for serotypes A1 and T10. It
is important to show that starvation cells can be resuscitated if they show different
colony morphology or become non-culturable in/on their usual isolation media.
Postgate & Hunter (1962) described Aerobacter aerogenes as being dead when they
failed to multiply, but noted that some cells retained their osmotic barriers and could
therefore be alive. These were described by Kaprlyants et al., (1993) as dormant
forms of non-sporulating bacteria which have formed due to low substrate conditions
and were not able to produce colonies on agar surface without a prior resuscitation
phase. Morita (1985) cited research on the study of marine organisms from the Gulf
coast. Post fdtration of the water took place then the samples had to be incubated in
dilute nutrient broth for at least 21 days at 21 or 35° C which was then then used as an
inoculum for dilute nutrient agar plates. Vibrios, Aeromonas spp, Pseudomonads and
Alcaligenes spp were all isolated and developed into normal sized bacteria upon
nutrient conditioning. Resuscitation has been shown to result in the usual lag,
exponential phase with the lag phase directly proportional to the length of the prior
starvation period (Morita., 1985). However, Novitsky & Morita (1976) grew starved
Ant-300 without a significant lag phase and they regained normal size and shape
within 48 hours and Roszak & Colwell (1987a) showed that seawater populations can
respond kinetically to organic enrichment within a period of -12 hours. Magarinos et
al. (1994), studying dormant Pasteurella piscicida, found that it was difficult to
ascertain whether the non-culturable cells were resuscitated, grew or did both when
optimal conditions were restored.
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This study shows that although the micro-colonies observed on agar, when the
organisms seemed nutritionally stressed, were very small, the microscopic
examination revealed larger than normal bacteria. Bretz (1962) using slide cultures
reported bacteria that he described as moribund and which were observed to swell
only during the period required for the other cells to divide. These cells eventually
formed micro-colonies and were therefore considered viable. Kogure et al. (1979)
developed a technique for counting viable non-culturable bacteria with the use of
nalidixic acid and yeast extract. Nalidixic acid is an antibiotic which inhibits DNA
gyrase, and thus DNA synthesis, but the presence of yeast extract allows nutrient
uptake into the starving cell. This results in large elongated bacteria which can be
clearly observed microscopically. The descriptions of these organisms are very similar
to the micro-colonies observed in this study. The fact that subculture reveals a return
to 'normal' colony morphology suggests that the bacteria are in a dormant starvation
phase before the nutrients affect the bacteria and allow division to take place. As
pointed out by Roszak & Colwell (1987b), the actual number of bacteria, using the
above method and other specially developed detection methods, exceed the numbers
indicated by viable counts.
The described behaviour of changes in morphology point to signalling mechanisms.
These signals must allow sensing of low nutrient states to induce starvation
mechanisms and vice versa once nutrients become available as described by NystrOm
(1993). These signals have been called chemical crosstalk (Pennisi, 1995), cell density
sensing (Gomer, 1994) or quorum sensing (Claiborne-Fuqua, 1994). Kaprelyants &
Kell (1996) uses the term microendocrinology, as bacterial growth has been shown to
respond to hormones, cytokines and pheromones all of which have implications for
pathogens residing in-vivo such as Pasteurellae.
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With the addition of nutrients in this study a rapid increase in viability was not always
observed. The response was either slow (from 2-10 days) or a decline in viability or
loss of 'normal' colony morphology. The decline of viability after a resuscitation
period may indicate behaviour described by Postgate & Hunter (1962) as substrate
accelerated death. The induction of growth via added nutrients is so rapid (in the
context of starvation behaviour) that the nutrients are exhausted quickly and cannot
maintain cell division so enter into decline unless fresh nutrients are continually
supplied. This suggests that P. haemolytica and P. trehalosi possess the ability to
survive for long periods but not if the starvation regime is intermittent and only if the
influx ofnutrients is constant as is the case with bacteria inoculated into nutrient broth
for resuscitation.
Signalling mechanisms which allow bacteria to multiply in a given environment may
have some importance in the relative species specificity shown by the serotypes in
different tbws and serum. The results showed that this was not due to an IgG
bactericidal effect and so was probably a nutritional signal as the amounts of nutrients
that would have allowed growth did not differ. Growth and survival may be superior
for bacteria in the fluids from the preferred host due to the signalling mechanisms
being unique to the host. In the case of Pasteurellosis the disease is limited to
ruminants and the growth in murine tbw may be due to the reproducibility of
Pasteurellosis in a mouse model. This does not explain the survival in human tbw by
serotype Al. The fact that B. bronchiseptica grew in 7 different species of tbws was
proposed to reflect its broad host range. However, B. avium, B. pertussis and B.
parapertussis showed no species specificity (Porter & Wardlaw, 1993). The lack of
survival in sera may be due to the dilution effect on any growth signals present.
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Low temperatures in the environment usually coincide with low nutrient availability,
so it is not surprising that these situations are comparable. Viable Pasteurellae were
evident in fluids at low temperatures which previously at higher temperatures would
not allow survival. Kjelleberg et al., (1987) stated that the low temperatures may help
to decrease endogenous metabolism to a low rate which matches the maintenance
energy requirements and improves the chances of prolonged viability. Blasser et al.,
(1980) in similar work also showed that at 4°C Campylobacter fetus subsp. jejuni
survived significantly longer in faeces, water ( 4 weeks), milk and urine.
The ability to survive in water is another feature of lowering temperatures which was
seen with P. haemolytica and P. trehalosi. Porter et al., (1991) and Porter & Wardlaw
(1993) showed that B. bronchiseptica not only grew in PBS, reagent grade water, lake
and pond waters but retained viability for 24 weeks. Although the serotypes did not
survive as long as other organisms have, a few days is still a window of time in which
an animal could pick up the organism from body fluids present in the field,
accommodation or in drinking water. This work is in agreement with that of Porter &
Wardlaw (1993) that previous obligate, non-invasive, respiratory tract parasites may
survive in environments outside the host respiratory tract thereby creating potential
reservoirs of disease. The reservoir state of bacteria which can become viable non-
culturable (VBNC) is extremely important to public health and to that of animals.
This appears not to be the case for pasteurellae and a more extensive investigation is
required. The intermittent ability to culture from starvation cultures suggests that
there may be such a state. Magwood et al. (1969) reported that in the nasal passages
of calves the bacterial flora fluctuated in species and numbers, and although P.
haemolytica could dominate the flora it could also not be detected for weeks at a time.
Pass & Thompson (1971) also failed to consistently culture P. haemolytica in daily
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swabs from known colonised animals. Although this situation can be interpreted in
different ways it may indicate that if competition increases and nutrients are scarce a
VBNC state could be induced in-vivo and this is worthy of further research.
The changes observed in morphology for P. haemolytica and P.trehalosi were
encouraging in their adaptation to starvation. The cells straight from tbws and sera
showed smaller bacteria than the normal pleomorphic cells of P. haemolytica and P.
trehalosi. Size reduction is one of the more common responses to starvation and
serves to reduce the surface area to volume ratio and so employ an efficient nutrient
and metabolic state in the organism. The aggregation in a polysaccharide-like matrix
(as observed with ManevaTs stain) was reminiscent of biofilms and looks remarkably
similar to the in-vivo P. haemolytica A2 collected by Sutherland et al. (1990). Brown
& Williams (1985) state that the formation of biofilms in a polysaccharide matrix is
the mode of growth for all but a small fraction of bacteria in the natural environment.
Coglan (1996) states estimates that 99% of the planet's bacteria live in biofilms.
Although not demonstrated in this study, an increase in hydrophobicity is also a well
documented survival mechanism and is also associated with polysaccharide matrices
(Kjelleberg & Hermansson, 1984). The lack of ability to observe the bacteria by
Gram's stain indicates changes in the cell wall, especially the peptidoglycan layer
which has been reported for other organisms (Morita 1988; 1993; Ostling et al., 1993).
This state is different from the micro-colony appearance discussed earlier.
One of the reasons that these states of survival are important is that many pathogenic
bacteria have the ability to maintain virulence for their hosts during survival or VBNC
states. Examples include Pasteurellae piscicida and Shigella dysenteriae ( Magarinos
et al., 1994; Rahman et al.t 1996). The ability of P. haemolytica and P.trehalosi to
adapt with starvation/survival mechanisms requires further investigation. The areas of
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most importance are whether starvation cells resemble those which colonise the upper
respiratory tract and can cause disease in animals.
181
CHAPTER 5
THE USE OF IMMUNOMAGNETIC SEPARATION TECHNIQUES FOR IN-
VIVO CAPTURE OF P. HAEMOLYTICA AND P. TREHALOSI
5.1. Introduction
The previous two chapters discussed the employment of in-vivo fluids to mimic an
in-vivo environment in order to culture bacteria. A technique was required to isolate
Pasteurella spp from both diseased tissues in the lower respiratory tract and colonised
tissues in the upper respiratory tract. This would enable a more accurate assessment of
the changes in virulence factors observed in chapter 3 and if colonising bacteria
resemble those observed during survival culturing. Immunomagnetic separation is a
commonly used technique in the diagnosis of bacteria in food and fluids (Olsvik et al.,
1994) and is based on the specificity of the antibody employed to capture the target
organism. The possibility that this could be used to isolate target bacteria from a
mixture of host proteins and other bacteria for subsequent analysis would overcome
many of the drawbacks of isolation of in-vivo bacteria.
5.2. Adsorption of antiserum
The first step in immunomagnetic separation (IMS) is the production of antibodies
with which specific capture takes place. Earlier studies (Chapter 3) describe the
production of rabbit antiserum raised against each of the three serotypes to be
investigated. Although each separate serum is raised against a specific serotype, cross-
reacting antibodies will be present and must be removed to increase the specificity.
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Fig 5.1 shows antiserum recognition using dot blots of all three serotypes and the
subsequent decrease in cross reaction after absorption of the antisera against the
serotypes which are not the target organism. The pre-bleed serum shows no antigenic
recognition of the serotypes, whereas pre-absorbed sera show high degrees of cross
reaction.
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Fig 5.1. Dot blots of rabbit antiserum raised against A1 (A), A2 (B) and T10 (C)
showing cross reactions with A1 (1), A2 (2) and T10 (3) of pre bleeds (a), pre
adsorbed antiserum (b) and adsorbed antiserum (c).
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5.3. Standardisation of technique
The methods used in this chapter are summarised in Fig 5.2. Using the direct method
bacterial recovery from beads was compared to that of ordinary direct plating
techniques for viable counts to assess the sensitivity of the method. The results in
Table 5.1 show the effectiveness of the bead capture in detecting bacteria beyond the
levels obtained by traditional direct plating. This was apparent with all serotypes and
the system was proven to be very sensitive. As the beads can bind approximately 4
bacteria/bead the potential numbers of colonies arising from the beads is
underestimated because one bead will give rise only to one colony. Fig 5.3 shows
fluorescently labelled bacteria attached to the beads
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Fig 5.2. Diagramatic representation of the direct and indirect methods of IMS. (from
Cell Separation and Protein Purification, Technical Handbook, second edition, Dynal)
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Fig 5.3. Photograph showing acridine orange stained A1 bound to immunomagnetic
beads. Observed at x 100 magnification and image captured with a single chip colour
camera (Hitachi KPC 571) and image printed using a videoprinter (Sony CVP-ML).
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Table 5.1. Comparison of direct plating method and recovery by IMS in different
dilutions of P. haemolytica and P.trehalosi serotypes. Samples were diluted and half
of the sample (0.5 ml) was exposed to the direct method of IMS isolation. When this
was complete all samples were plated onto blood agar for colony counting.
The specificity of the anti-serotype antibody-coated beads was investigated in
mixtures of all three serotypes with E. coli as a control in various combinations
(Table 5.2). IMS with beads coated by Alor A2 antisera was successful in the specific
isolation of the respective serotype only in the presence of each other. When present
in the mixture serotype T10 or E.coli were always isolated with the target organism
or were isolated in pure culture. The reverse was not true for T10 anti-beads which






Al, E. Coli Al, E. coli
Al, A2 Al Al
Al, A2, T10 Al
A1.T10 Al, T10
A2 A2
A2, E.coli A2, E.coli
Al, A2 A2 A2
A2, T10 T10
Al, A2, T10 A2, T10
T10 T10
T10, E. coli T10, E. coli
T10, Al T10 T10
T10, A2 T10
T10, Al, A2 T10
Table 5.2. Assessment of the specificity of each antiserum coated bead for the specific
target in a mixture of bacteria. Using the direct IMS technique after mixing together
various serotypes and E. coli the specificity of the antibody for the target organism
could be made.
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5.4. Reduction of non-specific binding
Treatments which had reduced or eliminated non-specific binding in other studies




Al PBS/Tw20 WASH Al (40), E. coli (8)
Al PBS WASH E. coli (10)
BEADS ALONE PBS/Tw20 WASH E. coli (2)
BEADS ALONE PBS WASH E. coli (1)
Al SKIMMED MILK E. coli (30)
BLOCK
Al RABBIT SERUM E. coli (50)
BLOCK
Al NORMAL SHEEP E. coli (30+)
SERUM BLOCK
Al HORSE SERUM BLOCK E. coli (70+)
Al NEWBORN CALF E. coli (150+)
SERUM BLOCK
Al PROTAMINE 0
Al GELATIN E. coli (20)
Al NONINDET P40 Al ( 20), E.coli (15)
Al* PBS/Tw 20 Al (100), E. coli (I)
Table 5.3. The effects of various detergent washes, blocking steps and treatments on
the recovery of A1 from a mixture of A1 and E. coli with A1 antiserum coated beads.
Al*, A1 antiserum further absorbed against E. coli, M. ovis and M. bovis.
Addition of the detergent Tween 20 gave the best recovery by reducing the Al to
E.coli ratio to 40:8 whereas PBS alone produced only E. coli and the detergent
Nonidet P40 was not as successful. The blocking steps had an increased recovery
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effect on E. coli, which was also shown to bind uncoated beads. Protamine also had a
deleterious effect by reducing recovery to zero. Although the PBS/Tween recovery
ratio of 40 A1 colonies to 8 E. coli colonies was a substantial reduction, further
reductions in the E. coli count were considered essential.
Fig 5.4; 5.5 and 5.6 show the cross-reactions of the absorbed antiserum when reacted
with envelope preparations of the three serotypes. It was evident that cross-reacting
proteins were still recognised by the adsorbed antiserum and in turn these may be
generally cross-reactive with other gram-negative bacteria. This could explain the
isolation of E. coli. Another adsorption of the antiserum against E. coli, M. ovis and
M. ovis cells was carried out and this resulted in a significant reduction of E. coli
recovery (Table 5.3).
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Fig 5.4. Western blots using pre bleed (lane 9), pre adsorbed (lanes 5-7) and adsorbed
(lanes 2-4) rabbit antiserum raised against serotype A1 and used to probe envelope
preparations of Al, A2 and T10 to monitor closely cross reating antibodies.
Molecular weight markers (lane 1), Al (lane 2), A2 (lane 3), T10 (lane 4), T10 (lane
5), A2 (lane 6), Al (lane 7), molecular weight markers (lane 8) and Al (lane 9).
Fig 5.5. Western blots using pre bleed (lane 9), pre adsorbed (lanes 5-7) and adsorbed
(lanes 2-4) rabbit antiserum raised against serotype A2 and used to probe envelope
preparations ofAl, A2 and T10 to monitor closely cross-reating antibodies.
Molecular weight markers (lane 1), Al (lane 2), A2 (lane 3), T10 (lane 4), T10 (lane
5), A2 (lane 6), Al (lane 7), molecular weight markers (lane 8) and Al (lane 9).
Fig 5.6. Western blots using pre bleed (lane 1), pre adsorbed (lanes 2-4) and adsorbed
(lanes 6-8) rabbit antiserum raised against serotype T10 and used to probe envelope
preparations ofAl, A2 and T10 to monitor closely cross-reating antibodies.
T10 (lane 1), T10 (lane 2), A2 (lane 3), Al (lane 4), molecular weight markers (lane
5), T10 (lane 6), A2 (lane 7), Al (lane 8) and molecular weight markers (lane 9).
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Monoclonal antibodies were also investigated to see if the increased specificity of the
antibody was an important factor in recovery. Table 5.4 shows that cross-reactions
with T10 still occurred and the monoclonal antibodies against A2 were very poor.
Both monoclonal antibodies against A1 capsule and A1 LPS were very effective. The
simplicity of the indirect technique using Mab 7/45 meant that the antiserum was




Al, A2 32/4 A2
A2, T10 ANTI A2 LPS T10
Al, A2, T10 T10
A2 A2
Al, A2 32/2 Al
A2, T10 ANTI A2 30/40K LPS T10
Al, A2, T10 A1,T10
A2 A2
Al, A2 36/30 Al
A2, T10 ANTI A2 40KLPS T10
Al, A2, T10 Al
A2 A2
Al, A2 36/34 Al
A1,T10 ANTI A2 LPS Al
Al, A2, T10 Al
A2 A2
Al, A2 36/2 Al
A2, T10 ANTI A2 40K T10
Al, A2, T10 Al, T10
A2 A2
Al, A2 37/2 Al
A2, T10 ANTI A2 40K T10
Al, A2, T10 Al
A2 7/13 Al
Al, A2, T10 ANTI Al CAPSULE Al
Al 7/45 Al
Al, A2, T10 ANTI Al LPS Al
Table 5.4. Table showing the specificity of recovery of target serotypes when beads
are coated with monoclonal antibodies.
193
5.5 In-vivo isolation
The initial recovery of bacteria from animal tissue was very successful (Table 5.5).
A1 was recovered easily from lung tissue (which appeared normal on gross
inspection) of an experimental calf (C284) challenged with the same A1 strain in an
earlier experiments.
ANIMAL TISSUE ANTISERUM BACTERIA
NUMBER RECOVERED
C284 CRANIAL LUNG A1 A1
C284 CAUDAL LUNG A1 A1
C282 CRANIAL LUNG A1 0
C282 CAUDAL LUNG A1 0
127 NASAL SWAB A2 MIXED NASAL
FLORA
268 NASAL SWAB A2 MIXED NASAL
FLORA, A2
98 NASAL SWAB A1 MIXED NASAL
FLORA
112 NASAL SWAB T10 MIXED NASAL
FLORA
Table 5.5. Table showing results of in-vivo isolation of target bacteria. All antiserum
was absorbed polyclonal from rabbits as described in section 5.4 except for A1 which
was the monoclonal antibody 7/13.
Calf 282 did not yield any organisms and was shown to be clear of bacterial infection
by all methods employed. A1 recovery from a nasal swab of a lamb challenged with
A1 bacteria did not produce any target bacteria. This was true also for the other nasal
swabs except for animal 268 where A2 was identified along with other nasal bacterial
flora. These results did not differ from those obtained by direct plating of nasal swabs.
It was not definitely known if these animals were colonised and so the success of the
experiment at this time was unknown.
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5.6. Release of captured bacteria
It appeared that direct sampling of infected tissues was effective in isolating in-vivo
organisms. Initial experiments on the analysis of these complexes was problematic as
BSA and antibody in the mixture interfered with the analyses. This was rectified by
omitting BSA from the post-capture steps and introducing procedures which detach
the bacteria from the beads while leaving the antibody still attached through cross-
linking (see Fig 5.7).
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In order to separate the bacteria from the antibody the principles of affinity column
elution were applied. Standard elution buffers were added to the bead/target mixture.
The beads were then separated using the magnet and these and the supernatant
(containing bacteria but no antibody) fractions were compared for the presence of
viable bacteria ( Table 5.6).
TREATMENT LOCATION OF BACTERIA
BEADS SUPERNATANT
ACID GLYCINE (2.5M) ++ -
TRIETHYLAMINE ++ ++
(pH 11.5)




1% SDS - -
2M UREA ++ ++
WATER ++ ++
50% ETHYLENE ++ ++
GLYCOL (pH 11.5)
Table 5.6. The effects of elution reagents on the recovery of target bacteria. ++,
substantial bacterial growth; indicates no growth.
Acid glycine did not allow separation of the bacteria from the antibody/bead
complex. Using SDS both fractions resulted in loss of viability. All other treatments
were effective but still appeared to retain as many bacteria as were eluted.
Using selected elution solutions this technique was applied to infected lung tissue for
evaluation for in-vivo use. This time the tissue pellet was compared as well. Table 5.7
shows clearly that water, urea and magnesium chloride gave the greatest recovery of
bacteria in the supernatant. Although there were more bacteria recovered in the
supernatant fraction than the bead fraction with magnesium chloride and urea it was
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decided to use water as this would have the least effect on the bacterial structures
during elution.
TREATMENT LOCATION OF BACTERIA
TISSUE PELLET BEADS SUPERNATANT
TRIETHYLAMINE +++ + ++
MAGNESIUM +, CONTAMINANTS ++ +++
CHLORIDE
UREA +, CONTAMINANTS ++ +++
WATER +++ +++ +++
ETHYLENE GLYCOL +++ + -
Table 5.7. Comparison of the effect of elution reagents on the recovery of target
bacteria directly from tissue and after crosslinking the specific antibody to the beads.
The crosslinking method using water as an elutant was applied to post mortem
specimins used earlier in the study (except for the calf tissue).
ANIMAL TISSUE CAPTURE DETECTABLE DETECTABLE
NUMBER ANTIBODY IN TISSUE BY BEADS
C35 CRANIAL M Ab 7/13 + (A1) + (Al)
LUNG
C35 CAUDAL M Ab 7/13 + (A1) + (A1)
LUNG
C35 TRACHEA M Ab 7/13 + (A1) + (Al)
C35 TRACHEA M Ab 7/13 + (A1) + (Al)
127 LUNG SERUM + (A2) + (A2)
268 LUNG SERUM - -
268 NASAL SERUM + (A2) + (A2)
TURBINATE
268 NASAL SERUM - -
SEPTUM
268 TONSILS SERUM + (A2) + (A2)
112 LUNG SERUM - -
112 NASAL SERUM - -
TURBINATE
112 NASAL SERUM - -
SEPTUM
112 TONSILS SERUM + (T10) + (T10)
Table 5.8. Isolation of in-vivo bacteria from post mortem tissues prior to analysis
using crosslinking of antibody and water as an elutant.
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Table 5.8 shows the ability to detect pasteurellae straight from tissue homogenate
which was plated onto blood agar and from beads which were mixed with tissue
homogenate. A1 was isolated from different areas of the lung and the trachea of an
experimentally infected animal. Lambs 127, 268 and 112 were the lambs used for
convalescent antiserum production and at post mortem, lung, nasal septum, turbinates
and tonsils were removed and prepared for isolation of target bacteria with IMS. Table
5.8 also shows that A2 was isolated from the lung of lamb 127 and from turbinates
and tonsils of Lamb 268. T10 was also isolated from the tonsils of 112. The latter two
animals were colonised.
5.7. Analysis of isolated in-vivo bacteria
Recovered bacteria were separated from the beads and analysed (after checking for
purity by culture on blood agar) by SDS PAGE and Western blotting with in-vitro
grown whole bacteria as a comparison.
When compared to in-vitro grown cells (Fig 5.8), serotype A1 from pneumonic lung
tissue gave a protein profile which differed slightly. Three high molecular weight
proteins were observed in the in-vivo bacteria (approx. 205, 200, >205 kDa) and
these were not present in the in-vitro bacteria. Other proteins not present in-vitro were
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Fig 5.8. Silver stained SDS PAGE of serotype A1 whole cells from in-vivo and in-
vitro growth.
Molecular weight markers (lane 1), A1 from broth culture (lane 2) and A1 from
pneumonic lung tissue (lane 3). > denoted bands present in broth cultured bacteria
which are not present in in vivo bacteria, ► denoted bands present in in vivo bacteria
which are not present in broth cultured bacteria, indicates increases in proteins.
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Fig 5.9. Silver stain of SDS PAGE of in-vivo and in-vitro isolated A2 and T10 whole
cells.
T10 from tonsils (lane 1), T10 from TSB (lane 2), A2 from nasal turbinates (lane 3),
A2 from TSB (lane 4 ) and molecular weight markers (lane5). >denoted bands present
in broth cultured bacteria which are not present in in vivo bacteria, ► denoted bands
present in in vivo bacteria which are not present in broth cultured bacteria.
indicates increases in proteins.
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approximately 68, 48, 38 and 40 kDa. Many proteins, however, seemed to be missing
from the in-vivo bacteria when compared with the in-vitro bacteria (approx. 100, 70,
50-55, 45, 37, 36 and 29). There were also some notable increases of protein at
molecular weights of 66, 45, 35 and 30 kDa. Whether these were increases in existing
proteins or new proteins is unknown. Serotype A2 isolated from nasal turbinates (Fig
5.9) also had high molecular weight proteins at 205 kDa and greater which did not
appear in in-vitro samples. New proteins of approximately 120, 70, 50, 35, 28 and 17
kDa were apparent however, while proteins at 100, 80, 79, 45, 35-40 and 30 kDa were
present in in-vitro but not in in-vivo samples. Serotype T10 from tonsils (Fig 5.9) had
proteins of approximately 100, 68, 50 and a high molecular weight protein -205 kDa
present in in-vivo bacteria. In-vitro bacteria possessed proteins not present in in-vivo
samples at 120, 80, 70, 52, 50, 40 and 35 kDa. Both A2 and T10 in-vivo bacteria
showed increases in molecular weight regions of 66 and 45 kDa and these were the
same as two of the increased proteins seen in Al.
Western blots of serotype Al (Fig 5.10) in-vivo and in-vitro bacteria probed with
anti-Al sheep convalescent serum showed very little recognition of any in-vivo
protein bands. Those which were recognised were also present in the in-vitro sample.
Fig 5.11 shows results for the same experiment with A2 probed with anti-A2 sheep
convalescent serum. Again, recognition ofproteins is very low in the in-vivo samples.
One protein, however, was strongly recognised at approximately 40 kDa which is not
equally recognised in the in-vitro sample.
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Fig 5.10. Western blot of in-vivo and in-vitro A1 samples probed with convalescent
lamb serum raised against serotype A1 (chapter 3).
A1 in-vitro (lane 1), A1 in-vivo (lane 2) and molecular weight markers (lane 3).
Fig 5.11. Western blot of in-vivo and in-vitro A2 samples probed with convalescent
lamb serum raised against serotype A2 (chapter 3).














The application of the IMS technique to P. haemolytica and P. trehalosi was
relatively successful. It was determined that the technique could detect the presence of
serotypes at dilutions which conventional counting methods could not. Wright et al.,
(1994) and others (Olsvik et al., 1994; Safrik et al., 1995) have shown that E. coli
0157 isolation by IMS was more sensitive than direct culture. Cujoe et al. (1994)
found that the subsequent culture was also important in detecting the target organism.
Using IMS for the capture of salmonellae in foods he found that the technique was
improved when the beads were plated onto XLD after capture, rather than direct
culture on a selective agar. Authors such as Vermunt et al. (1992) found that IMS
recovery of the target can be lower than in other systems available due to loss of
bacteria during washing steps, with inhibited growth due to attachment to the bead.
Prolonged incubation was found to increase numbers of salmonellae though recovery
of non-target organisms showed an increase.
There was a problem with non-specific binding in this study with serotype T10 and E.
coli. The nature of the binding is unknown and did not happen with Al and A2 which
would have been expected due to the apparent cross-reactivity between the two and
their close relation to each other in comparison to T10 and E. coli. The situation with
the non-specific binding was not improved with the introduction of monoclonal
antibodies, although Al anti-LPS and anti-capsule Mabs did appear to be superior in
their affinity for the serotype and a lack of cross-reaction. E. coli had a binding
affinity for the beads alone. Johne & Jarp (1988) found that although S. aureus did not
bind straight onto the beads, if coated in FCS they would. This caused the
contaminating presence of coagulase negative staphylococci, Streptococcus spp and E.
204
coli. Blocking steps had no effect on the non-specific binding even though authors
such as Vermunt et al.{ 1992) and Mullins et al.(1995) found them successful. Some
treatments and detergents such as the use of protamine (Okrend et al., 1992) or NP-40
(Morgan et al., 1991) have been attempted to increase recovery and reduce non¬
specific binding. In this study protamine resulted in no bacterial recovery and the NP-
40 was no different from any of the other detergents. Wipat et al. (1994) stated that
detergents can be used to reduce non-specific binding but that they can also affect the
viability of the bacteria. As the use of Tween-20 has been shown to reduce
contamination consistently (Wright et al., 1994; Olsvik et al., 1994; Safrik et al.,
1995) and was the most successful treatment in this study (even though not 100%) this
technique was employed. The Western blots of envelopes from the three serotypes
probed with the absorbed rabbit antiserum used for immunocapture do point to cross-
reacting antigens remaining which may be why they were not particularly specific.
Once further absorption was carried out, the non-specific binding was reduced to
levels which were acceptable as far as contaminating organisms were concerned. It
must be noted that a panel of non-related bacteria has not been screened and this could
pose problems in the future. Concurrent direct plating of immunocaptured samples
however, would always check this situation if it arises as contaminants would be
observed.
Initial in-vivo isolation from lung samples of calves experimentally challenged with
serotype Al was extremely successful. All sites yielded pure cultures of P.
haemolytica Al whereas direct plating produced, as well as P. haemolytica, colonies
which were regarded as contaminants. The ease by which contaminants were excluded
using IMS could be due to the numbers present in this instance. In the case of
pneumonic lung tissue the dominant organism present is that which is responsible for
205
the pneumonia, in this case P. haemolytica. The competition for binding sites on the
beads is higher for non-target organisms. The same in-vivo isolation procedure was
carried out on nasal swabs in an attempt to isolate colonising organisms. All animals
produced mixed nasal flora from direct plating and from IMS isolation. Lamb 268 did
have A2 colonies present but this was overwhelmed by other nasal bacteria. This is
the opposite situation than that encountered with the lung tissue isolation.
P. haemolytica is probably in the minority in the total population of the nasal passages
and although the specificity of the antibody on the beads may be higher for
P. haemolytica the presence of many other organisms is greater and may well increase
the likelihood of non-specific binding.
The later tissue analysis at necropsy sheds some light on why isolation from swabbing
was not successful. Serotype A2 (127) was present only in the lung and T10 only in
the tonsils which would not have been reached by swabbing. In lamb 268, A2 was
present in the turbinate area and not the septum. A2 was previously isolated with
mixed flora from nasal swabs and this result indicates that A2 was present alone in
the turbinate while absent from the septum area. Quirie (1984) found that A2 was
isolated commonly from ventral nasal meatus, floor of nasopharynx, lateral wall of
nasopharynx and lateral wall of oropharynx but not from the dorsal nasal meatus,
ventral turbinate (rostral and caudal) nasal septum or lateral wall of nasopharynx
(opposing membranes pharyngeal septum). It is likely that the original swab was
taken from an area of the nasal cavity in which A2 was present with other flora. Pass
& Thompson (1971) pointed out that a single swabing was not representative of the
nasal cavity as a whole. Magwood et al. (1969) showed that P. haemolytica was
capable of dominating the nasal flora for several days at a time. Magwood's study was
confirmed by Quirie (1984) who showed that the bacterial population could fluctuate
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in species and numbers present. What could have happened with lamb 268 is that
between swabbing and necropsy (assuming the swab was taken from the same site
sampled at necropsy) the flora of the nasal cavity had changed dramatically with A2
present as the dominant bacteria. If it can be assumed that the sites of swabbing and
necropsy tissue are not the same it calls into question the accuracy of swabbing as an
indicator of the presence of certain bacteria in the nasal cavity and this is in absolute
agreement with the findings of Pass & Thompson (1971).
The cross-linking procedure and subsequent elution of bacteria free of antibody and
BSA, added to the clear visualisation of proteins on SDS PAGE. A1 organisms from
pneumonic tissue differed markedly from in-vitro grown organisms, but convalescent
antiserum did not recognise any proteins in the in-vivo sample that were not
recognised in the in-vitro sample. This indicates none of the induced proteins were
recognised by the antiserum although subtle changes in protein epitopes or
glycosylation may mask them from antibodies. It may also be the case that the
bacterium (a bovine isolate) from bovine tissue will not react as well with ovine
antiserum as it would with a bovine convalescent serum. Previous data (Chapter 3)
suggested that sufficient antibody recognition had occurred. Davies (1994b)
developed an intraperitoneal implant chamber for the study of A1 in-vivo organisms.
Significant antibodies against P. haemolytica were present pre-inoculation and these
antibodies did not change in content either quantitatively or qualitatively over the
course of the experiment. The Western blot profiles were not compared to in-vitro
grown organisms and as only outer membrane proteins were analysed and not whole
organisms, as in this study, little comparison can be made with the findings in this
work. Davies (1994a) examined lung isolates of P. haemolytica A1 and showed that
bacteria had reduced expression of 31 and 39.5 kDa proteins with enhanced
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expression of proteins at 71, 77 and 100 kDa. The latter three proteins were probably
IRPs and although present in one of the strains examined were not as evident in
another strain. Reduction of an 18 kDa protein and the induction of one at 19 kDa is
quite important as is the 52 kDa protein in the lung cells in comparison to the 50 kDa
protein in the in-vitro cells. Davies suggested that the 19 kDa protein is novel and
that the reduced expression of the 18 kDa protein is the same as the 17 kDa protein
described by Donachie and Gilmour (1988) present in serotype A2. It may be that all
these proteins are functionally the same and the in-vivo conditions, strain variation or
SDS PAGE conditions differing slightly will make all the difference when an
individual interprets results. In light of this, the A1 proteins in this study at 68 kDa in
in-vivo only bacteria and 29 and 37 kDa in in-vitro bacteria may be similar proteins to
the 70, 31 and 39.5 proteins of Davies. Confer et al. (1992) also examined P.
haemolytica Al in chamber implants in calves. As whole cells were analysed it is
probably more appropriate to this study although it is questionable whether chamber
grown bacteria and lung isolated cells are representative of each other ( Davies 1994a
suggests that they are). Confer found that using broth and solid media grown bacteria
as a comparison to in-vivo, all growth conditions produced encapsulation with similar
LPS profiles. In-vivo bacteria produced extra proteins >150 kDa. Rabbit antiserum
did not recognise any bands > 100 kDa but antiserum from calves did, suggesting
these were probably precursor proteins not produced in-vitro.
The SDS PAGE profile of T10 isolated from the tonsils differs from that of the
organism grown in-vitro. In reviewing the literature no studies have been carried out
on the analysis of in-vivo growth or isolation of P. trehalosi. The pathology of the
disease makes in-vivo isolation from systemically infected animals difficult.
P. haemolytica serotypes causing bovine pneumonia have been isolated using lung
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washes (plenty of contaminating host molecules present) and implant chambers
(which may not represent the state of the organism in the lung) and ovine pneumonia
serotype isolation has used chambers and pleural fluid of infected animals. P.
trehalosi is not always found in large numbers in the lung and direct isolation from
blood, spleen, liver and other tissues would have been problematic. IMS has enabled
the isolation of T10 directly from tissue and is probably of use in other areas.
Mazurek et al. (1996) enhanced and enriched the detection of Mycobacterium
tuberculosis from CSF using IMS and Johne & Jarp (1989) isolated S. aureus from
milk.
Serotype A2 envelopes from pleural fluid organisms have been studied by Donachie
and Gilmour (1988). The identification of 100, 70 and 17 kDa proteins in-vivo may
correspond to proteins of 70 and 17 kDa in this study. Sutherland et al. (1990)
identified proteins of 105, 100, 95, 70, 66, 53 and 23 kDa (the latter two proposed to
be heavy and light chain portions of IgG). The 70, 50 and 35 kDa in this study could
correspond to the 70, 53 and 28 of the above in-vivo bacteria. The in-vivo bacteria
also lacked 36 and 24 kDa proteins which may be functionally similar proteins to
those in this work of 30, and 35-40 kDa proteins. Western blotting was not carried out
on these samples and no comparisons can be drawn. Donachie and Gilmour (1988)
showed a 55 kDa protein recognised on Western blots which was not observed by
SDS PAGE. The induced 100 kDa protein on the other hand did not react with
antiserum (same result as Davies 1994a). The analysis of A2 and T10 in this study
deals with colonising bacteria. Many of the proteins from all serotypes, differ from the
in-vitro proteins (or vice versa) by only a few kilodaltons in molecular weight and this
implies that they are possibly the same protein with slight changes such as
glycosylation or binding of host components. It is possible that just as bacteria grown
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in vitro differ from those grown in vivo, then colonising bacteria may be different
from their pathogenic state. Those bacterial mechanisms which protect the organism
from destruction by the host, such as mimicry of host structures and capsules may
become much more important in a colonising state. Sialic acid has been shown on the
LPS of serotypes A1 and A5. The presence of sialic acid in prokaryotes is rare and
when present is usually a constituent component of the capsule (Utley et al., 1992).
The colominic acid present in the capsule of A2 is non-immunogenic and has been
implicated in the lack of immunity observed in bacterin vaccines (Adlam et al., 1987).
Leukotoxin at sub-inhibitory concentrations has been shown to downregulate MHC
Class II molecules in macrophages and so will interfere with antibody recognition
(Hughes et al., 1994). Sutherland et al.( 1990) showed results similar to Confer et al.
(1992) in that LPS and capsules were unchanged in in-vivo bacteria. Sutherland et al
also found that A2 aggregated together and may have prevented host defence
mechanisms from being effective in removal of the organisms. The lack of available
nutrients as evidenced by low numbers of bacteria present during colonisation and
competition from other resident microbial flora suggests that colonising bacteria are
probably better represented by those bacteria grown under starvation, stress and
biofilm situations. In nature bacteria hardly ever grow in single species colonies and
99% of the planet's bacteria are thought to live in biofilms. 30 to 40 % of the proteins
in Ps. aeruginosa have been shown to differ from those in biofilms and from free
living bacteria ( Coghlan, 1996).
This study has shown differences between serotypes tested with respect to comparison
of in-vitro and in-vivo produced organisms. Western blots showed very little
recognition of in-vivo antigens and only A2 possessed an antigen not recognised in
vitro (T10 was not tested). The antiserum used to probe for A2 was from the same
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animal that the bacteria were isolated from. This situation raises questions of
convalescent states in pasteurellosis. The animal has been shown to be immune to
challenge, shows antibody recognition of envelopes and other antigens, leukotoxin
neutralising capacity and is bactericidal (Chapter 3; M. Maley pers comm). This
however, does not prevent colonisation and suggests that serum antibody is not
important for removal of colonising bacteria. Mucous membranes rely on IgA for
effective removal of bacteria, rather than IgG which is derived from serum. It is not
known whether IgA prevents colonisation. Vaccination of calves has been shown to
inhibit colonisation, only serum IHA titres though (to monitor capsule recognition)
were measured as a response. The role of IgA therefore remains unknown. Mc Vey et
al. (1990) showed IgA to be serotype specific and with changing mucosal flora it may
be difficult to maintain protection. If a convalescent animal is predisposed by other
infections or environmental factors the possibility it will succumb to pasteurellosis (if
it is colonised) is of concern in protection against the disease.
This study needs more attention in the areas of defining more clearly the differences
between in-vitro, colonising and disease-state bacteria. The question of prevention of
colonisation is also important and this appears to lie in finding more information
about the role of IgA in the mucosal areas of ruminants, what will stimulate IgA and if




THE DETECTION AND CHARACTERISATION OF SUPEROXIDE
DISMUTASE
6.1. Introduction
Investigations into superoxide dismutases in bacteria have shown some evidence to
suggest that these enzymes may be important during disease especially in survival
against the respiratory burst of phagocytic cells ( Mandell, 1975; Beaman & Beaman,
1984). The identification of a copper/zinc SOD ( still a particularly rare metal active
site for a bacterial SOD) in Haemophilus spp (Kroll et al ,1991) and then further
evidence that these enzymes were present in many mucosal colonising bacteria (Kroll
et al., 1995) suggested that this may also be the case for Pasteurella spp.
6.2. Demonstration of SOD activity in P. haemolytica and P. trehalosi
Bacterial lysates of P. haemolytica serotypes Al and A2 and P.trehalosi serotypeTIO
were assayed for superoxide dismutase (SOD) activity using a native PAGE gel and
staining system. SOD activity was detected readily in crude lysates of all three
serotypes (Fig 6.1). Only one zone of enzyme activity was apparent in Al and A2
serotypes, the former migrating more rapidly than the latter. By contrast two zones of
activity were detected in the T10 serotype, one of which migrated similarly to the that
of Al and the other migrating to a point between those observed for Al and A2. The
levels of activity were measured using an assay which is more sensitive than PAGE
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Fig 6.1. Native PAGE containing whole lysates of Al, A2 and T10 and stained for
superoxide dismutase activity.
Serotype Al (lane 1), Serotype A2 (lane 2) and Serotype T10 (lane 3).
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but the differences in activity correlate with the strength of reaction observed on the
gel. A2 activity (472.7 SOD units) was 27 times greater than A1 (17.35 SOD units)
and 4 times greater than T10 (112.2 SOD units). This activity was not due to a greater
protein concentration loaded onto the gel as Al, A2 and T10 had 0.15mg, 0.055mg
and 0.045mg ofprotein loaded respectively.
6.3. Characterisation of SOD enzymes
Inhibition studies were used to identify the SOD isotype by specific inactivation (>
50%) of the metal active site. EDTA is used to commonly inhibit all SODs, H202
inhibits iron SODs and KCN inhibits copper/zinc SODs. Manganese SODs are
resistant to the above allowing identification by a process of elimination.
Serotype Control (H,0) KCN H,0, EDTA
Al 6.77 (0.7) 6.83 (0.6) 7.1 (0.5) 7.9 (4.2)
A2 274.82 (86.2) 51.23 (10.1) 296.32 (95.5) 221.32 (102)
T10 102.65 (28.2) 104.8 (27.9) 116.0 (32.9) 157.23 (71.9)
Table 6.1. Inhibition of SOD activity by various inhibitors.
Results are expressed as the means of four separate experiments (SOD units mg"1
protein) with the standard error of the mean in brackets. Inhibitors are at 5mM.
Table 6.1 (for raw data see Appendix II) shows that A2 was inhibited only by KCN
(81.4%), thus defining it as a Cu/Zn SOD. This was also seen using the PAGE system
(Fig 6.2) where other inhibitors had no effect. No inhibition of the SODs of any
serotypes could be achieved with EDTA or H202 even at elevated molarities. Other
metal chelators such as aa dipyridyl, EDDA and sodium azide (the latter an inhibitor
of Fe and Mn SODs at 4 and 20 mM respectively) also failed to inhibit the enzymes.
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Fig 6.2. Native PAGE showing A2 superoxide dismutase activity (lane 1) and loss of
activity in the presence of potassium cyanide (lane 2).
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6.4. Identification of sodC gene
The identity of the A2 SOD enzyme was confirmed by the development of a PCR
based assay which recognises a fragment of the sodC gene ( this gene codes for
Cu/Zn SOD). Fig 6.3 shows the PCR product produced only in the lanes which
contained A2 DNA with no product produced from samples of serotypes A1 and
Fig 6.3. Agarose gel showing PCR product (arrow) of serotype A2 when amplified
using nested primers specific for copper/zinc superoxide dismutase.
X Hind III markers, bp (lane 1), positive control (a fragment of A2 which has been
cloned following the production of a PCR product which has been confirmed by the
use of nested PCR and Southern hybridisation to be part of the SOD gene) (lane 2),








6.5. Location of SOD
In order to identify the location of the enzyme in the bacterial cell, five methods were
employed to obtain separate cytoplasmic and periplasmic fractions. The results can be
seen in Table 6.2. With all three serotypes, those methods which employed the use of
detergents produced unacceptable cytoplasmic contamination of the periplasmic
contents. Chloroform proved slightly better but the high presence of MDH in the
periplasm meant the correct location of the enzyme could not be determined with any
confidence. The freeze-thaw technique, less harsh on the bacteria than detergents or
solvents produced consistently low contamination of MDH in the periplasm of all
serotypes. The SOD enzyme of serotypes Aland A2 were present in the periplasm
83.8% and 75.2% respectively, whereas the enzymes of T10 were predominantly
present in the cytoplasm (59.1%). Although the amount of SOD in the periplasm of
T10 was 40.9% and the activity of MDH was 33.3% the difference was not large
enough to confidently consider that this serotype possessed a predominant
periplasmic SOD.
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UNITS OF UNITS OF % SOD % MDH





A1 PERIPLASM 8.8 0.07 57.3 92.1
A1 CYTOPLASM 7.6 0.006 46.3 7.9
A2 CHAPS / PERIPLASM 122.2 0.3 80.5 78.9
A2 LYSOZYME CYTOPLASM 29.7 0.08 19.5 21.1
T10 PERIPLASM 97.1 0.2 85.3 66.7
T10 CYTOPLASM 16.8 0.1 14.7 33.3
A1 PERIPLASM 124 0.2 86.5 99
A1 CYTOPLASM 19.3 0.002 13.5 1
A2 EDTA / PERIPLASM 14.5 0.04 51.2 80
A2 LYSOZYME CYTOPLASM 13.8 0.01 48.8 20
T10 PERIPLASM 93.1 0.3 77.9 97.1
T10 CYTOPLASM 26.4 0.009 22.1 2.9
A1 PERIPLASM 68.9 0.03 76.7 60
A1 CYTOPLASM 20.9 0.02 23.3 40
A2 CHLORO¬ PERIPLASM 475.3 0.07 87.7 58.3
A2 FORM CYTOPLASM 66.6 0.05 12.3 41.7
T10 PERIPLASM 35.1 0.05 47.2 83.3
T10 CYTOPLASM 39.3 0.01 52.8 16.7
A1 PERIPLASM 49.9 0.01 70.2 76.9
A1 CYTOPLASM 21.2 0.003 29.8 23.1
A2 OSMOTIC PERIPLASM 3.8 0.009 26.9 31
A2 SHOCK CYTOPLASM 10.3 0.02 73.1 69
T10 PERIPLASM 59 0.2 59.9 90.9
T10 CYTOPLASM 39.4 0.02 40.1 9.1
A1 PERIPLASM 52.3 0.01 83.8 2.4
A1 CYTOPLASM 10.1 0.4 16.2 97.6
A2 FREEZE PERIPLASM 475.3 0.009 75.2 23
A2 THAW CYTOPLASM 156.5 0.03 24.8 77
T10 PERIPLASM 24.6 0.04 40.9 33.3
T10 CYTOPLASM 35.5 0.08 59.1 66.7
Table 6.2. Comparisons of different fractionation methods to determine the location of
SOD using MDH as a marker of cytoplasmic contamination.
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6.6. Effects of iron restriction on SOD
Movement of SOD enzymes into the periplasm under certain growth conditions has
been shown ( Barnes et al 1996 Schnell et al 1995). As the bacterial cell's response to
iron restriction in vivo is an important aspect of pasteurellae infection lysates of iron-
restricted (in 200pM EDDA) P. haemolytica and P. trehalosi cells were assayed for
SOD. These were compared with bacteria cultured in normal media. The location of
the enzyme was also investigated using the freeze thaw method which was shown
previously to give favourable results.
Sample Units of SOD activity/mg Protein




Table 6.3. Comparison of SOD activity from serotypes grown with and without iron
restriction.
Sample Units of SOD Units of MDH % location of % location of
activity/mg activity/mg SOD MDH
protein protein
Al periplasm 0.147 0.03 9.4 79
Al Cytoplasm 1.411 0.008 90.6 21
A2 Periplasm 53.81 0.001 99.4 8
A2 Cytoplasm 0.341 0.012 0.6 92
T10 Periplasm 0.611 0.017 78.1 45
T10 Cytoplasm 0.171 0.021 21.9 55
Table 6.4. Location of SOD activity from serotypes grown under iron restriction.
219
Table 6.3 shows the reduction in the units of SOD activity present in the bacteria. This
was the situation for all of the serotypes when the bacteria are grown under iron
restriction in comparison to those in ordinary culture. There is also a shift in the
location of the enzyme and this can be seen in Table 6.4(for raw data see Appendix
II). Most of the SOD activity in A1 is now restricted to the cytoplasm and in contrast,
T10 now has predominantly periplasmic SOD. A2 SOD activity remains periplasmic.
6.7. Effects of exogenous superoxide on P. haemolytica and P. trehalosi
Changes in oxygen availability or environmental detection of superoxide may also
trigger movement of the enzyme into the periplasm. A bactericidal assay was used to
follow the survival of whole live bacteria in the presence of exogenous superoxide.
This would indicate a possible mechanism of enzyme relocation into the periplasm
under superoxide stress. Fig 6.4 shows that A2 and T10 had no significant difference
in viability from that of the controls over a 30 minute period, a result which is
consistent with the movement of the enzyme into the periplasm as seen under iron
restriction. Al, however, did not survive 30 minutes in comparison to the control.
When exogenous SOD was added into this milieu the effect on Al was abrogated,
showing that the loss of viability was due to damage caused by the presence of
superoxide.
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Fig 6.4. Survival of serotypes Al, A2 and T10 by viable count in the presence of
exogenous superoxide. Controls (open symbols) omitted only xanthine oxidase and
samples ( bold symbols) contained xanthine oxidase to initiate superoxide generation.




Lainson et al (1996) tested a large number of P. haemolytica and P. trehalosi
serotypes for the prevalence of Cu/Zn SOD using correlation of PCR, southern
hybridisation and inhibition with KCN. The results showed that all A2 strains tested
were positive for the enzyme. A7 strains, however, gave both positive and negative
results for Cu/Zn SOD suggesting another SOD type was present. It was thought that
a comparison of these strains might give some information as to a specialised role for
the Cu/Zn SOD. The bactericidal assay (Fig 6.5, for raw data see Appendix II) shows
that strains M74 and L94f were still viable at 30 minutes and strains DO800 and L48c
were not. The latter strains, however, were the strains which possessed the Cu/Zn
SOD, so this does not correlate with the ability to survive the presence of exogenous
superoxide. The importance placed on the presence and location of Cu/Zn SODs and
the role of survival in macrophages was also investigated. Fig 6.6 (for raw data see
Appendix II) shows survival in ovine alveolar macrophages. Although strain DO800
was still viable after 2 hours phagocytosis and is SOD positive, so was strain L94f and
this strain is negative. The strains M74 (SOD negative) and L48c (SOD positive) also
showed no survival following phagocytosis and do not correlate with the presence or
absence of the enzyme. The pattern is similar in bovine alveolar macrophages (Fig
6.7, for raw data see Appendix II). Strains DO800 and L94f survived phagocytosis in
bovine alveolar macrophages (the same was observed in OAM). M74 (Cu/Zn SOD
positive) survived in the bovine cells and L48c (positive for Cu/Zn SOD) does not.
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Fig 6.5. Survival of A7 strains in the presence of exogenous superoxide, two of which
possess Cu/Zn SOD (DO800 and L48C) and two of which do not (M74 and L94F).
Survival was monitored by viable counts. Controls are strains marked with an asterisk.
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30
Fig 6.6. and Fig 6.7 show A7 Cu/Zn SOD positive and negative strains survival in
ovine (Fig 6.6) and bovine (Fig 6.7) alveolar macrophages. Bacteria were incubated
with macrophages at a ratio of 10:1 bacteria to macrophage for 2 hours. Gentamicin
was added to kill any extracellular bacteria and then the macrophages were lysed and
the bacteria counted using viable counts. Results are the mean of three separate
experiments.
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Fig 6.7. Phagocytosis survival at 2 hours by A7 strains in bovine
alveolar macrophages




6.8. Serum antibody to SOD
The possibility that this enzyme may elicit an immune response during infection was
also investigated. Convalescent ovine antiserum was pre-incubated with lysates and
then run on native PAGE and stained for SOD activity. Fig 6.8 shows activities of
each serotypes mixed with homologous convalescent antiserum. The active
component appeared to be bound by a serum component and carried down the gel but
was not inactivated. Serum alone did not show this effect. In order to see if this effect
was due to immunoglobulin G (IgG), IgG was purified from the serum (Fig 6.9 shows
the degree of purity of the IgG). The purified IgG was mixed and incubated with the
lysates and treated in the same way as whole serum. Fig 6.10 shows the results
obtained with serotype A2 as an example. The other serotypes showed the same
results. There is no difference in the electrophoretic mobility of the enzyme indicating
no binding of IgG.
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Fig 6.8. Native PAGE showing the effect of superoxide dismutase activity when pre
incubated with homologous convalescent lamb serum (chapter 3).
A1 with A1 antiserum (lane 1), A2 with A2 antiserum (lane 2), T10 with T10
antiserum (lane 3), A1 antiserum (lane 4), A2 antiserum (lane 5) and T10 antiserum









Fig 6.9. Coomassie stained SDS PAGE showing purified IgG (chapter 3).
Molecular weight markers (lane 1), IgG from A1 convalescent lamb serum (lane 2),




Fig 6.10. Native PAGE showing the effects of purified IgG on superoxide dismutase
activity.
A2 whole lysate (lane 1), A2 lysate pre mixed with IgG purified from convalescent
lamb serum raised against A2 (lane 2), IgG alone (lane 3) and A2 lysate pre mixed
with IgG purified from lamb serum raised against orf virus (lane 4). A2 is shown here





1 2 3 4
serum
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Fig 6.11. Coomassie stained Native PAGE to show where BSA (lane 1), whole
(lane 2), convalescent lamb purified IgG (lane 3) and purified IgG from lamb
raised against orf virus (lane 4) are positioned on the gel.
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As the gel system may not be quite sensitive enough to detect minor changes in SOD
activity the assay was used. The basis of the method relies on the affinity of Protein G
for the IgG molecule. If IgG recognises and binds SOD, Protein G ifpresent will bind
IgG. Centrifugation then removes the Protein G complex and the supernatant is
assayed for SOD activity.
Sample Purified IgG Protein G * Mean SOD units
source mg"1 protein (SE)
A1 antiserum - 4.47 (0.6)
A1 A1 antiserum + 3.02 (0.4)
control serum - 4.84(1.1)
control serum + 4.1 (0.7)
A2 antiserum - 21.21 (3)
A2 A2 antiserum + 16.56 (4.8)
control serum - 23.64 (0.4)
control serum + 24.61 (3)
T10 antiserum - 9.99 (3.3)
T10 T10 antiserum + 6.01 (1.97)
control serum - 8.2(1.8)
control serum + 5.4(1.3)
Table 6.5. The effect of specific IgG on SOD activity.
* no protein G; +, lOOpg protein G. Results are mean values of 4 separate
experiments. Control serum IgG was incorporated to ensure that any reduction in
activity was due to specific IgG. Antibody binding of SOD without loss of activity
was monitored by the presence or absence of Protein G.
Table 6.5 (for raw data see Appendix II) shows a reduction in enzyme activity when
specific IgG and Protein G were present with serotypes A1 and A2 but not T10. This
result was not statistically significant. It was therefore concluded that there was no
specific IgG response. The binding component was further investigated. As serum
albumin constitutes a large component of serum, bovine serum albumin was mixed
with lysates and treated as previously on native PAGE. Fig 6.11 shows a native gel
stained with Coomassie blue to show the electrophoretic mobility of albumin
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Fig 6.12. Native PAGE showing BSA as the responsible serum component for the
binding of superoxide dismutase.
A2 with BSA (lane 1), A2 with serum (lane 2), BSA alone (lane 3) and serum alone
(lane 4).A2 was used as an example but all serotypes tested behaved in the same way.
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Fig 6.13. Western blot on a Native PAGE gel probed with rabbit antiserum raised
against the copper /zinc superoxide dismutase ofHaemonchus contortus.
Molecular weight markers (lane 1), A1 lysate (lane 2), A2 lysate (lane 3) and T10
lysate (lane 4).
Note there is no recognition of a band in A2 which is not present in the other two
serotypes.
Fig 6.14. Western blot on an SDS PAGE gel probed with rabbit antiserum raised
against the copper /zinc superoxide dismutase of Haemonchus contortus.
Molecular weight markers (lane 1), A1 lysate (lane 2), A2 lysate (lane 3) and T10
lysate (lane 4).













compared to IgG and whole serum. Fig 6.12 then shows the SOD activity associated
with the albumin and was identified as the component binding SOD (in the same way
observed for whole serum). The activity seen on the gel correlates with the position
observed on the Coomassie stained gel of the proteins and the expected position of the
SOD if it had bound IgG.
Western blots of whole cell lysates of the three serotypes were probed with a rabbit
antiserum raised against the recombinant Cu/Zn SOD of the nematode Haemonchus
contortus. Fig 6.13 and 6.14 show that the antiserum did not recognise any Cu/Zn
SOD epitopes on P. haemolytica A2 or any of the other serotypes. This was the case
in both native PAGE (Fig 6.13) and SDS PAGE (Fig 6.14) gels showing that no cross
reaction exists of the enzyme under the conditions tested.
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6.9. Discussion
Detection of SOD in lysates using PAGE was a relatively simple procedure, although
activity in A1 was so low that visual detection of this serotypes was not always
reliable. To overcome this an assay was used alongside PAGE to confirm the results
and to detect subtle changes not obvious using PAGE.
The relative mobilities of the enzymes from the three serotypes differed markedly as
did the strength of the activity. A2 possesses one enzyme which has SOD activity
greater than that of the other serotypes combined. This enzyme was also not induced
under certain growth conditions as is the case with other organisms from the
Haemophilus, Actinobacillus and Pasteurella (HAP) group (Kroll et al., 1995)
suggesting the enzyme is under the control of a strong promoter. The relative
electrophoretic mobilities of the enzymes suggest that Al and T10 share one of the
SODs. The level of SOD activity in comparison to Al ( 6 times greater) may be
explained by the presence of two enzymes in T10. These differences suggest a
diversity not only within the Pasteurellaceae but also within P. haemolytica itself.
Identification of the enzyme was a straightforward procedure with serotype A2. Both
the gel and assay inhibition studies with KCN identified for the first time a Cu/Zn
SOD in P. haemolytica. This was confirmed by PCR and southern hybridisation
techniques developed by this group (Lainson et al., 1996). Serotypes Al and T10,
however, were not inhibited by any of the standard inhibitors applied. Because T10
possesses two SODs, neither of which is a Cu/Zn SOD, it may be assumed to have
one Fe and one Mn SOD, one of which is shared with serotype Al. This distinction
between the inhibition of the Cu/Zn SOD and the lack of inhibition of the Al and T10
enzymes may be due to structural differences. Cu/Zn and Fe/Mn are two separate
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families of SODs, and there is a complete lack of DNA, protein or structural
homology between the two. It may also be the case that the use of a whole lysate
means that other enzymes may be present and these may have Cu, Zn, Mn or Fe at
the active site which may interfere with inhibition. In the case of inhibition with H202,
a characteristic catalase reaction (a violent evolution of bubbles) was observed with
A1 and A2. This may explain the lack of inhibition of the A1 enzyme. In contrast,
T10 is catalase-negative and so does not explain the lack of inhibition with this
serotype. The levels of inhibitors investigated should have overcome any of these
effects. A purified enzyme or active recombinant enzyme from A1 and T10 may help
in their identification. A PCR based technique similar to that used for the Cu/Zn
enzyme could be employed, as was the case for Haemophilus spp with unreproducible
inhibition using KCN whereby the authors switched to a molecular identification
system (Kroll et al., 1995). The inhibitors EDTA and H202 have been used in
numerous studies at the same and lower concentrations than those in this study, yet no
inhibition was observed. The A2 SOD was markedly, but not completely inhibited by
KCN indicating the analytical system was appropriate for the definition attempted.
The insensitivity of the SODs to inhibition may indicate that the conformations of the
bacterial enzymes, in particular at the active site differ from existing defined SODs. In
contrast the active site of Cu/Zn SODs is highly conserved even though its other
domains show little cross-reactivity between species (Hassan, 1989; Kroll et al.,
1995). This high degree of conservation may explain the clear inhibition with KCN
observed with A2. A new type of SOD was described in 1983 by Beaman et al. for
Norcardia asteroides and contained Mn, Fe and Zn. The enzyme was closely related
to the Mn SOD of Mycobacterium smegmatis. It was inhibited by H202 and was
therefore a Fe SOD but only 40% of the activity was associated with this. The SODs
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of A1 and T10 remain uncharacterised and in the light of current knowledge are
relatively novel.
Bacterial Cu/Zn SODs have been shown to be periplasmic. Caulobacter cresentus and
Brucella abortus have been shown to possess two types of SOD with one (Fe or Mn)
in the cytosol and a Cu/Zn SOD in the periplasm (Steinman & Ely., 1990; Stabel et
al., 1994). Haemophilus spp have been shown to secrete Cu/Zn SOD in E. coli
minicells carrying the cloned sod c gene and the presence of an N-terminal leader
peptide motif in other species has led to the authors' surmise that this is evidence for
periplasmic location of the enzyme ( Kroll et al., 1991; 1995). Superoxide generated
in the cytosol as a byproduct of normal respiratory metabolism does not pass through
the membrane into the periplasm. Thus periplasmic SOD is thought to deal with
externally generated superoxide (Hassan, 1979). Some organisms secrete SOD into
the medium and these include Mycobacterium tuberculosis (Kusnose et al., 1976)
and Norcardia asteroides (Beaman et al., 1990), whose secretion has been shown to
protect it from the killing effects of neutrophils. Investigation of the location of P.
haemolytica and P.trehalosi SODs was carried out in the light of the identification of
a Cu/Zn SOD. Methods based on those described by Stabel et al. (1994) and Lainson
et al. (1991), using various detergents and solvents were used to separate periplasmic
and cytoplasmic fractions. The freeze thaw technique was reproducibly less harsh on
Pasteurella spp and gave the least observable cytoplasmic contamination. This was
controlled by the parallel measurement of malate dehydrogenase, an enzyme which
takes part in Kreb's cycle and is unique to the cytoplasm. Al and A2 had 83.8 % and
75.2% of SOD activity respectively therefore the SODs were periplasmic, whereas the
T10 enzyme remained cytoplasmic (59.1% of activity). This result for A2 brings the
serotype into line with other Cu/Zn SODs identified so far. Al SOD location was
236
unexpected although the results correlated with these obtained by the chloroform
method. The cytoplasmic location of T10, was surprising, especially as two enzymes
were clearly present.
It was thought that the location may depend on the growth environment. The SOD of
C. cresentus locates preferentially in the periplasm in stationary phase growth
(Schnell & Steinman, 1995), whereas an environmental signal such as changes in
oxygen or iron availability may stimulate secretion into the periplasm and this has
been shown for the manganese SODs of the fish pathogen Aeromonas salmonicida
(Barnes et al, 1996) and mucoid Pseudomonas aeruginosa (Polak et al., 1996).
Although the overall SOD activity from iron restricted cells was reduced for all
serotypes, T10 did contain measurable activity located in the periplasm when cultured
under these conditions. The location of A2 SOD had not changed but Al SOD was
confined to the cytoplasm. Another indication of induced transport across the inner
membrane was when whole bacteria were assayed for their resistance to externally
generated superoxide. T10 and A2 were unaffected by the presence of external
superoxide, whereas Al did not survive for 30 minutes. This indicates the possible
movement of the enzymes due to environmental signals, which locate the enzymes
where they are most required. In the case of Al, although it has been shown to be
periplasmic in resting cells it is comparatively not of a high activity and so resistance
is low in in-vitro assays. Serum bactericidal activity results in a loss of viability after
only 15 minutes at dilutions of 1 in 100 (M. Maley, pers comm). It may be that, in-
vivo, 30 minutes during infection may be long enough to ensure bacterial survival
when structural features and virulence factors are taken into account. It now appears
that it is possibly the location of the enzyme that is important and not so much the
metal found at the active site.
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The lack of techniques to produce isogenic mutants for pasteurellae led to the use of
some A7 strains which were Cu/Zn SOD positive and negative. This could give some
information on the possible importance of Cu/Zn SODs when directly compared to
other strains which do not differ in any obvious way (M. Maley, pers comm). The
results were surprising in that those which appeared resistant to the effects of
superoxide were the strains negative for Cu/Zn SOD. Those strains which were
positive showed a survival similar to that observed previously for Al. This adds
weight to the assumption that other factors may be involved in resistance to
superoxide. These strains were not assayed for their location of the enzyme which
may play a more important role. Steinman (1993) investigating C. cresentus found
that Cu/Zn SOD deficient mutants were also sensitive to citrate, which arose from a
reduced affinity for magnesium and calcium. Those results suggested to the author
that Cu/Zn SOD protects the cell envelope functions which bind Mg2+ and /or Ca2+ by
the stabilisation of LPS, though this was deemed to be unlikely. However, if the
enzyme was compartmentalised in the periplasm it could have some selective
advantage. Simpson et al. (1989) showed that Pseudomonas aeruginosa alginate
scavenges free radicals from macrophages. It is possible then, that, other
polysaccharide molecules may have the same properties.
In-vitro assays with macrophage survival also gave no evidence as to the role of SOD
in protection of possible oxygen-dependent killing mechanisms. Only two strains
survived for 2 hours in both ovine and bovine macrophages and one was positive and
one negative for Cu/Zn SOD. This situation could arise if some of the organisms
entered via complement receptors which have been shown not to trigger the release of
oxygen intermediates ( Tsolis et al., 1995). These strains were not opsonised and so
this would be unlikely. Leukotoxin production will interference with macrophage
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function and was possibly produced during the course of the assay. These results do
indicate the presence of other factors in protection of the bacteria and question the
importance placed upon Cu/Zn SODs. Latimer et al. (1992) produced a Cu/Zn SOD
mutant in Brucella abortus which showed no difference in a mouse virulence model
with the wild type, this was in agreement with Tatum et al. (1992) who showed that
survival and growth of mutant strains were comparable to wild type strains in both
HeLa cells and J774 macrophages. The study did reveal that in contradiction to
Latimer's work, mutant strains in BALB/C mice had 10 fold lower splenic recovery of
organisms of the vaccine strain used but the virulent strain splenic levels were again
lower and spleen weights in mutants were consistently lower. Mandel (1975)
investigating Staphylococcus aureus found no correlation between SOD content and
virulence in mice. Exogenous SOD did not enhance mouse lethality whereas catalase
did and although phagocytosis could not be impaired, on catalase addition the ability
of the phagocytes to kill in-vitro was impaired. These results indicate the importance
of catalase which can follow superoxide dismutation in catalysing the conversion of
hydrogen peroxide to oxygen and water. Franzon et al. (1990) found that with
Shigella flexneri the Fe SOD was important in pathogenesis and catalase appeared to
make a limited contribution.
Analysis of immune reactions against SOD indicated that no specific response was
raised against any of the enzymes tested. A study by Beck et al. (1990) identified an
antigenic protein of Brucella abortus recognised by bovine convalescent serum and
this turned out to be Cu/Zn SOD. Brucella abortus however, showed lack of immune
response in-vivo and failed to demonstrate a cell-mediated response when synthetic
peptides were used in cattle (Stevens et al., 1994). When observing the effects of
Cu/Zn SODs, the high degree of conservation of the active site (85%) must be taken
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into consideration. The raising of antibodies against an enzyme which is also shared
with the host could have catastrophic repercussions to the host. This may be why the
Cu/Zn SOD rabbit antiserum did not cross react with the enzyme in A2 as those
regions of surface antigenic domains to which a response would be raised are less
conserved.
It is not known whether the binding of albumin is specific and /or significant.
Albumin is recognised as a carrier protein but its role in binding SOD may be purely
co-incidental. During acute phase response albumin scavenges divalent cations and
may bind SOD because of the metal active site, but as the enzyme is not inactivated it
is not particularly advantageous to the host.
The presence of periplasmic SODs has been proposed as important, not only during
the protection of phagocytic respiratory burst, but also from oxygen radicals generated
at the tissue surface and the mucus during colonisation (Pruitt et al., 1994; Salyers &
Whitt, 1994). It has also been suggested that SOD may not be as important in defence
and it is the subsequent production of hydrogen peroxide (Kroll et al., 1995) where
the advantage lies. This has been shown to disrupt ciliary function (Burman & Martin,
1986) and would be advantageous for a respiratory pathogen like pasteurellae. The
presence of a periplasmic Cu/Zn SOD in A2 and not in Al shows a phenotypic
difference which may confer an advantage for the organism in vivo. A2 is by far the
most prevalent serotype isolated from nasopharyngeal carriers and ovine pneumonic
and septicaemic cases. In P.trehalosi, T10 is also prevalent in tonsillar carriage and
systemic disease cases. This may indicate that the periplasmic induction or presence
of SOD may play a role in its ability to colonise and cause disease in areas of the host
which are not under oxygen stress, or in the case of pneumonia those areas which are
under oxygen stress.
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Characterisation of the enzyme alone does not give a specific role for the enzyme in
pathogenesis. The evidence for SOD mutants losing virulence is minimal, and it is
hoped that this may be rectified when more organisms are studied. The differences




INTERACTION OF P. HAEMOLYTICA AND P. TREHALOSI WITH OVINE
AND BOVINE ALVEOLAR MACROPHAGES
7.1. Introduction
The alveolar macrophage is the first line of host defence against bacterial invasion of
the lower respiratory tract. Serotype A1 is an important pathogen in ruminants
particularly in cattle. The interaction with bovine bronchoalveolar macrophages has
been extensivley studied but few reports deal with the interaction of ovine
macrophages with serotypes A2 and T10 both of which are significant serotypes as
causative agents of pasteurellosis. This study sets out to compare the interaction of all
three important serotypes with both ovine and bovine macrophages, especially in light
of the data concerning superoxide dismutase production. In observing the effects of an
interaction on both bacterial survival and effects on the macrophage it is hoped that
these will produce greater knowledge of the interactions.
7.2. Survival of bacteria in macrophages
A phagocytosis assay was developed to determine the survival of P. haemolytica and
P. trehalosi in ruminant macrophages. Live Pasteurellae cells were incubated with
macrophages (isolated from healthy adult sheep) for a set period of time ( either 15,
30, 45, 60, 90 or 120 mins), followed by addition of gentamicin to kill extracellular
organisms. The only viable bacteria are those located internally which are then
released from the macrophages (after cell lysis) and counted. Fig 7.1 (for raw data see
Appendix II) shows the survival over time for serotypes Al, A2 and T10 in ovine
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alveolar macrophages (OAM). After 2 hours incubation A2 showed the highest
number of surviving bacteria followed by A1 then T10. Using bovine alveolar
macrophages (BAM), A2 was again the best survivor followed by T10 with A1
showing no survival after 45 minutes (Fig 7.2, for raw data see Appendix II).
Although A1 did not survive well in BAM, a 1 hour incubation period was chosen for
further studies (this is a common incubation period for many studies which have been
undertaken with macrophages and pasteurellae or components of pasteurellae) to
monitor more closely the interactions taking place.
Listeria monocytogenes and Listeria ivanovii were used as controls. Listeria
monocytogenes is a known intracellular pathogen of macrophages and other cell types,
Listeria ivanovii in contrast is similar but is regarded as less virulent. Both species
were only sampled at the end of the experiment (2 hours incubation) and showed little




Fig 7.1. Phagocytic survival of serotypes Al, A2 and T10 by ovine alveolar
macrophages. As controls the intracellular pathogen Listeria monocytogenes and
another Listeria spp L. ivanovii were used but sampled only at the end of the
experiment. The average inoculum (Log 10 cfu/ml) was L. monocytogenes - 8.3 and L.
ivanovii - 8.4. After 2 hours incubation these were L. monocytogenes - 6 and L.
ivanovii - 6.1.
Macrophages were incubated for various times with the serotypes then any
extracellular bacteria were killed by the addition of gentamicin. The macrophages
were washed then lysed and viability determined by plating onto blood agar to
determine the number of live bacteria which were intracellular. Results were




Fig 7.2. Phagocytic survival of serotypes Al, A2 and T10 by bovine alveolar
macrophages. As controls the intracellular pathogen Listeria monocytogenes and
another Listeria spp L. ivanovii were used but sampled only at the end of the
experiment. The average inoculum (Log 10 cfu/ml) was L. monocytogenes - 8.3 and L.
ivanovii - 8.4. After 2 hours i ncubation these were L. monocytogenes - 5.7 and L.
ivanovii -6.1.
Macrophages were incubated for various times with the serotypes then any
extracellular bacteria were killed by the addition of gentamicin. The macrophages
were washed then lysed and viability was determined by plating onto blood agar to
determine the number of live bacteria which were intracellular. Results were
expressed as the mean of three separate experiments (see Appendix II).
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7.3. Effects of opsonisation on phagocytosis
This section looked at the effects of various pre-treatments of bacteria upon
subsequent survival of phagocytosis. Opsonisation by antiserum, heat-treated
antiserum (to destroy complement) and tbws ( to look at local lung responses) were
carried out to ascertain which, if any, would affect phagocytosis and survival by the
serotypes. In Fig 7.3, 7.4 and 7.5 (for raw data see Appendix II) when serotypes
were incubated with ovine convalescent antiserum and various other pre-treatments,
then added to OAM the number of bacteria which survived appeared to increase in
comparison to unopsonised bacteria. Although the results differed in the amount of
surviving bacteria when serotypes were compared (A2 and T10 surviving better than
Al), pre-treatments had no significant effect on survival of each individual serotype.
In BAM (Figs 7.6, 7.7 and 7.8, see Appendix II ) the serotypes, with respect to
survival, were similar to the results found with OAM. Certain pre-treatments appeared
to have deleterious or beneficial effects on bacterial survival but were not statistically
significant. Results for serotype comparisons did again show that their survival
differed from each other. Al again showed little or no survival of phagocytosis
whereas A2 survived better. T10 survived noticeably less than in OAM.
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Fig 7.3. Survival of serotype A1 after 1 hour in ovine alveolar macrophages
after being subjected to opsonins for 15 mins.
Serotype A1 was incubated alone, with convalescent antiserum (98), heat
treated convalescent lamb serum (98*) and ovine and bovine tbws and
incubated with ovine macrophages for 1 hour. Treatment post incubation is as
described previously (Fig 7.1) and results are the mean ofbetween 3 and 5
separate experiments (see Appendix II).
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Fig 7.4. Survival of serotype A2 after 1 hour in ovine alveolar macrophages
after being subjected to opsonins for 15 mins.
Serotype A2 was incubated alone, with convalescent antiserum (268), heat
treated convalescent lamb serum (268*) and ovine and bovine tbws and
incubated with ovine macrophages for 1 hour. Treatment post incubation is as
described previously (Fig 7.1) and results are the mean of between 3 and 5
separate experiments (see Appendix II).
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Fig 7.5. Survival of serotype T10 for 1 hour in ovine alveolar macrophages
after being subjected to opsonins for 15 mins.
Serotype T10 was incubated alone, with convalescent antiserum (112), heat
treated convalescent lamb serum (112*) and ovine and bovine tbws and
incubated with ovine macrophages for 1 hour. Treatment post incubation is as
described previously (Fig 7.1) and results are the mean ofbetween 3 and 5
separate experiments (see Appendix II).
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Fig 7.6. Survival of serotype A1 for 1 hour in bovine alveolar macrophages
after being subjected to opsonins for 15 mins .
Serotype A1 was incubated alone, with convalescent antiserum (98), heat
treated convalescent lamb serum (98*) and ovine and bovine tbws and
incubated with bovine macrophages for 1 hour. Treatment post incubation is as
described previously (Fig 7.1) and results are the mean ofbetween 3 and 5
separate experiments (see Appendix II).
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Fig 7.7. Survival of serotype A2 for 1 hour in bovine alveolar macrophages
after being subjected to opsonins for 15 mins.
Serotype A2 was incubated alone, with convalescent antiserum (268), heat
treated convalescent lamb serum (268*) and ovine and bovine tbws and
incubated with bovine macrophages for 1 hour. Treatment post incubation is as
described previously (Fig 7.1) and results are the mean ofbetween 3 and 5
separate experiments (see Appendix II).
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Fig 7.8. Survival of serotype T10 for 1 hour in bovine alveolar macrophages
after being subjected to opsonins for 15 mins .
Serotype T10 was incubated alone, with convalescent antiserum (112), heat
treated convalescent lamb serum (112*) and ovine and bovine tbws and
incubated with bovine macrophages for 1 hour. Treatment post incubation is as
described previously (Fig 7.1) and results are the mean of between 3 and 5
separate experiments (see Appendix II).
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7.4. Cytotoxicity of the serotypes for macrophages
The possibility that macrophage death caused by cytotoxicity of bacteria for the
macrophages may have been responsible for the low viable counts emerging from the
previous study was investigated. If the internal bacteria lysed the macrophages they
would have been released into the medium and killed by the gentamicin present. A
commercial cytotoxicity kit which measures the release of lactate dehydrogenase from
lysed cells was used to test this hypothesis. In OAM (Fig 7.9, for raw data see
Appendix II) A1 showed the lowest killing of macrophages (10%) followed by A2
(20%) and T10 (50%). Opsonised antiserum did not alter the killing. With BAM (Fig
7.10, for raw data see Appendix II) the killing of macrophages was slightly lower
than that observed in OAM but antiserum slightly increased killing in comparison to
unopsonised bacteria. This slight increase was, however, similar to that of
unopsonised bacterial effects in OAM. An experiment which allowed the overnight
incubation of bacteria with macrophages in the presence and absence of gentamicin in
the medium (data not shown) was carried out to record the final outcome of
phagocytosis. Microscopic analysis showed the absence of macrophages, except in
control wells (macrophages alone) indicating total lysis of all macrophages. The wells
which contained no gentamicin showed observable bacterial turbidity, which on
subculture produced pure cultures of each representative serotype. In contrast the
wells which contained gentamicin in the medium showed no bacteria or macrophages.
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SEROTYPES (with opsonisation)
Fig 7.9. Killing of ovine alveolar macrophages by serotypes incubated alone or
post opsonisation (indicated by the number of the homologous convalescent
serum). Bacteria were incubated with the macrophages for 1 hour and the
macrophages were then subjected to the cytotoxicity assay (Promega kit) as





Fig 7.10. Killing of bovine alveolar macrophages by serotypes incubated alone
or post opsonisation (indicated by the number of the homologous convalescent
serum). Bacteria were incubated with the macrophages for 1 hour and the
macrophages were then subjected to the cytotoxicity assay (Promega kit) as
described in Chapter 2
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This shows that all macrophages were eventually killed and on lysing, the cells were
then released into the medium to re-infect other cells with the result that bacteria with
no gentamicin present were allowed to continue replicating whereas those in the
presence of gentamicin were killed.
7.5. Bacterial entry mechanisms into macrophages
Bacteria can enter cells via different mechanisms; direct invasion of cells (not
applicable in this study), phagocytosis which uses actin microfilament formation
within the cell and receptor-mediated endocytosis which employs microtubule
formation via tubulin formation. The latter two mechanisms have been used
extensively in the study of bacterial and virus uptake into cells via the use of specific
inhibitors (Roof et al., 1992; Schlegel et al., 1982; Bass et al., 1995). Cytochalasin D













































Table 7.1. The effect of inhibitors on the uptake of P. haemolytica and P.trehalosi by
ovine alveolar macrophages. Macrophages were pre-incubated with inhibitors for at
least an hour prior to bacterial incubation.
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In OAM (Table 7.1) T10 uptake appears to be prevented by both CD and MDC
which indicates the organism employs both uptake mechanisms. A1 was inhibited
only by MDC and A2 by CD indicating differing mechanisms of receptor-mediated
uptake and phagocytosis respectively. The effects differed in BAM (Table 7.2) and






CYTOCHALASIN D A1 0, 0,0 0 0
CYTOCHALASIN D A2 0, 0,3 1 1
CYTOCHALASIN D T10 0, 0,3 1 1
MONODANSYL
CADAVERINE
A1 0, 0,3 1 1
MONODANSYL
CADAVERINE
A2 0, 0,0 0 0
MONODANSYL
CADAVERINE
T10 0, 0,0 0 0
Table 7.2. The effect of inhibitors on the uptake of P. haemolytica and P.trehalosi by
bovine alveolar macrophages. Macrophages were pre-incubated with inhibitors for at
least an hour prior to bacterial incubation.
7.6. Bacterial location during macrophage interaction
The use of a differential fixation technique and subsequent staining allowed the
location of the bacteria to be monitored. The use of methanol which permeabilises the
macrophage cell membrane allows the visualisation of both intracellular and
extracellular bacteria. Fixation with formaldehyde allows extracellular bacteria only to
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be observed. The difference, therefore, between the two allows a distinction between
intra- and extracellular bacteria to be calculated. The differences in staining









Al 47.7 11.8 88.2
A2 69 70.2 29.8
T10 66.7 18.1 81.9
Table 7.3. Table showing the number of ovine macrophages infected with P.
haemolytica and P. trehalosi and the subsequent ratio of intracellular and extracellular
bacteria.
Table 7.3 shows that in OAM just under 50% of the total number of macrophages
present were infected when incubated with Al. This infection rate was 69% with A2
and 66.7% with T10. There was a dramatic difference between the numbers of
intracellular and extracellular bacteria present in the infected macrophages. A2
contained 70.2% intracellular organisms, whereas this was only 11.8% for Al and








Al 45.7 16.2 83.8
A2 78.7 42.3 57.7
T10 70.3 22.6 77.4
Table 7.4. Table showing the number of bovine macrophages infected with P.
haemolytica and P. trehalosi and the subsequent ratio of intracellular and extracellular
bacteria.
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The pattern was very similar in BAM (Table 7.4) with infected macrophages at
45.7%, 78.7% and 70.3% for Al, A2 and T10 respectively. A2 extracellular bacteria
(57.7%) were higher than intracellular (42.3%). These numbers were still higher than
those observed for Al and T10 intracellular bacteria (Al-16.2%, T 10-22.6%). Al and




Fig 7.11. Photographic representation of T10 interaction with ovine alveolar




The intracellular survival ofphagocytosed pasteurellae was monitored over a two hour
period. Phagocytosis was a rapid event with intracellular bacteria detected at 15
minutes. The numbers of viable intracellular bacteria detected declined over the period
of time monitored. A2 were detected in larger numbers than A1 and T10 in both OAM
and BAM. Serotype A1 fared better than T10 in OAM whereas in BAM the situation
reversed indicating the two serotypes had a reduced ability for survival in both
macrophage types. A decline in Log 10 viable counts of 3-4 logs at 15 minutes
indicated that a substantial number of the bacteria were extracellular at this point and
were killed by the gentamicin present in the media. Contradictory results for P.
haemolytica A1 phagocytosis in macrophages have been reported. Benson et al.
(1978) showed a poor rate of phagocytosis, wheras in contrast Maheswaran et al.
(1980) showed that 90% of the bacteria were phagocytosed. Wilkie et al. (1990) also
showed rare ingestion of pasteurellae by BAM and the inability of macrophages to
phagocytose in-vitro after in-vivo infection with P. haemolytica has also been
reported (Walker et al., 1980). Walker et al.( 1984) compared log phase grown cells
with those in decline phase and found that log phase bacteria were not phagocytosed
whereas those in decline phase were. When comparing results, the source of
macrophages, the bacterial growth phase, incubation times all have different effects
on the outcome. Any prior exposure to pasteurellae will have an effect on the
subsequent ability of macrophages to deal with the organism. In this study a pooled
sample of bovine macrophages were used from frozen stocks. In contrast ovine
macrophages showed poor viability and adherent capabilities from frozen stocks and
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so fresh macrophages from different animals were used. This did show some degree of
animal to animal variation, hence the use of repeated experiments and the inclusion of
standard errors in results. The subsequent decline in bacterial numbers observed over
time could be due to killing of bacteria by macrophages. However, killing of
macrophages by bacteria could also cause a decline in bacterial numbers, as bacteria
released from lysed macrophages encounter gentamicin-containing medium.
Gentamicin leakage into macrophages has been identified as a cause of loss of
viability of the intracellular bacterium Listeria monocytogenes when investigated in
murine macrophages (Drevets et al. 1994). The L. monocytogenes and L. ivanovii
controls in this experiment were unaffected by the presence of gentamicin in this
study and may indicate a difference between the uptake of gentamicin by ovine,
bovine and murine macrophages. It would also have been expected that if this was the
method of killing, then the overnight incubation in the presence of gentamicin would
result in some intact viable macrophages remaining. It must be taken into
consideration, however, that if the toxicity of the bacteria was due to leukotoxin this
would be unaffected by the presence of gentamicin once it is released by the
organisms. Leukotoxin, also at low concentrations, could have many detrimental
effects on macrophage function such as the downregulation of MHC class II
molecules (Hughes et al., 1994). As respiratory burst or other phagocytic killing
mechanisms were not measured it is not known whether the macrophages were
activated and therefore macrophage killing of the bacteria is also unknown. As the
numbers of L. monocytogenes remained high at the end of the experiment it seems
likely that destruction of the macrophages is the most likely cause of the decline in
bacterial viability. This result indicates that pasteurellae has no capacity for extended
survival in macrophages such as those reported for the intracellular pathogens L.
monocytogenes and Rhodococcus equi or the recently reported Bordetella pertussis
which is a respiratory pathogen (Friedman et al., 1992; DeChastellier & Berche, 1994;
Hondalus & Mosser, 1994) due to its toxicity for macrophages.
A 1 hour incubation period was chosen to monitor the interactions of the bacteria and
macrophages to gain a clearer insight into the mechanisms involved. As it was likely
that a number of macrophages were being killed during the incubation period a
cytotoxicity assay was used to measure this effect. Surprisingly few ovine
macrophages were killed by serotypes Al and A2 whereas at least half were killed by
T10. The killing was increased slightly with Al and T10 in the presence of antiserum
but not with A2. The pattern was repeated with bovine macrophages with A2
antiserum this time increasing killing slightly. Sutherland & Donachie (1986), using
bovine macrophages at a ratio of 1:1 bacteria to macrophage (lower than this study),
found higher killing of macrophages with Al and A2 with T10 giving similar results.
The differences between percentage killing may be due to the detection method for
dead cells. Sutherland & Donachie (1986) used trypan blue exclusion, a method
which identifies dead cells by their permability to the dye and they appear blue under
the microscope, whereas this study used LDH release, apparent only during cell lysis.
A drawback of this assay in comparing the status of bacteria and macrophage at this
time period is that damaged cells will lose their ability to adhere ( Markham & Wilkie
1980a) and in assays measuring phagocytosis they will be removed during washing
steps and account for the lack of observable macrophages. The cytotoxicity assay does
not employ washing steps so the number of killed macrophages is a measure of dead
cells but does not take into account for those which are damaged and have
subsequently lost their ability to adhere.
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Monitoring the effects of various pre-treatments on phagocytosis showed there was a
trend for certain pre-treatments to have certain effects on the serotypes indicating the
possible involvement of antibody and/or complement to varying degrees. However,
when phagocytosis of opsonised A1 bacteria in OAM and BAM was investigated it
was found that there was no significant difference in the treatments. Survival of A1
was repeatedly low, therefore, either A1 was not entering the macrophages (resistant
to phagocytosis) and/or was engulfed and killed efficiently by the macrophages. The
high level of survival with A2, regardless of pre-treatment, is in contrast to that of
Al. A2 survived well and it appears this serotype must have been intracellular. The
uptake was not affected by pre-treatments and was still phagocytosed in the absence
of antiserum. This suggests other possible mechanisms such as a lectin,
lipopolysaccharide binding or mannose/fucose- N-acetylglucosamine terminated
glycoprotein-containing receptors on macrophages involved in uptake. T10 showed
similar patterns of phagocytic uptake in OAM to that already observed for A2. In
BAM T10 were similar to Al.
Sutherland (1989) demonstrated a significant increase in phagocytosis of A2 in OAM
with opsonisation. Active serum complement was seen to induce significant
opsonophagocytosis, although complement-mediated opsonisation could not be
shown to be synergistic with antibody-mediated opsonisation. Results using purified
IgG indicated this to be the major opsonin present in serum. The process of uptake via
complement confers an advantage for some bacteria as entry via C3b and C3bi
receptors inhibit the release of toxic oxygen species (Wright & Silverstein, 1983) in
the phagocytes (ie. no respiratory burst). This may indicate that the uptake of A2 and
T10 (in OAM) via a variety of mechanisms could still induce an oxidative burst and
would therefore need to withstand this attack as the results of viable organisms have
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suggested. Earlier results presented in this thesis may suggest a possible explanation
in the presence of superoxide dismutase. The ability of A2 and T10 to withstand an
attack by superoxide has been demonstrated, whereas A1 is not as capable at
surviving in the presence of superoxide. If A1 has the capacity to enter macrophages
via complement receptors which do not induce the release of superoxide, superoxide
dismutase will not be required by the bacteria to protect them from the effects of
respiratory burst, which may be the case.
The use of tbws on the effect of macrophage uptake was also investigated. These had
no effect on survival of phagocytosis in comparison to the untreated bacteria.
Markham & Wilkie (1980b) had reported the inhibition of phagocytosis in
macrophages in the presence of broncho-alveolar washings. Although the
predominant antibody present in BAW is IgG which, if specific for pasteurellae,
would enhance uptake, a substantial amount of IgA is present and would block uptake
as there are no IgA receptors on macrophages. There may be, therefore, inhibitory
factors present in BAW (Markham & Wilkie, 1980b). They showed that serum
antibody could compete with the inhibitory effect, indicating that during disease the
increased presence of serum antibody could increase uptake. In the absence of serum
antibody killing of pasteurellae would rely on bactericidal effects as reported by
McDonald et al. (1983).
Different entry mechanisms into macrophages in the absence of antiserum was
demonstrated for the serotypes in OAM but not as evident in BAM. Bacterial entry
into cells has been investigated by a number of authors by using cytochalasin D (CD)
and monodansyl cadaverine (MDC). Brucella abortus entry into vero cells ( Detilleux
et al. 1991) was inhibited by both CD and MDC, the latter in a dose dependent
manner. CD was shown to inhibit uptake of B. pertussis in human macrophages with
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MDC having no effect (Friedman et al. 1992). This was also the mechanism of entry
for the organism in HeLa 229 cells and human respiratory epithelial cells (Ewanowich
et al. 1989). Al enters ovine macrophages by what appears to be receptor-mediated
endocytosis (RME), whereas in bovine macrophages the mechanism was
inconclusive. This is the opposite with A2 as phagocytosis occurs in ovine
macrophages. T10 was inhibited by both treatments in ovine macrophages. There may
be a lack of effect of the inhibitors on BAM and this needs more attention. As Al and
T10 were later found to be predominantly extracellular, entry is an ambiguous
measurement with these serotypes. Other inhibitors could be employed and more
experiments may pinpoint the exact mechanisms involved. The end result of
internalisation is the same regardless of the mechanism and it is unknown whether the
difference in uptake results in one type of killing mechanism being induced against
which the bacteria has defences. A larger study would increase the understanding of
the mechanisms and outcome, as would the extension of the study to other phagocytic
cells.
The investigation of extracellular versus intracellular bacteria suggests that
especially in serotype A2 there is no evasion of phagocytosis. Mustafa (1995) reported
increased uptake of opsonised killed A2 with the serum containing high anticapsular
titres. In bovine macrophages the prior incubation with purified capsular
polysaccharide reduced the phagocytosis of Al (Czuprynski et al., 1991b). Both of
these reports infer that capsule can hinder phagocytosis and that the presence of
anticapsular antibody would abrogate that effect. The results presented here suggest
that A2 is phagocytosed and can survive intracellularly in comparison to the other
two serotypes. It appears that Al and T10 do possess evasive factors and that they
can exert an equally toxic effect on the macrophages by adhering to the surface of the
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cell. The observation of A1 and T10 bacteria on the surface of the macrophages of
both species may account for the lower recovery of viable bacteria from phagocytosis
assays as they would be susceptible to the gentamicin. The possession of O-antigen
LPS on A1 and T10 observed in an earlier chapter may indicate the possibility of
binding of LPS to lipopolysaccharide binding protein which in turn binds to CD 14 on
the macrophage.
There are many differences between the interactions of the three serotypes
investigated on the two macrophage species. These could be investigated further
preferably with the use of isogenic mutants deficient in selected structures and
virulence factors which would point to where these differences lie. The end result of
the interaction is death of the macrophage regardless of these differences. The obvious
difference in the A2 serotype of large numbers of intracellular bacteria which enter
via a variety of mechanisms and which appear not to be affected by macrophage
killing mechanisms deserves more attention. A1 and T10 possess mechanisms which
enable them to effectively evade phagocytosis and this needs to be investigated
further. The results indicate that the presence of antibody or complement does not
enhance phagocytic clearance and specific antibodies may enhance this. Initial
clearance in the lung may require high levels of bactericidal activity. It may be that
cytokines play an important role in the induction of specific killing mechanisms and
are not being stimulated or are being blocked by bacterial factors. Specific IgA at the
upper respiratory tract (URT) mucosal surface to prevent colonisation would possibly
reduce the cases of pasteurellosis. Such research would also lead into areas of




The initial studies in this thesis focused on the use of serum and tracheobronchial
washings as culture medium in order to imitate in-vivo growth conditions. Many of
the induced proteins have been previously described but few have undergone
extensive characterisation. Western blotting utilising convalescent lamb serum also
revealed antibody recognition of antigens some of which have been described
previously. These particular antigens are of interest in vaccine improvement and
require further characterisation. Each serotype responded differently in each of the
culture fluids represented by the differences observed in the bacterial and
immunogenic profiles. Only A2 in-vivo bacterial cells were available for comparison
with the culture fluid grown bacteria. The profiles of proteins from otbw and serum
cultures were similar to the in-vivo grown samples particularly in terms of
immunogenicity. The main focus were the IRPs as many of these proteins are already
well characterised. In most cases serum-grown bacteria produced IRPs at molecular
weights already reported. There was however, a lack of recognition of the A2 35 kDa
IRP by the convalescent lamb serum. Whether the effects observed are due to induced
or reduced expression or maybe just changes in the epitopes which the antibodies
recognise remains unknown and deserves more attention. The capsular polysaccharide
showed various size capsules depending on the culture medium, and the lack of
observable LPS from btbw culture highlights adaptation to various environments by
Pasteurella spp. Antigen recognition of LPS and leukotoxin showed little cross
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reaction when samples were probed with heterologous antiserum and this may have
important implications for protection.
The in-vivo fluids sustained viability of the three serotypes beyond that expected.
There was obvious species specificity for survival only in ruminant and murine fluids
which maintained viability and favoured survival in tbws rather than serum as survival
fluids. This has implicated respiratory tract secretions in the ability to maintain
bacteria in long-term survival at low nutrient concentrations. Survival in water was
also observed and though this was only for a few days it has important implications
for the spread of the disease by susceptible animals in the vicinity of an infected
animal. The morphology of the bacteria changed dramatically and this is similar to
that observed for other organisms undergoing starvation/survival. Serotype A2 was
substantially more robust than the other serotypes. Whether this was linked to the fact
that A2 is the most common nasopharyngeal isolate of both sheep and cattle is yet to
be investigated.
Chapters 3 and 4 highlighted the requirement for a method where the isolation of in-
vivo bacteria would have been useful for further analyses of the bacteria. The IMS
technique was relatively successful with even non-specific binding reduced where
there would not be any interference with analysis. This study highlighted the possible
differences not only between in-vitro grown and in-vivo isolated bacteria but also
between those which colonise and those which are present in diseased tissue. There
was also evidence that colonising P. haemolytica and P. trehalosi possessed
mechanisms which evade immune defences and the future of protection against
pasteurellosis may be improved by stimulation of mucosal immunity and the
prevention of colonisation.
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Superoxide dismutase was readily detected in all 3 serotypes. A2 was different in that
it possessed a periplasmic copper/zinc SOD. This enzyme was, however, no more
effective against the effects of superoxide when compared to the enzyme in serotype
T10. As whole bacterial lysates were used in this study, a purified enzyme or isogenic
mutant deficient in the SOD gene would help in defining a role for the enzyme in
pathogenesis.
The three serotypes again differed in their interaction with alveolar macrophages.
These differences were observed mainly with serotype A2 which survived
phagocytosis the longest. All serotypes caused the eventual death of all macrophages
present. Phagocytic uptake and survival was high for A2 in the absence of
convalescent serum components and this suggests differences in receptor uptake
mechanisms. This was apparent by the substantially higher ratio of intracellular-
located A2 in comparison to the other serotypes which were predominantly
extracellular which for A1 and T10 suggest phagocytic evasion mechanisms. All
serotypes eventually overcome the macrophage and extended investigations into the
mechanisms involved and to stimulate factors which may participate in the effective
removal of the bacteria.
This thesis has shown serotype A2 to be very different in all ways investigated from
the other two serotypes. This is not entirely an isolated view. Davies & Donachie
(1996) have recently shown that serotype A2 rRNA analysis places the serotype into
a separate group. This ability of A2 to adapt and survive in the host results in an
organism extremely pathogenic for sheep and it appears that protection against this
serotype will prevent the majority of deaths from pasteurellosis. Serotype T10 was
reclassified recently into a separate species and has not been extensively researched. It
may in the future receive the attention it deserves due to the similarity of the disease
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produced to septic shock in other species, and there are good animal models available
for study in sheep. T10 is a successful organism as demonstrated by its ability to
withstand superoxide attack and to cause substantially more damage to macrophages
than the other two serotypes, even with the presence of a comparatively less potent
leukotoxin. The importance of serotype A1 in bovine pasteurellosis cannot be ignored
even though it appears to be deficient in effective mechanisms when compared to A2
and T10.
All three serotypes possess aspects which require more attention in order to
understand the pathogenesis of the disease and allow progress towards better
protection. It must be stressed that the in-vivo situation should always be prominent in
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1) Method of Jackson & Burrows (1956)
4.12g KH2P04 in 300ml of distilled water (pH 6.8 - 8.0 with NaOH)
2.24g Glucose (3.7ml of 60% solution) *
0.53g NH4CL
0.53g (NH4)2 S04 in 100ml of water
0.12g DL-phenylalanine
0.06g DL-methionine









lml Biotin (1.25 mg/L)
O.lg Mg S04 7H20
lml Zn S04 7H20 (0.01%)
lml Mn S04 7H20 (0.01%)
lml Lactic acid (4% v/v)
20g Agar
Medium was made up to 1L adjusted to pH 7 with NaOH.
Broth was made by omitting agar.
Iron replete contained 0.025g haemin in 0.01M NaOH, in iron restricted medium this
was omitted.
* made separately and filter sterilised.
2) Method ofHu et al. (1986)
32.3g Na, HP04 12H20
1.36g KH2P04
1.19g NaCL















15g of agar per litre was added to produce solid media.
This medium should contain <0.02pg/ml of iron so for replete broths and agar 50pM
FeCl3 was added.
















2.10g Citric acid *
4.36g K2HP04*
0.278g Fe S04 *







pH to 7.4 and add 15g of agar for solid medium.
* in 100ml of distilled water pH to 6.5 with NaOH.
Fe S04 omitted in iron restricted media.
SDS PAGE for protein detection.
2 x 0.75 mm 10% gels
Resolving gel - 15.9ml Distilled water
10 ml Buffer (1.91g tris, 0.4g SDS, water to 100ml, pH 8.8)
12.7ml Acrylamide ( 30% BDH)
2.22g Sucrose
15)4.1 TEMED
15 Op Ammonium persulphate
Stacking gel - 4ml Distilled water




Electrode buffer - 14.4g Glycine
3.03g Tris
lg SDS
Make up to 1L with distilled water.
Coomassie blue - lg Coomassie brilliant blue R250 (Sigma)
100ml Glacial acetic acid
500ml Methanol
400ml Distilled water
Dissolve overnight and filter through a Whatman's No 1 filter paper. Pour directly
onto the gel and stain for a minimum of 2 hours.
Destain - 70ml Glacial acetic acid
230ml Methanol
700ml Distilled water
Pour off stain, add destain and change until required staining is achieved.
Silver Stain - step 1- 50% Methanol
10% Glacial acetic acid
step 2-5% Methanol
7% Glacial acetic acid
step 3 - 10% Glutaraldehyde
step 4 - Prolonged washing overnight.
step 5 - 500pl lmg/ml dithiothreitol
step 6-0.1% Ag N03
step 7 - Rinse in distilled water
step 8 - Rinse in developer (3% Na^Oj, 50pl of 37% formaldehyde in
100ml of water), develop to staining requirement.
step 9 - Terminate development with 2.3M citric acid.
Western Blotting
Electrode buffer 3g Tris
14.42g Glycine
250ml Methanol
To 1L with distilled water
Blot wash buffer 5ml Tween 20
0.37g EDTA
20.45g NaCl
100ml lOx PBS (400g NaCl, lOg KC1, 57.5g Na2HP04, lOg
KH2P04 distilled water to 5 litres)
To 1L with distilled water
PAGE for detection of LPS
2 x > 0.75 mm 14% gels











Stacking gel - 3.5ml Distilled water





Electrode buffer - 6.057g Tris
28.827g Glycine
2g SDS
Make up to 2L with distilled water.
PAGE for SOD detection
2 x 0.75 mm 7% gels




















Electrode buffer - 9g Tris
43.2g Glycine



















All viable counts are the mean of triplicate counts from duplicate samples
* Denotes mixture of normal and micro-colonies
0 Denotes addition of fresh fluid
\ Denotes no growth on agar
mc denotes micro-colonies only
Fig 4.1a RAW DATA
DATE DAY A1 A2 T10
30/11/93 0 1.1X105 4x10s 2.2xl05
1/12/93 1 5X108 1.2x10s 2.3xl08
14/12/93 14 1X106 3xl05 \
6/1/94 37 3X105 3xl05 mc
2/3/94 92 1.3X106 7xl05 \
21/3/94 111 1.6X105 2xl05 \
22/7/94 244 mc 0 6xl05 0 mc
25/7/94 247 mc 0 lxlO4 0 mc
27/7/94 249 1.2x10s 4x105 mc
9/8/94 264 mc 4xl05 mc
31/8/94 286 \ 8xl07 \
28/9/94 314 mc 5x10s \
Fig 4.2a RAW DATA
DATE DAY A1 A2 T10
31/8/93 0 3X108 1.2xl09 9x10s
1/9/93 1 1.3X108 1.8x10s 8xl07
3/9/93 3 6X106 3xl06 7xl07
6/9/93 6 5X106 4xl05 7xl06
28/9/93 28 5X105 6xl05 1.5x10s
27/10/93 59 9X105 9xl05 2.4x104
2/11/93 65 5X105 4xl05 1.5x10s
10/11/93 73 5X105 4xl05 6x10s
23/11/93 86 4X105 5x10s \
1/12/93 94 7X105 4xl05 1.5x10s
14/12/93 107 1.5X105 4.8xl05 mc
6/1/94 130 9X105 5xl05 mc
13/1/94 137 2.4X105 2.7xl05 mc
3/2/94 158 1.3X105 1.8x10s mc
2/3/94 185 6X105 4xl05 mc
21/3/94 204 1X105 2xl05 mc
22/7/94 337 5X103 0 7xl04 0 mc
25/7/94 340 mc 0 mc 0 mc
27/7/94 342 lxlO4 4xl05 \
9/8/94 357 mc 3xl06 9xl04
31/8/94 379 mc lxlO7 \
28/9/94 407 mc 6xl05 mc
Fig 4.1b RAW DATA
DATE DAY A1 A2 T10
1/3/94 0 1.2X106 4X105 6xl05
2/3/94 1 3X104 3X104 8xl04
21/3/94 20 1X103 1X104 mc
22/3/94 153 7X103 0 mc 8xl03 0
25/3/94 156 2.2X104 0 1.4xl04 0 3xl04 0
27/3/94 158 1.1X104 lxlO4 3xl04
9/8/94 173 9X106 4xl06 lxlO7
31/8/94 195 8X104 \ 1.4xl05
28/9/94 203 2X106 5x10s 6xl05
Fig 4.2b RAW DATA
DATE DAY A1 A2 T10
1/3/94 0 5X109 7X107 2xl07
2/3/94 1 1X106 1X105 2xl05
21/3/94 20 2X105 6X104 lxl 03
22/7/94 153 1X104 0 6X103 0 4xl04 0
25/3/94 156 ocoO>< mc 0 mc 0
27/3/94 158 7X104 6xl03 mc
9/8/94 173 2X104 lxlO4 lxlO3
31/8/94 195 3X107 9xl06 \
28/9/94 203 9X104 3xl03 mc
Fig 4.1c RAW DATA
DATE DAY A1 A2 T10
30/11/93 0 1.1X105 4X105 2.2X105
1/12/93 1 8X107 2X108 2X107
14/12/93 14 3X107 5X106 1.2X107
6/1/94 37 4X106 5X105 9X106
2/3/94 92 3X106 6X106 1.6X107
21/3/94 111 2X105 3.1X105 1.5X105
22/7/94 244 1.5X104 1X106 2X105
25/7/94 247 1.2X104 4X105 5X105
27/7/94 249 1.5X105 7X105 1.8X106
9/8/94 264 4X103 1X106 8X105
31/8/94 286 \ 9X105 5X10s
28/9/94 314 3X106 2X105 5X105
Fig 4.2c RAW DATA
DATE DAY A1 A2 T10
30/11/93 0 11X109 o©so oOo
1/12/93 1 2.3X108 1.5xl09 6xl07
14/12/93 14 1.1X107 2xl07 lxlO7
6/1/94 37 1.2X107 6xl06 2xl06
13/1/94 44 1.4X107 1.5xl06 1.3xl07
3/2/94 65 1.3X106 5x10s 5xl06
2/3/94 92 1X107 l.lxlO6 2xl07
21/3/94 111 4X105 4xl05 2.5xl06
22/7/94 244 1X104 2xl05 2.2xl05
25/7/94 247 mc 1x10s 3xl05
27/7/94 249 mc 2xl05 lxlO6
9/8/94 264 3xl03 1.9xl05 3xl05
31/8/94 286 5xl04 4xl05 6xl05
28/9/94 314 mc 2xl06 2xl06
Fig 4.Id RAW DATA
DATE DAY A1 A2 T10
30/11/93 0 1.1X105 4X105 2.2xl05
1/12/93 1 4X108 1.2X109 5xl07
14/12/93 14 2X106 7X105 lxlO5
6/1/94 37 1.7X106 6X104 2xl06
2/3/94 92 3X107 9X107 4xl06
21/3/94 111 1.1X107 1.5X106 2xl06
22/7/94 244 4X103 4X105 6xl05
25/7/94 247 1X104 2X104 7xl04
27/7/94 249 1.3X106 1.1X106 1.3xl06
9/8/94 264 1X104 4X104 5x10s
31/8/94 286 3X104 mc mc
28/9/94 314 2X104 7xl04 3xl05
Fig 4.2d RAW DATA
DATE DAY A1 A2 T10
30/11/93 0 11X109 lOxlO10 10x10'°
1/12/93 1 1X108 oooT—(X 7xl07
14/12/93 14 8X107 9xl06 8xl06
6/1/94 37 1.4X107 1.4xl07 7xl06
13/1/94 44 2.8X107 1.5xl07 2.2xl07
3/2/94 65 9X106 6xl06 6xl06
2/3/94 92 6X107 3xl06 2xl07
21/3/94 111 3X106 4xl05 4xl06
22/7/94 244 2X105 5x10s 4xl06
25/7/94 247 2X104 6xl04 1.3x10s
27/7/94 249 7X105 mc 2x10s
9/8/94 264 3X105 4x10s lxlO4
31/8/94 286 mc 1.5xl06 3xl06
28/9/94 314 mc 2x10s 2x10s
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Abstract
Representative strains of Pasteurella haemolytica serotypes A1 and A2 and Pasteurella trehalosi serotype T10 were examined
for the presence of superoxide dismutase. Visualisation of superoxide dismutase enzyme activity on polyacryiamide gels, and
specific inhibition with potassium cyanide verified a copper/zinc (Cu/Zn) superoxide dismutase only in serotype A2 whereas
serotypes A1 and T10 showed other superoxide dismutase activity. Using a simple freeze-thaw method the cellular location of
superoxide dismutase enzyme activity was determined in all three serotypes. In serotypes A1 and A2 but not T10 superoxide
dismutases were located in the periplasm. The viability of serotypes A2 and T10 cells in the presence of exogenous superoxide
was unchanged over a 30 min period, whereas serotype A1 cells declined in viability between 15 and 30 min. Purified
immunoglobulin from sheep convalescent serum did not reduce superoxide dismutase activity in the serotypes in an in vitro
assay. The presence of this enzyme within the pasteureilae suggests a supportive role in the virulence of this major pathogen of
ruminants.
Keywords: Pasteurella-, Superoxide dismutase; Periplasm
1. Introduction
Pasteurella haemolytica, a Gram-negative bacte¬
rium responsible for pneumonia in all ages of sheep,
comprises 13 identifiable serotypes of which A2 is
the most prevalent cause of pasteurellosis in the
U.K. Pasteurella trehalosi, which was until recently
classified as the T biotype of P. haemolytica [1]
* Corresponding author. Tel.; +44 (131) 664 3262:
fax: +44 (131) 664 8001.
causes systemic disease in young lambs and older
sheep [2], Both species colonise the upper respiratory
tract of apparently healthy sheep, with P. haemoly¬
tica residing mainly in the nasopharynx and P. tre¬
halosi in the tonsils.
Superoxide dismutases (SOD) are metailoenzymes
that catalyse the conversion of highly toxic superox¬
ide radicals to hydrogen peroxide and oxygen. Three
distinct forms of SOD have been identified; iron
(Fe), manganese (Mn) and copper/zinc (Cu/Zn).
The first two are common in the cytoplasm of pro-
0378-1097/97/S17.00 0 1997 Published by Elsevier Science B.V. All rights reserved
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karvotes and Mn SOD is also present in the mito¬
chondria of eukaryotes. Cu/Zn SODs are found in
the cytoplasm of eukaryotes and were thought to be
unique to these organisms until their discovery in the
fish bacterium Phoiobacterium leionalhi [3], Since
then. Cu/Zn SODs have been identified in an increas¬
ing number of bacteria, especially in Gram-negative
bacteria and including P. haemolytica [4], It is
thought that possession of this enzyme contributes
to the bacterium's ability to cause disease and/or
survive in its host [5]. Although the potential role
of SOD in pathogenesis has been investigated using
molecular biology little is known about its role in
vivo [3,6.7].
2. Materials and methods
2.1. Bacterial strains and culture
P. haemolytica serotype Al (strain M4/1/2, iso¬
lated from calf lung), A2 (strain 124/92, isolated
from sheep lung) and P. trehalosi T10 (strain 152/
94, systemic disease isolate) were maintained at
Moredun Research Institute as reference strains
itored at — 70°C. All bacteria were grown on 7%
■heep blood agar (Oxoid) or in nutrient broth No. 2
Oxoid) at 37°C overnight.
'.2. Bacterial lysates and native PAGE
These were prepared according to the method out-
ned by Lainson et al. [4],
J. SOD assay
This was carried out according to the manufactur¬
es instructions (RANSOD kit. Randox, Co.. An-
im. U.K.). Samples were mixed with substrate,
id xanthine oxidase was added to start the reaction,
bsorbance of samples and standards were read at a
—avelength of 500 nm after 30 min incubation at
om temperature.
I. Malate dehydrogenase assay
The assay was carried out following the method
—scribed in the Worthington Enzyme Manual [8].
2.5. Inhibition studies of SOD
These experiments were carried out to identify the
type of SOD in the bacteria. EDTA inhibits all SOD
types, hydrogen peroxide inhibits Cu/Zn and Fe
SODs and potassium cyanide inhibits only Cu/Zn
SOD [3]. Prior to electrophoresis or assay, samples
were incubated for 30 min with final concentrations,
in aqueous solutions, of 5 mM potassium cyanide.
5 mM hydrogen peroxide or 5 mM EDTA. During gel
staining the inhibitors were also present in the nitro-
blue tetrazolium (NBT) and riboflavin solutions.
2.6. Preparation of periplasmic and cytoplasmic
fractions
Bacterial cultures (20 ml) were washed twice in
phosphate buffered saline, pH 7.4 (PBS) and resus-
pended in 500 ul of PBS. The cell suspensions were
then frozen at —20°C and thawed at 37°C at least 10
times. After centrifugation at 11 000 Xg the superna-
tants (periplasmic fraction) were removed for assay.
The remaining bacterial pellets were lysed using the
beadfbeating method described previously [4] to re¬
lease cytoplasmic contents. All periplasmic and cyto¬
plasmic contents were assayed for SOD activity and
malate dehydrogenase (the latter acts as a cytoplas¬
mic marker) [9].
2.7. Bactericidal assay
Bacterial cultures were grown in nutrient broth at
37°C with shaking for 4.5 h. The bacteria were
washed twice in PBS and resuspended in 0.1 M phos¬
phate buffer pH 7.5. Using a microtitre plate, the
contents of control wells containing xanthine (0.05
mM). 2-(4-iodophenvl)-3-(4-nitrophenol)-5-phenvlte-
trazoiium chloride (INT, 0.025 mM) in 0.1 M phos¬
phate buffer pH 7.5 and 0.002 units of xanthine ox¬
idase were mixed and the production of visual
formazan dye monitored to show that production
of superoxide had occurred. As INT is toxic to Pas-
teurella this was omitted from the test wells. Control
samples contained xanthine, buffer and bacteria at
10° cfu/ml-1. Experimental wells had xanthine, xan¬
thine oxidase and the same bacterial inoculum. The
plate was incubated at 37°C and 10 pi samples were
removed at times 0. 15 and 30 min. Samples were
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Fig. I. Native PAGE gel of bacterial lysates (5 |il loaded) stained
for SOD activity. Lane 1, serotype Al (17.35 units SOD activity
in 0.15 mg protein); lane 3. serotype A2 (472.7 units SOD activ¬
ity in 0.055 mg protein); lane 3, serotype TIO (112.2 units SOD
activity in 0.045 mg protein).
diluted serially, plated onto 7% sheep blood agar in
duplicate and incubated at 37°C overnight.
-.8. Reactivity with antiserum
Antiserum was raised in specific pathogen-free
lambs inoculated with live P. haehiolytica or P. tre-
halosi cells. Briefly the lambs [10] were inoculated
intratracheally with 2 ml and subcutaneouslv with
1 ml of a 106/ml_i bacterial suspension at 0 and 3
weeks. A final intranasal inoculation with 2 ml of a
l09/ml~' bacterial suspension was administered
2 weeks later. Seroconversion of the lambs was
monitored using western blot analysis of bacterial
envelope preparations and an indirect haemaggiuti-
nation assay. Negative control serum was obtained
from specific pathogen-free lambs infected with orf
virus.
To determine whether specific IgG bound to and
inhibited SOD activity, 10 u.1 of sample was mixed in
a total volume of 100 mg ml-1 of purified IgG [11] in
0.1 M Tris/HCl pH 8. This was incubated with mild
agitation at room temperature for 1 h. Protein G (5
ml Protein G insolubilised on Sepharose 4B. Fast
Flow, Sigma) was added and incubation continued
for a further 30 min. Samples were centrifuged and
the supernatant removed and assayed using the Ran-
sod kit.
3. Results and discussion
Superoxide dismutase activity was detected readily
in crude lysates of all three serotypes (Fig. 1). Differ¬
ences were observed in the electrophoretic*mobilities
of the enzymes from the three serotypes and T10
showed two zones of activity. The levels of activity
measured in the assay correlated with the strength of
reaction observed on the gel. The three serotypes
therefore contain different isoforms and levels of ac¬
tivity suggesting a diversity not only within the Pas-
teurellaceae but also within P. haemolytica itself.
Inhibitors of SOD activity were used to identify
SOD types. Table 1 shows clearly that potassium
Table 1
Superoxide dismutase activity in the presence of the inhibitors KCN. HiOi and EDTA
Serotype Control (H-.O) KCN HjO: EDT
Al 6.7(0.7) 6.8(0.6) 7.1(0.5) 7.9(4.2)
A2 274.8 (86.2) 51.2 (10.1) 296.3 (95.5) 221.3 (102)
T10 102.6 (28.2) 104.8 (27.9) 116.0 (32.9) 157.2(71.9)
Results are expressed as mean (4 separate experiments) SOD units mg"1 protein showing the standard error of the mean in brackets. Controls
contained HoO and the concentration of inhibitors was 5 mM in each case. Inhibition of enzyme activity is defined as a decrease of £50°.'• of
the control activity.
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Time (mins)
'ig. 2. Survival of serotypes Al, A2 and T10 by viable count in the presence of exogenous superoxide. Controls (open symbols) omitted
nly xanthine oxidase and samples (bold symbols) contained xanthine oxidase to initiate superoxide generation. □, Al; a, A2; O. T10;
, Al; a, A2; •, T10.
yanide inhibited only A2 SOD activity (81.4% in-
ibition) thus confirming it as a Cn/Zn SOD. No
thibition of the SOD of any serotypes could be
chieved with EDTA or H2O2 even at elevated mo-
irities (data not shown). The inhibitors EDTA and
[2O2 have been effective in numerous studies at the
tme or lower concentration than those in this study
:t no inhibition was observed here. The A2 SOD
as markedly, but not completely, inhibited by KCN
dicating that the analytical system was appropriate
■r the definitions attempted. The insensitivity of the
her SODs to inhibition may indicate that the con¬
formations of the bacterial enzymes, particularly at
the active site, differ from existing defined SODs. In
contrast, the active site of Cu/Zn SODs is highly
conserved, even though its other domains show little
antibody cross reactivity between species [3,5], and
this may account for the clear inhibition by cyanide.
The SODs of Al and T10 remain uncharacterised
and in light of current knowledge are relatively nov¬
el.
Bacteria have been shown to possess SOD en¬
zymes in the periplasm and the periplasmic location
of SOD has also been indicated by the presence of an
ble 2
sasurement of SOD and malate dehydrogenase activity from preparations of peripiasmic and cytoplasmic contents using a freeze-thaw
thod
mple Units of SOD activity
mg"1 protein




% Location of malate
dehydrogenase
periplasm 52.3 0.01 83.8 2.4
cytoplasm 10.1 0.4 16.2 97.6
periplasm 475.3 0.009 75.2 . 23.
cytoplasm 156.5 0.03 24.8 77
) periplasm 24.6 0.04 40.9 33.3
) cytoplasm 35.5 0.08 59.1 66.7
;ation is expressed as a percentage of the combined activity of both cytoplasmic and peripiasmic contents.
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N-terminal leader peptide sequence [5,12], Superox¬
ide generated in the cytosol does not pass through
the cytoplasmic membrane inta the periplasm. Thus
periplasmic SOD is thought to deal with external
superoxide [13.14]. This prompted investigation
into the location of the enzyme in P. haemolytica
and P. irehalosi. Table 2 shows that SOD activity
was located in the periplasm of A1 (83.8%) and A2
(75.2%, Cu/Zn), but was in the cytoplasm of serotype
T10 (59.1%). It is possible that the location of T10
SOD may depend on the growth phase of the bac¬
teria as the SOD of Caulobacter cresentus locates
preferentially in the periplasm in stationary-phase
growth [13]. An environmental signal such as a
change in oxygen availability may stimulate secretion
into the periplasm although this may happen only in
vivo. Survival of T10 in the presence of exogenously
generated superoxide (Fig. 2) showed some indica¬
tion of the presence of such a mechanism. Serotype
A2 also possessed a good degree of resistance to
superoxide whereas A1 did not survive beyond 30
min. This effect was reversed when superoxide dis-
mutase was also added externally showing loss of
viability was due to superoxide generation (data
not shown). This experiment indicates that the pos¬
session of a Cu/Zn SOD or a periplasmic located
enzyme is not indicative of protection from super¬
oxide. In vivo, however, 30 min may be long enough
to ensure the bacteria survive the encounter espe-
201
daily when structural features and bacterial virulence
factors are taken into account.
To determine whether the enzyme elicited an im¬
mune response during infection, neutralisation of en¬
zyme activity was attempted using punned IgG from
homologous convalescent antiserum and compared
with control serum from orf virus infected lambs.
The results in Table 3 show a trend towards a reduc¬
tion in enzyme activity when specific antiserum and
protein G are present with serotypes A1 and A2 but
not T10. This result was, however, not statistically
significant. Specific antibodies neither neutralised en¬
zyme activity nor bound the enzyme as similar activ¬
ity was present when Protein G was incorporated
into the mixture. The absence of a significant anti¬
body reaction is not unusual. The lack of antibody
response to SOD in vivo has been shown with Bru¬
cella abortus, and the same study also failed to dem¬
onstrate a cell-mediated immune response [6],
This study has shown that the Cu/Zn SOD of P.
haemolytica serotype A2 is located in the periplasm
and that A2 does not appear to contain a second
SOD enzyme. The presence of the SOD enzyme
can be important in protecting the bacteria not
only during the respiratory burst of phagocytes but
also from oxygen radicals generated at the tissue sur¬
face and mucus during colonisation [15]. It has been
suggested that it may not be the production of SOD
which is important, but the subsequent production
Table 3
The effect of specific IgG on SOD activity
Sample Purified IgG source Protein G* Mean SOD units mg~l protein (S.H.)
At A1 antiserum - 4.5 (0.6)
A1 antiserum + 3.0 (0.4)
Control serum - 4.8 (1.1)
Control serum +■ 4.1 (0.7)
A2 A2 antiserum - 21.2 (3)
A2 antiserum + 16.6 (4.8)
Control serum - 23.6 (0.4)
Control serum + 24.6 (3)
T10 TI0 antiserum - 10.0 (3.3)
T10 antiserum + 6.0 (1.97)
Control serum - 8.2 (1.8)
Control serum + 5.4 (1.3)
, no Protein G; +, 100 p.g Protein G. Results are mean values of -A separate experiments. Control serum IgG was incorporated to ensure
that any reduction in activity was due to specific IgG. Antibody binding of SOD without loss of activity was controlled for by the presence or
absence of Protein G.
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of hydrogen peroxide [12]. This has been shown 10
interfere with ciliary function [16] and this disruption
would be advantageous for a respiratory pathogen
like P. haemolytica. Serotype A2 is by far the most
prevalent serotype isolated from nasopharyngeal car¬
riers and cases of pneumonic pasteurellosis [2] and
the presence of the Cu/Zn enzyme in A2 and not in
Al may confer an advantage for the organism in
vivo. The SODs from all serotypes tested do not
appear to elicit an antibody response in vivo even
though their periplasmic location would place them
in contact with the hosts immune system. While lo¬
cation is important, the type of SOD present may
confer an even greater advantage. The response of
whole bacteria to the effects of extraneous superox¬
ide indicates that resistance to superoxide cannot be
explained by characterisation of the enzyme alone
ind other factors must be taken into consideration.
Further investigation will clarify the putative role of
sOD enzymes in pathogenesis.
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Abstract
Fifty-two ovine strains of Pasteurella haemolytica and P. trehalosi representing serotypes 1-16 were examined for the
presence of [copper, zincjsuperoxide dismutase DNA sequences. This was done using a combination of polymerase chain
reaction with degenerate primers based on the sequence of the [Cu.Zn]superoxide dismutase gene (sodC) in related species and
Southern hybridization using a fragment of sodC from P. haemolytica A2 serotype as a probe. Both detection methods
identified a fragment of the sodC gene in 9/9 strains of P. haemolytica serotype 2 examined and in 5/8 strains of serotype 7. No
evidence of this gene was found in any other serotype of P. haemolytica or in any P. trehalosi serotype. Comparison of DNA
sequence showed near identity between sodC from the A2 and A7 serotypes of P. haemolytica and substantial similarity (70%)
to sodC previously sequenced in P. multocida, Haemophilus parainfluenzae and H. influenzae. Analysis by gel electrophoresis of
the superoxide dismutase activity present in cell lysates showed that one or more superoxide dismutase is present in all
serotypes. However, cyanide-inhibitable activity, corresponding to [Cu.ZnJsuperoxide dismutase. was detected only in those
strains of serotypes A2 and A7 which showed evidence of the sodC gene fragment.
Keywords: Pasteurella haemolytica: [copper, zinc]Superoxide dismutase: sodC: Ovine; Superoxide dismutase
1. Introduction
Pasteurella haemolytica and P. trehalosi are impor¬
tant bacterial pathogens of sheep. Both species are
carried in a commensal state in the nasopharynx of
apparently healthy animals [1], but each causes a
different disease syndrome. P. haemolytica, of which
there are 13 recognized serotypes, produces pneumo¬
nic disease whereas the four serotypes of P. trehalosi
* Corresponding author.
produce a septicaemic infection. The factors which
cause the progression from commensal to pathogenic
behaviour are uncertain, but some bacterial factors
are recognised as putative virulence determinants.
These include leukotoxin, iron-uptake proteins and
lipopolysaccharide. Leukotoxin production has been
shown to lead to activation of lung neutrophils [2],
resulting in generation of an oxidative burst, produc¬
tion of oxygen-free radicals [3], and consequent host
tissue damage. While the damage caused to host cells
may facilitate bacterial survival, the products of the
oxidative burst are potentially highly detrimental to
0378-1097/96/S12.00 Copyright © 1996 Federation of European Microbiochemical Societies. Published by Elsevier Science B.V.
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Fig. 1. Alignment of [Cu.ZnJSOD peptide sequence from P. haemolytica A2 with P. multocida [7] and H. parainfluenzae [5]. Sequence
shown corresponds to residues 88-174 of the 187-amino-acid H. parainfluenzae protein [5]. Dots signify identity between adjacent se¬
quences: black arrowhead indicates an invariant Zn2+-ligand His; X indicates additional amino acids conserved across all known bacte¬
rial [Cu.ZnJSOD sequences, excluding the highly divergent Caulobacter crescentus peptide sequence; open arrowhead indicates a residue
previously found to be invariant in bacterial SODs.
the infecting bacteria, and factors allowing organ¬
isms to withstand their action may potentiate viru¬
lence.
Superoxide dismutase (SOD) is a key metallo-en-
zyme involved in the detoxification of oxygen-free
radicals. Single electron reduction of Op, achieved
through the action of cytochrome oxidase in the
course of aerobic metabolism or by NADPH oxidase
at the phagocyte membrane, generates superoxide
radical anion, which in a further series of reactions
leads to production of the highly toxic hydroxyl ra¬
dical. Mechanisms to remove free superoxide are
correspondingly widely found, three varieties of
SOD being recognised. In the bacterial cytosol,
iron- or manganese-cofactored SOD protects cellu¬
lar proteins and DNA from free-radical attack.
However, as the cytoplasmic membrane is imperme¬
able to superoxide, these SODs cannot dismute
superoxide produced outside the cell, for example
by neutrophils, leaving the cell surface and periplas-
mic contents vulnerable. A novel SOD. cofactored
by copper and zinc ([Cu.ZnjSOD) and encoded by
the gene sodC, has been described in the periplasm of
a wide range of Gram-negative commensal and
pathogenic bacterial organisms, including members
of the Haemophilus-Actinohacillus-Pasteurella family
[4-9], The part that this form of the enzyme plays in
bacterial biology is unknown, but it is appropriately
located to be involved in dismutation of superoxide
produced in the course of host defence against bac¬
terial infection and. as such, is a potential further
determinant of bacterial virulence. A polymerase
chain reaction (PCR) approach to the identification
of sodC genes has been developed based on se¬
quences conserved across a range of organisms [7].
Using this approach, coupled with Southern hybridi¬
zation and activity assays, we demonstrate here the
presence of [Cu.ZnJSOD in P. haemolytica, but not
in P. trehalosi, and show that it has a restricted sero¬
type distribution.
2. Materials and methods
2.1. Bacterial strains
Table 1 lists the ovine strains of P. haemolytica
and P. trehalosi (serotypes 1-16) examined in this
study. These were from a collection of reference
strains held at Moredun Research Institute.
2.2. [Cu.ZnJSOD activity detection on PAGE
P. haemolytica was plated on blood agar and
grown for 16 h at 37°C to form a bacterial lawn.
Bacteria scraped from the surface of the agar were
resuspended in 5 mM Tris-HCl buffer, pH 6.8, con¬
taining 1 mM EDTA, 0.5 mM NADP and DNAase
at 0.5 mg/ml and disrupted with a reciprocating bead
beater operating at 4000 cycles/min using washed 0.1
mm diameter 'zirconia' silica beads (Biospec Prod¬
ucts Inc., cat. no. 11079101Z) suspended in 0.5 vol.
of distilled water. Samples were centrifuged to re¬
move cellular debris and the protein concentration
of the supernatant determined using the BCA Pro¬
tein Assay Reagents (Pierce). Supernates were then
stored at —70°C. Total cellular proteins (10 ug) were
separated on a non-denaturing PAGE gel with a
4.5% (w/v. acrylamide) stacking gel. pH 6.8, and a
10% resolving gel, pH 8.8. SOD activity was detected
in the gel using the colorimetric method of Beau-
champ and Fridovich [10]. For specific inhibition
of [Cu,Zn]SOD activity potassium cyanide was
added at a final concentration of 5 mM.
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2.3. DNA manipulations
P. haemolytica strains were grown at 37°C over¬
night in shaken broth culture and genomic DNA,
prepared using the Genome DNA Kit (Bio 101),
was used as template in PCR amplification and in
Southern blot analysis. PCR was carried out using
Taq polymerase and buffer (Boehringer) with degen¬
erate oligonucleotide primers. 3'-univsod and 5'-univ-
sod [7], Thermal cycling conditions were 30 cycles of
denaturation at 94°C for 1 min; annealing at 45°C
for 1 min: extension at 72°C for 1 min. followed by a
single extension at 72°C for 10 min. Confirmation of
recovery of the sodC sequence from different strains
was obtained by PCR using nested primers P6748
(AAGGTGGCAAGCTCACAGCAG) and P6749
(TTCAAGCGAGGGGCTAATACT), constructed
on the basis of the DNA sequence determined
from the cloned fragment of the P. haemolytica sero¬
type A2 sodC gene. Thermal cycling conditions
were as before except that the annealing temperature
was raised to 51°C. PCR fragments were cloned into
the vector pCRII (Invitrogen) and the resulting plas-
mids propagated in E. coli JM109. DNA sequence





Fig. 2. Southern hybridization of ///ndlll-digested genomic DNA
from representative P. haemolytica serotype A2 and A7 strains
probed with the cloned sodC PCR product from P. haemolytica
serotype A2 strain 124/92 (pNTl). Lane 1, serotype A2 strain
124/92; lane 2, A2 strain M65: lane 3, A2 strain M64B; lane 4,
A7 strain L40I; lane 5, A7 strain D0800.
A
B
Fig. 3. Determination of SOD activity by gel electrophoresis. Ly-
sates of each of the strains of P. haemolytica and P. trehulosi
were separated by acrvlamide gel electrophoresis and stained for
superoxide dismutase activity without cyanide (A) or in the pres¬
ence of 5 mM potassium cyanide (B). Lanes contain extracts
from strains as follows: lane 1, serotype T10 strain L52E: lane
2. T3 strain M75; lane 3, A7 strain L45B: lane 4. A7 strain
L40I: lane 5. A2 strain 124/92; lane 6. Al strain L48D.
forward and reverse primers or primers constructed
on the basis of determined sequence and the fmol
DNA sequence system (Promega). For Southern
blot analysis, DNA was transferred to Hybond N
membrane (Amersham) as described by Smith and
Summers [11], DNA probes were cloned PCR frag¬
ments of sodC from P. multocida [7] or P. haemoly¬
tica serotype A2 strain 124/92 (pNTI) (this work).
Probes were labelled with digoxygenin (DIG) using
the DIG DNA random primed labelling system
(Boehringer). Blots were processed using the DIG
DNA luminescence detection system (Boehringer).
For detection of sodC in genomic DNA autoradio¬
graphy were typically exposed for 1-16 h depending
on the sensitivity required.
I
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Table 1
Fifty-two strains of ovine P. haemolytica and P. trehalosi, grouped according to serotype. + or — indicates the presence or absence of
sodC DNA sequences as determined by PCR or Southern hybridization, and [Cu.Zn]SOD activity as determined after non-denaturing
PAGE
Species/serotype" Strain PCR Hybridization15 [Cu.ZnJSOD activity
A1 D0652 - - -
L48D - - -
L47 - - -
A2 L48A + + (6.0) +
M53 + + (6.0) +
M64B + + (2.0) +
M65 + + (5.0) +
M103A + + (2.0) +
M105C + + (6.0) +
LI 1 IN + + (6.0) +
124/92 + + (6.0) +
D0136 + + (2.0) +
T3 T635 - - -
M75 - - -
L94CC - - -
T4 D0693 - - -
L55 - - -
M110A - - -
A5 R341B - - -
A6 D0135 - - -
L48E - - -
M61A - - -
A7 L48C + + (2.1) +
L40I - - -
L45B + + (2.1) +
M74 - - -
LI 11H + + (2.1) +
L131D + + (2.1) +
L94F - - -
D0800 + + (2.1) +
A8 D0200 - - -
C53 - - -
A9 D0775 - - -
L52I - - -
M76A - - -
T10 D0770 - - NT
L52E - - -
Ml 14 - - -
All B561 - - -
L52G - - -
L98B - - -
A12 DO 132 - - -
L59E - - -
M58 - - -
A13 D0804 - - -
L59D - - -
L62B - - -
I
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Table 1
(continued)






a A denotes/1, haemolytica and T, P. trehalosi.
b The figures in parentheses indicate the approximate size (kbp) of the restriction fragment identified by hybridization.
NT = not tested.
3. Results
The sodC gene was identified provisionally in P.
haemolytica serotype A2. strain 124/92, by Southern
hybridization using a gene probe prepared by PCR
from P. multocida [7](data not shown). The same
degenerate oligonucleotide primers. 3'-univsod and
5'-univsod. that had been used to recover sodC se¬
quence from P. multocida were used in PCR with
templates of chromosomal DNA from strains repre¬
senting each of the serotypes of P. haemolytica and
P. trehalosi (Table 1). By analogy with P. multocida.
recovery of a band of 304 bp was taken as prelimi¬
nary evidence of the presence of sodC. Such a band
was seen only with A2 and A7 serotypes of P. hae¬
molytica.
The PCR product from strain 124/92 was excised
from an agarose gel, cloned in the plasmid vector
pCRII to produce pNTl. and its identity as a frag¬
ment of sodC confirmed by nucleotide sequencing,
the deduced amino acid sequence being 71% identical
to the P. multocida and H. parainfluenzae sequences
(Fig. 1). Nested sodC oligonucleotide primers P6748
and P6749 were synthesized based on the 124/92 se¬
quence and used in PCR to confirm, by production
of a band of 169 bp, that the PCR products obtained
with 3'-univsod and 5'-univsod were in each case
derived from sodC. The PCR product from the sero¬
type A7 strain D0800 was also cloned (pNT2) and
sequenced, and the sequence compared to that from
the serotype A2 strain 124/92. The two were almost
identical (98% identity at nucleotide level. 100%
identity at deduced amino acid sequence level).
DNA sequences have been submitted to the EMBL
database. Accession numbers are U59225 for the A2
serotype and U59226 for the A7 serotype.
To ensure that local sequence variation was not
responsible for failure to detect sodC sequences by
PCR, the complementary Southern hybridization ap¬
proach was used. Genomic DNA samples from rep¬
resentative strains of P. haemolytica and P. treha¬
losi were digested with HindWl and examined by
Southern hybridization using pNTl as a probe
(Fig. 2. Table 1). The distribution across strains of
the sodC gene identified by hybridization was iden¬
tical to that determined by PCR. Positive signals
were obtained from 9/9 of the A2 serotype strains
and from 5/8 A7 strains tested. In each case the
probe reacted with a single fragment. In the A2
strains the fragment size showed variation: in five
strains the sodC gene was located on a 6 kb frag¬
ment, in one strain on a 5.0 kb and in three strains
on a 2.0 kb fragment. In each of the A7 hybridiza¬
tion-positive strains the fragment was 2.0 kb (Fig. 2).
None of the other serotypes showed a hybridization-
positive fragment even after extended autoradio¬
graphic exposure.
SOD activity corresponding to sotlC expression
was sought in all strains by detection of enzymatic
activity in polyacrylamide gel after non-denaturing
PAGE. Fig. 3 shows the pattern of expression of
SOD activity in various strains of P. haemolytica
and P. trehalosi. Only serotypes A2 and A7 exhibited
a band of SOD activity which could be inhibited by
KCN, indicating that this was [Cu.ZnjSOD (results
summarised in Table 1).
4. Discussion
[Cu,Zn]SOD activity and the sodC gene were de¬
tected in all P. haemolytica A2 serotype strains (9/9)
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and in some A7 serotype strains (5/8). None of the
strains in other serotype groups of P. haemolytica or
P. trehalosi showed evidence of [Cu,Zn]SOD activity
or of possession of the sodC gene. Two methods
were used to screen strains for a fragment of the
sodC gene. PCR detection provided a rapid screening
method but has the disadvantage that it may not
identify the sodC gene where there is localized se¬
quence heterogeneity at a PCR primer site. This
technique was therefore complemented by Southern
blot hybridization using as a probe the cloned sodC
PCR fragment recovered from P. haemolytica sero¬
type A2 strain 124/92. However, in all the P. haemo¬
lytica and P. trehalosi strains examined. PCR and
Southern hybridization identified the same set of
strains. Additionally, Southern blot analysis showed
that there is variation in the size of the //ffidlll re¬
striction fragment that the sodC gene is located on in
the A2 serotype. DNA sequence analysis demon¬
strated a very high degree of similarity (98%) be¬
tween A2 and A7 sodC fragments. These sequences
also show a substantial degree of similarity with the
sodC gene in the related bacterial species. H. parain-
fluenzae and H. influenzae (71%) [5]. In each of the
strains containing the sodC gene fragment, corre¬
sponding [Cu.ZnjSOD activity was also identified.
This situation differs from H. influenzae phvlogenetic
division II of serotypes a. b. e and f where, despite
the sodC gene sequences being present. [Cu.ZnjSOD
activity cannot be detected [5]. In the case of type b
this has been ascribed to a point mutation affecting a
crucial Cu2+ ligand. Resolution of SOD activity by
PAGE indicated that more than one form of SOD is
present in P. haemolytica. While only A2 and A7
serotype strains have [Cu.ZnjSOD activity, all sero¬
types express an additional form of SOD which is
not inhibitable by cyanide. Similarly P. trehalosi
strains contain non-[Cu.Zn]SOD activity. This has
not been characterized here but presumably repre¬
sents iron- or manganese-SOD.
In diseases caused by P. haemolytica and P. treha¬
losi, bacterial survival in the presence of activated
neutrophils is a central feature. The leukotoxin of
P. haemolytica Al. implicated in the pathogenesis
of bovine pasteurellosis, is a potent neutrophil acti¬
vator [2,3], and similarly neutrophil activation is a
feature of ovine pneumonic pasteurellosis caused by
a range of P. haemolytica serotypes. This activation
of neutrophils is attended by a burst of production
of superoxide and more toxic free-radical products
of its further reaction with hydrogen peroxide, but
factors in pasteurella strains conferring resistance to
their bactericidal action remain to be characterized.
We suggest that [Cu.ZnjSOD may play a part in this.
[Cu.ZnjSOD has been shown to be periplasmic. or
such a position is deduced by the presence of a lead¬
er peptide directing export from the cytoplasm in the
translated protein sequence, in all bacterial examples
studied [5.9,12-15], and it would seem reasonable to
infer that the pasteurella [Cu.ZnjSOD is similarly
located. A protective role has been demonstrated
for surface-exposed bacterial SOD in Nocardia aster-
oides. which shows reduced survival within macro¬
phages when the enzyme is inactivated by bound
monoclonal antibody [16]. It would be going too
far to suggest that [Cu.ZnjSOD is a crucial determi¬
nant of pasteurella virulence, as its distribution ap¬
pears to be restricted to A2 and certain A7 serotype
strains of P. haemolytica. while all serotypes can be
found as animal colonists or pathogens. Rather, it
might be that the enzyme modulates virulence, en¬
hancing the survival of serotypes in which it is found
and so increasing the risk of disease. It is striking
that A2 and A7 serotypes are those most commonly
isolated from ovine infection in Britain, with A2 ac¬
counting for 54"/> and A7 for 5% of clinical referrals
of ovine isolates to Moredun Research Institute in
1982-1993 [lj. It should be informative to character¬
ize further strains from diverse origins to establish
whether there is a true correlation between expres¬
sion of [Cu.ZnjSOD and productive infection.
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